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Zahid has a theory that autistic people
are the normal ones because they see
things as they really are while
neurotypicals add an extra layer of
meaning on to things.
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Network analyses, such as of gene co-expression networks are an important approach for
the systems-level study of biological data. For example, understanding patterns of
co-regulation in mental disorders can contribute to the development of new therapies and
treatments.
In a gene regulatory process a particular Transcription Factor (TF) or non-coding RNA
(ncRNA) can up- or down-regulate other genes, therefore it is important to explicitly con-
sider both positive and negative interactions. Although exists a variety of software and li-
braries for constructing and investigating such networks, none considers the sign of inter-
action. It is also required that the represented networks have high accuracy, where the inter-
actions found have to be relevant and not found by chance or background noise. Another
issue derived from building co-expression networks is the reproducibility of those. When
constructing independentnetworks for the samephenotype, though, usingdifferent expres-
sion datasets, the output network can be remarkably distinct due to biological or technical
noise in the data. However, most of the times the interest is not only to characterise a net-
work but to compare its features to others. A series of questions arise from understanding
phenotypes using co-expression networks: i) how to construct highly accurate networks;
ii) how to combinemultiple networks derived fromdifferent platforms; iii) how to com-
pare multiple networks.
For answering those questions, i) I improved the weighted Topological Overlap (wTO)
method to construct highly accurate networks, where now each interaction in a network
receives a probability. This method showed to be muchmore efficient in finding correct in-
teractions than other well-knownmethods; ii) I developed amethod that is able to combine
multiple networks into one building a Consensus Network (CN). This method enables the
correction for background noise; iii) I developed a completely novel method for the com-
parison of multiple co-expression networks, Co-expression Differential Network Analysis
(CoDiNA). This method identifies genes specific to at least one network. It is natural that
after associating genes to phenotypes, an inference whether those genes are enriched for
a particular disorder is needed. I also present here a tool, RichR, that enables enrichment
analysis and background correction.
I applied the methods proposed here in two important studies. In the first one, the aim
was to understand the neurogenesis process and how certain genes would affect it. The
combination of the methods shown here pointed one particular TF, ZN787, as playing an
important role in this process.
viii Abstract
Moreover, the application of this toolset to networks derived from brain samples of indi-
viduals with cognitive disorders identified genes and network connections that are specific
to certain disorders, but also found an overlap between neurodegenerative disorders and
brain development and between evolutionary changes and psychological disorders. Co-
DiNA also pointed out that there are genes involved in those disorders that are not only
human-specific.
Keywords: Co-expression networks; Networks Construction; Networks Comparison; Con-
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OMPLEX-SYSTEMS AND PHENOTYPES can be better understood by using co-expression
network analysis. In a co-expression network, genes are represented as nodes and
two genes are connected if they have a significant correlation on its expression. In
this approach the interest lies in pinpointing how two genes share co-expression patterns,
by doing so, we are allowed to characterise the network of a particular phenotype. Although
network approaches became central for understanding those phenotypes,methods for con-
structing highly accurate networks are still lacking.
Unfortunately, the construction of such networks depends on the data used as input.
This reliance on data results in networks that are not reproducible, and therefore, might not
represent the real gene-gene interactions in a particular system. Therefore, methods that
enable the construction of a network that combines multiple networks, and hencemultiple
datasets can result in a more informative and reproducible network.
Finally, in most of the studies, the interest does not lie in characterising one complex-
system but in comparing it under different systems. However, no method is available for
comparing multiple networks and classifying interactions and genes according to its pres-
ence in the conditions under investigation. Finding genes that are different or specific to
certain conditions can be used as signature genes that can allow for better treatments and
diagnosis in complex disorders, such as, mental illness.
I applied thosemethods in twostudies. Thefirst studyconcernsaboutunderstanding the
neurogenesis process. The interest lied in characterising new genes that highly involved in
that process. In a second study, the aimwas to find signature genes formental disorders and
understand if there is a co-regulation pattern of those disorders that are similar to infants or
other primates.
2 1. Introduction
1.1 Organisation of this PhD dissertation
This PhD dissertation is organised in three parts. In the first part, two chapters comprise a
short introduction to the underlying biology of the transcriptomics world (Chapter 2) and
an introduction to network theory that are used tomodel gene interactions derived fromco-
expression analysis (Chapter 3). Few definitions that did not completely fit in the text can
be found in the Glossary.
The second part of this dissertation contains the three methods I developed. All three
methods are available as R packages and can be easily downloaded from the Compreensive
R Archive Network (CRAN). The vignettes are available inside the package and a detailed
manual can be found on my web page https://deisygysi.github.io/rpackages/ and
in Appendix A, Appendix B. Chapter 4 refers to thewTO approach for constructing networks
and the CN, implemented in the wTO R package. This package is able to construct highly
accurate co-expression networks from expression and co-occurrence networks from abun-
dance data inmetagenomics, for independent samples, repeatedmeasures and time series.
Just by characterising one co-expression network one is allowed to better comprehend the
phenotype under study. However, often the interest lies in the comparison of at least two
networks andunderstanding its similarities, differences and specificity. Therefore, amethod
that allows for these comparisons had to be developed and it is described in Chapter 5, my
second methodology and R package CoDiNA. Chapter 6 concerns about a gene enrichment
method, implemented in a package, RichR, that given a list of genes and a list of disorders
allows for understanding if a particular disorder is enriched in the dataset. It is particularly
useful in a combination with CoDiNA for understanding the patterns of differential or spe-
cific co-expression.
The third part of this dissertation focus on the application of the methods. In the first
application (Chapter 7), the objective is to describe and understand how the micro RNA
124 (miRNA-124) can shape the neurogenesis process. For that, induced Pluripotent Stem
Cell (iPSC) cells wild-type and knocked out for this micro RNA (miRNA) were followed for 4
days, I build the networks using the wTO package. Later, I applied CoDiNA for the identi-
fication of specific genes and one gene pointed out by CoDiNA was over-expressed in wild-
type cells and followed for 14 days. The cells had higher levels of apoptosis and were not
perfectly functional neurons. In a second application (Chapter 8), I used a combination of
the three methods I developed to understand how cognitive disorders might be related. In
the first moment, the interest lies in neurodevelopmental disorders such as Parkinson’s and
Alzheimer’s diseases. Later, I am interested in pinpointing similarities and specificities of
othermental illness such as Autism SpectrumDisorder, Bipolar Disorder, Major Depression
Disorder and Schizophrenia. In the last part of this chapter, I want to understand the pat-
terns of co-regulation of the Prefrontal Cortex (PFC) that kept constant in the human lineage
when compared to other primates.
The conclusion and further perspectives are presented on Chapter 9 and focus on the
power of the toolset developed in this PhD project; it also shows other applications of the
methods in the following studies: HIV and Tuberculosis co-infection; Glioma and its sub-
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kinds; a metagenomics time series study of the fungi environment in a marine ecosystem.
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Part of the literature review presented in Chapter 3 is part of the invited headline review
under preparation.
• D. M. Gysi, T. M. Fragoso and K. Nowick. “Construction, comparison and evolution
of networks in biology, social sciences, economy, and humanities - or: what can we
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mitted.
• D.M. Gysi, T. M. Fragoso, V. Busskamp, E. Almaas and K. Nowick. “Co-expression Dif-
ferentialNetworkAnalysis: How to comparemultiple networks simultaneously?”. Sub-
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An introduction to transcriptomics
“Begin at the beginning, ” the King said, gravely, “and go on till you come to an end;
then stop.”
– Lewis Carroll, Alice in Wonderland
2.1 From cells to genes
A
LL LIVING ORGANISMS consist of cells. Like us, they can grow, reproduce, respond to
stimuli and at some point, die. Organisms can have only one cell that is able to
cope with their daily life or can be multicellular, like us, humans, where their cells
re-organise in particular ways that become specialists in a few tasks. For example, blood is
composed ofmany cell types: erythrocytes (red blood cells) are responsible for transporting
the oxygen; leukocytes (also known as white cells) are part of the immune system and are
important for fighting infections, and platelets play an important role in clotting the blood
at a wound.
What makes those cells different and able to perform well in different tasks are the dis-
tinct set of proteins they express. Proteins serve as structural components in a cell and can
change its shape according to temperature, ion concentrations and other stimuli and as a
consequence, act as a sensor. Proteins can be responsible for what comes in and leave a cell;
can act as catalysts allowing reactions to occur or enzymes that make those reactions faster.
Another important function of a protein is that it acts as a switch by turning a gene on or off.
I will discuss more this function in Section 2.2.
The information associated with each protein function, when or how it should be pro-
duced is stored in a long polymer known as Deoxyribonucleic Acid (DNA). This polymer’s
three-dimensional structure is a double helix consisting of two anti-parallel and reverse
complementary strands, each having 5′ and 3′ ends that coil around a common axis. The
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DNA is constituted of nucleotides, often referred to as bases, because they contain cyclic or-
ganic bases. These bases are commonly abbreviated as Adenine (A), Thymine (T), Cytosine
(C) andGuanine (G) and are attached to theDNA structure by a covalent bond andprojected
out of the helical backbone. Each one of those nucleotides binds to another nucleotide of
the other strand by a hydrogen bond in a base pairing that follows a general rule, A pairswith
T and C with G. This complementary matching is extremely strong, and when this bound is
broken, they spontaneously bind back, under certain biochemical conditions. This strong
hybridisation process is useful for detecting one strand on the absence of the other. The
DNA is able to copy itself in a process called replication. This process is important to keep
the exact same information in all cells.
The DNA structures itself in the way that its information is linearly stored into discrete
functional units called genes. A gene consists of DNA sequence and can be a recipe for con-
structing proteins, however, not all genes code for proteins. Genes vary a lot in size, in hu-
mans, they can be few hundreds DNA base pairs (bps) to more than 2 million bps. The Hu-
man Genome Project estimated that humans have around 20, 000 and 25, 000 genes. The
DNA can be found inside the nucleus of a cell, it complexes with a protein set called histone
to form a nucleosome. Another histone, the H1 histone, binds on the outside of the nucle-
osome and forms a chromatosome, that folds into itself to make an extra tight folding that
results in a chromosome.
Two coupled processes are used to transform the stored information inside theDNA into
proteins, together they are called gene expression. The first part of this process is called
transcription and the second translation. This two process coupled with the replication of
the DNA is so important that is commonly referred to as the central dogma of biology and
it is represented in Figure 2.1.
In the transcription process, the coding part of a gene is copied into a Ribonucleic Acid
(RNA). A large enzyme, RNApolymerase, binds to theDNA and uses it as a template to catal-
yse the nucleotides’ linkages into an RNAmolecule.
AnRNA strand is similar to the complementary 3′ −→ 5′DNA, however, it is a single strand
version and does not contain Timine (T) but Uracil (U) instead. The RNA has different func-
tions than the DNA, one of these functions, is to store short copies of parts of DNA for a
small time frame. In eukaryotes, this initial RNA is processed into a smaller version, called
messenger RNA (mRNA), that carries the information out of the nucleus to the cytoplasm.
Translation, the second process starts in the cytoplasm. There is amolecularmachinery,
part protein and part ribossomal RNA (rRNA), called ribosome decodes the mRNA into an
amino acid chain, also called polypeptide. Every three nucleotides in the RNA forma codon.
The ribosome decodes the information by binding the complementary transfer RNA (tRNA)
anticodon sequences to mRNA codons. The other side of the tRNA has a specific amino
acid according to a general rule called genetic code (Figure 2.2). Every amino acid can be
generated by multiple codes, but one code can generate one amino acid, it means that it is
redundant, but not ambiguous, hence the genetic code is said to be degenerate. The pro-
cess of binding an amino acid into each other is executed until a stop codon is reached; at
this moment the ribosome releases the polypeptide into the cytoplasm, that can be later
processed into a functional protein.
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FIGURE 2.1: Central dogma of biology, from DNA to proteins: DNA is copied into DNA by the replication
process. The information contained in the DNA is copied into an RNA by the transcription process, and the
RNA is decrypted into proteins by the translation process.
2.2 Gene Regulation
Even though our cells are specialised in different functions, we have exactly the same collec-
tion of genes, the genome, in almost all our cells. However, not all genes are being expressed
throughout the whole organism, in all its cells or at the same time. Hence, the organisms
know when and where particular genes have to be transcribed. The set of genes that are
active or inactive in each cell is different according to their functions, and most of the cells
can change its response according to external signals or different conditions. It means that
the genes that are active or inactive depend not only on the cell type but also on its environ-
ment or time-point. For example, the brain is composed by different types of cells such as
neurons, glia, astrocytes, oligodendrocytes, etc and they arrange in diverse ways inside the
brain, creating areas that are responsible for specific functions. Moreover, the gene expres-
sion of a particular brain area of an infant is different from the same area in an adult.
The control of gene activity depends on Transcription Factors (TFs). They are DNA-
Binding Protein (DBP) that, as the name says, are proteins that bind to theDNAand can acti-
vate or repress the transcription of particular genes. These proteins contain a domain, DNA-
Binding Domain (DBD), that is specifically designed for a set of genes, instead of recognis-
ing all the genes. This domains recognise a short specific DNA sequence containing around
6−12 bps. Those sequences are specific and do not occur often in the DNA, assuring the TF
specificity to activation or repression. Proteins that are essential to the gene regulatory pro-
cess, but do not have a DBD (such as coactivators, chromatin remodellers, histone acetyl-
transferases, histone deacetylases, kinases and methylases) are not TF. TFs can work alone
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FIGURE 2.2: Genetic code, from nucleotides to amino acids:. Starting from the centre of the circle and
working to the outermost circle, this figure represents which amino acid’s are encoded by which codon.
or be combined into multiprotein complexes to mediate the gene regulatory process.
A promoter is a DNA sequence where the RNA polymerase binds and starts the tran-
scription of a gene. Oftentimes, the promoter is located far away from where the TF binds,
this regulatory sites can be tens of thousands of base pairs either upstream (opposite to the
direction of transcription) or downstream (in the same direction as transcription) from the
promoter. The regulation of a single promoter can be a result of a series of TFs allowing, as
a consequence, complex control of gene expression.
This complex control can be formed by the promoter and a series of control elements,
located near transcription start sites and by sequences located far from the regulated genes.
Such elements can be: TATA box (a conserved sequence found around 25 to 35 bp upstream
of the start site) or initiators (unconserved sequence containing a C at the−1 position and
a A at +1). The genes that are regulated using the TATA box or initiator have a well-defined
start and an end. However, this is not the case for all protein-coding genes. Many of these
genes can start its transcription at any possible site over an extended region, often in a range
of 20− 200 bp. Genes with this set-up result inmRNAs withmultiple 5′ alternative ends and
do not have an initiator a TATA box, instead, they contain a region (20 − 50 bp around 100
bp upstream the start-site region) rich in the bases G and C. The dinucleotide GC content
is underrepresented in vertebrates, therefore regions rich in GC, also called CpG island, up-
stream a start-site can suggest a transcription-initiation region. The housekeeping genes,
genes required for maintenance of basic cellular function, are normally controlled by CpG
islands.
Two general mechanisms are associated with the activation or repression of the regula-
tory process of the gene expression. In the first process, the regulatory proteins act along
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with other proteins andmodulate the chromatin structure, the second influences the ability
of general TF to bind to promoters.
Nevertheless, one TF alone binding to the DNA is, often, not enough to infer direct func-
tional effects on the levels of the gene expression of genes that are close to each other, that
are under control of multiple TFs simultaneously1. One way to measure the interaction of
TFs with binding sites is by using Chromatin Immunoprecipitation Followed by Sequencing
(ChIP-seq)2–4. This is a technique that uses an antibody that recognises either a TFs or the
histone modification for identifying binding locations by pulling down attached DNA.
2.3 Measuring gene expression
The genome is static and is exactly the same across almost all the cells. Opposite to it, the
transcriptome is extremely dynamic. A transcriptome or expression profile is the collec-
tion of genes expressed or transcribed from the DNA and it is the major determinant of the
cellular function and its phenotype. Hence, differences in the gene expression are responsi-
ble formorphological and phenotypic responses to different environmental stimuli, pertur-
bations. The transcriptome changes vastly according to the cell function and environment,
it is also highly dynamic and can change extremely fast to quickly respond to the environ-
mental conditions5–8.
How much of a gene is being transcribed can be measured by the amount of its mRNA
in the cell9. Two main procedures can be used for it. The former is done using microarrays
and the latter by sequencing the mRNA called RNA sequencing (RNA-seq).
By understanding the expression levels of genes in particular conditions or when and
where that gene is (over or under) expressed, we can comprehendmore about its function8.
Moreover, the joint changes of the co-expression of a set of genes can shed light on the reg-
ulatorymechanisms, broader functions inside the cell and consequently biochemical path-
ways. I will explore more about it on Section 2.5 and Section 3.3. And in Subsection 2.3.1
and Subsection 2.3.2 I will cover how the expression is measured and how to pre-process
and access the quality control of those data.
2.3.1 Microarrays
Microarrays or gene chips are, as the name says, chips with thousands of tiny spots in pre-
defined positions, with each spot containing a known DNA sequence or gene. The probes,
DNA molecules attached to each spot, can hybridise to a particular transcript (or a set of
mRNAs)10. There are three main kinds of microarrays: the two-channels, one-channel and
the oligonucleotide. In general, when performing a two-channel microarray analysis, the
mRNA molecules are collected from a reference and treatment samples. Both mRNA sam-
ples are converted into complementary DNA (cDNA), and different fluorophores are used
for labelling each probe. It means, for example, the treatment samples cDNA can be la-
belled with a red fluorescent dye (Cy5), while the reference, green (Cy3). Both samples are
thenmixed together and the cDNAmolecules hybridise to the microarray. Later, the chip is
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scanned tomeasure the expressionof eachgenecontained in themicroarray. The strengthof
the signal from a spot (gene) depends on the amount of target sample binding to the probes
present on that spot. Inour example,when theexpressionof aparticular gene ishigher in the
experimental sample than in the reference sample the corresponding spot on themicroarray
appears in red. However, if the expression in the reference sample is higher than in the ex-
perimental sample, the spot appears green. While in a case where the two samples have the
same expression the spot turns yellow8;10;11. To identify up-regulated and down-regulated
genes, the relative intensity of each fluorophore can be used in a ratio-based analysis12.
The one-colourmicroarrays provide the intensity value for each probe (or probe set) that
indicates the hybridisation level of a labelled target. However, the true abundance level is
not indicated by this value, but a relative abundance when contrasted to other samples or
conditions when processed in the same experiment. Therefore, the comparison of two con-
ditions requires two separated single-dye hybridisation. On the other hand, the usage of
one-channel arrays also have some strength, for example, i) a sample that has a bad quality
does not affect the raw data of the other samples, opposed to the two channels, where one
low-quality sample can reduce the quality a whole array; ii) data from different experiments
can be directly compared (when it is accounted for batch effects)13.
The last array type is the oligonucleotide. This array oftentimes carries probes that hy-
bridisewith RNA spike-ins and the target probes are normalised by the hybridisation of con-
trol probes. It alsomeasures the absolute level of gene expression across different spots and
can be corrected by a normalisation within samples and between samples14.
None of the microarrays directly measures the amount of mRNA, but the fluorescence
from the hybridisation of the cDNA to the probeDNA in the array. Oftentimes the probes are
not specific to one gene, but a set of genes. Therefore, this kind of data carries background
noise andoften the expression values are representative of a set of genes instead of one gene.
Because of that, adequate quality control and filtering of the data is extremely important.
The quality control for microarrays follows different steps according to the array type,
platform, company etc. where the expression was measured. Independent of the platform,
thefirst step is to remove thebackgroundnoise, followedby somenormalisationon thedata.
In the background correction, the background intensity of each spot is removed. This can be
doneusing a local subtraction, that estimates the background for each colour and removes it
from the foreground or a model based correction, where different (linear) models can com-
pute the signal component and a noise component. The normalisation removes systematic
variations of themicroarray that affects the expression levels of themeasured gene. Thenor-
malisation can be simple as a i) quantile normalisation, that aims to correct the variation
between the arrays andmake the samples comparable; ii) probe normalisation that aims to
correct for the variation within probe sets and it equalises the behaviour of the probes be-
tween the arrays. More sophisticated models exist such as z-ratio, Locally Estimated Scat-
terplot Smoothing (LOESS), LocallyWeighted Scatterplot Smoothing (LOWESS)15–17, Robust
Multi-array Average (RMA) and MicroArray Suite 5 (MAS5). The two last ones are more ro-
bust and therefore, the focus here.
The RMAuses amodel to normalise the whole chip, removes all probes that do not com-
pletely hybridise and returns a log2 intensity value. The MAS5 normalises each array sep-
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arated and sequentially using all the data (even mismatched probes) and returns a robust
average. Also, computes amatrix where allows the users to filter for probes that are present,
marginal or absent.
In the statistical environment R18 plenty of packages are available for dealing with mi-
croarrays. The packages affy19 or oligo20 can be used for an Affymetrix array and lumi21–23
for an Illumina array.
2.3.2 RNA-seq
Because the microarrays contain noise and also the DNA sequence has to be known prior
to the hybridisation, better methods had to be developed. The RNA-seq is a Next Gener-
ation Sequencing (NGS) technique, where the whole mRNA is converted into cDNA and
then sequenced using different platforms, that can be chosen accordingly to the researcher
goals24–26, such as Roche 454, Illumina, Helicos and PacBio (Pacific Biosciences) that uses a
DNA polymerase to drive their sequencing reaction or SOLiD (Life Technologies) and Com-
plete Genomics use a DNA ligase. Those platforms can be categorised as single molecule-
based (as the name says, that sequence a single molecule, such as Helicos and PacBio) or
ensemble-based (that sequence multiple identical copies of a DNA molecule, such as Illu-
mina and SOLiD)26.
Independent of the platform, the resulting data are often in FASTQ format. This format
contains a number that identifies each read, the read sequence and the quality score for
each base. In order to get informative data that can be used for further analysis, two main
preprocessing steps are often performed. The first step includes removing artefacts (such
as sequence adaptor), low complexity reads and check for contamination on the samples.
Public tools such as cutadapt27, Quake28, SeqTrim29, TagDust30 etc. can be used for solving
these issues. The sequencing errors can be removed in the intermediate step, based on the
quality score of each base, also, small reads should be removed. The tool FASTQC31 can be
used in order to solve this problem.
The next step is the alignment of the processed reads to a reference genome using an ap-
propriate aligner tool prior to performing the downstream analysis. The choice of an appro-
priate tool depends on theRNA-seqplatform, the application and the organismunder study.
Most of the commercial platforms have their own series of tools and analysis (pipeline). The
most used alignment tools are Bowtie32, TopHat33, Segemehl34–36 and STAR37. After that, for
a gene expression analysis, it is required to count the amount of mRNA that was mapped to
each gene. This can be done using rnacounter38, for example. The amount of each mRNA
counted per gene can be directly used for an analysis where the interest lies on understand-
ing (and pinpointing) which gene has a differential expression in two different conditions
(or tissues). Most of the times a normalisation on the data is needed. The most common
normalisation used in RNA-seq data are: Reads Per Kilobase Million (RPKM), Fragments
Per Kilobase Million (FPKM) and Transcripts Per Kilobase Million (TPM). Another method,
Kallisto, uses a pseudo-alignment, and is able to quantify and normalise RNA-seq much
faster than alignment methods39.
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2.4 Gene Differential Expression
In many studies, the interest lies in understanding the difference between the gene expres-
sion levels of two or more conditions. In a Differential Expression (DE) analysis, the interest
lies on associating genes to a phenotype using statistical modelling. The models to be used
depends on the kind of data and, of course, the nature of the trait under study. In a nutshell,
if the probability function of the expression data is normally distributed (after normalising
microarray data, for example), one can use linear models, when the probability function
of the expression data follows a Negative Binomial distribution (in RNA-seq experiments)
specificmodels can be used. Other set-upmodels can be used to solve it, for example, Gen-
eralised Linear Mixed Model (GLMM) or Nonlinear Mixed Effect Model (NLME). Although,
it is recognised that one gene is not responsible for a phenotype, rather a collection of genes
acting together might shape a phenotype, DE is still widely used to pinpoint associations.
2.5 Gene co-expression networks
Gene co-expression networks can be used for understanding how andwhich gene interac-
tions are involved in a particular system. Those networks have receivedmuch attention40;41
because they can shed light on themolecularmechanisms that underlie biological processes
or on disease associations of gene sets. Those networks enabled the identification of gene
functions and refine its annotation in plants such as cotton42, maize43 and papaya44. They
also added knowledge on complex disorders, such as Diabetes45, Major Depressive Disor-
der46;47, Bipolar Disorder48, Schizophrenia49–51, and revealedmany important hub-genes in
cancers40;52;53. They were used to comprehend how expression patterns in primate brains
have changed over the course of evolution54–56 and how soil treatments can affect the rice
production57. Co-expression networkswere also applied for providing insights into the neu-
rogenesis process in humans58 and tissue-specific regulatory processes59–61.
In general, a network that is not frommolecular data are often able to be observed, and
therefore, the weights and interactions are deterministic, meanwhile, in molecular biol-
ogy, most of the interactions are stochastic and indirectly measured, hence, associated to
a higher level of uncertainty. This might be a noise intrinsic to the network and should be
filtered out. For example, in a co-expression network, the weight of interaction is based on
estimating a correlation of the gene expression. Therefore, carries more noise than if the in-
teraction could be directly measured. The reasons for that noise are manifold and include
biological differences of the individuals such as gender, age or ethnic group, demographic or
technical differences such as array-platform, data quality and facilities that performed the
analysis. Hence, co-expression networks need correction approaches to reduce noise, such
as a consensus network, that combines multiple independent networks54;62.
A series of questions arise from understanding systems using co-expression networks: i)
how to build highly accurate networks; ii) how to combine multiple networks derived
from different platforms; iii) how to comparemultiple networks. But, before we are able
to answer them, I will take a journey into network science on Chapter 3.
3
Gene interactions using a network
approach
“Although this detail has no connectionwhateverwith the real substance of whatwe
are about to relate, it will not be superfluous, if merely for the sake of exactness in all
points.”
– Les Misérables, Victor Hugo
N
ETWORKS ARE BROADLY employed in many fields: from understanding how friends
connect inaparty tohowanimals relate to eachother,howsuper-heroes appear in the
same comic books to how genes can be associated to the same biological process. Net-
work analyses are especially beneficial for understanding complex-systems in any research
field. Examples of complex biological or medical systems include gene regulatory, ecologi-
cal and psychometry networks. Social networks can include scientific collaborations, rela-
tionships between actors, sexual partnerships and also can explore the relationship of social
insects. Gastronomy is also employing network analysis tools, for instance, in recipe build-
ing towards the perfect recipe, a recipe that tastes extremely good. In finance, the interest in
using networks often lies in predicting economic crises. Most networks are not static, and
they can differ from each other, for example, how genes connect in a particular disorder is
different than in controls, or how ingredients pair in a specific culture is different than in
another. Moreover, networks can change over time, be it withinminutes, for instance, when
the cell reacts to an environmental change or the stock market to the introduction of new
company assets, or within years, such as over the course of a lifetime or evolution.
In this chapter, I will give an introduction to the network theory and its applications in
biology. This chapter is based onmy review, where amuch broad application of networks in
other fields is available.
• D. M. Gysi, T. M. Fragoso and K. Nowick. “Construction, comparison and evolution
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of networks in biology, social sciences, economy, and humanities - or: what can we
learn from other disciplines”. Journal of Royal Society Interface. Invited headline re-
view. 2019.
3.1 Basic definitions on networks
The set of interactions among a set of entities is, in general, called a graph or a network63;64.
In graph theory, each entity is called a vertex, while in network notation, it is called anode63.
Accordingly, the connections between two entities are called edge or link, respectively63. In
this dissertation Iwill always refer to themusing thenetworknotation, unless required oth-
erwise (data formats, for example). The total number of nodes in a network will be denoted
as n and the number of links in a network will be denoted as l. While nodes can receive a
label, links in general, are not labelled63 (although, in many cases, weights can also be per-
ceived as a label and De Bruijn graphs are labelled).
A network can be represented i)mathematically as an adjacencymatrix (usually denoted
as A) or an edge list; or ii) visually as a graph (Figure 3.1). Links of a network can possess a
direction (normally depicted by an arrow), which indicates that the interaction is asymmet-
ric, e.g. one gene is regulating another gene or a person follows somebody else in a social
network. Networks with directed links are called directed networks, while networks with-
out directed interactions or inwhich the direction is not knownare referred to asundirected
networks, e.g. collaboration in the same paper or interactions between proteins. The links
can also have a weight to express the strength of the interaction, which results in a weighted
network63;64. Usually, theweight is graphically displayed as the thickness or the length of the
links.
A network is a pairG = {N,L} of a setN of nodes connected by a setL of links. A link can
have aweight, the weight is a measure of how strong a particular interaction is65, a link can
also have a direction, that specifies the source (starting point) and a target (endpoint) where
the interaction occurs66. Two nodes are considered to be neighbours if they are connected.
The degree of a node a is the number of nodes it interacts with65 and the strength of a node
is the sum of the weights attached to links belonging to a node67. Hubs are nodes with a
much larger degree compared with the average degree value67, those are nodes, that in gen-
eral are important to keep the topology of a network. A set of highly interconnected nodes
is amodule or cluster68, the clustering coefficient describes the degree with which a node
is connected to all its neighbours69 and the global clustering coefficientmeasures the to-
tal number of triangles in a network63. The average clustering coefficient, as the name says,
is the average of the clustering coefficient of all nodes in a network69. Two nodes are con-
nected, in a network, if a sequence of adjacent nodes, a path, connects them69, the shortest
path length is the number of edges along the shortest path connecting them69, the aver-
age path length is the average of the shortest paths between all pairs of nodes69 and the
diameter is the maximum distance between two nodes65.
A bipartite network is a network where the nodes can be divided into two disjoint sets
of nodes such that links connect nodes from the two sets to each other, but never inside the
3.2 Notation 19
same set63; The Topological Overlap (TO) is a measure of how interconnected two nodes
are based on common neighbours68;70, details are given in Chapter 4. In general, Global
measures are measures that describe the whole network, for example, degree distribution;
average clustering coefficient; path length; modularity index. The Localmeasures are char-




































































































































































































(D) Directed & weighted.
FIGURE 3.1: Graph example: Four networks are represented here beside its adjacency matrix. All networks
contain 6 nodes and 7 links. Networks on the left side are unweighted and on the right side are weighted. The
width of the links is proportional to the weight of the links. Networks on the top are undirected and on the
bottom directed. The arrows represent the direction of the interaction.
3.2 Notation
The notation used throughout the whole thesis is presented here. I will refer to it whenever
I use it. LetN be a set of nodesN = {N1, . . . , Nn}. The indices in the nodes in this thesis are
denoted by i, j oru. The total number of nodes in a network isn. Also, letLbe the set of links
L = {L1, . . . , Ll} and l the number of links in L. Moreover, letW be a set of independent
networks W = {W1, . . . ,Ww}. The index for the networks is k and the total number of
networks isw. A is an adjacencymatrix. Constructed using a correlationmeasure ρi,j from
a set of measures in a sample of sizem.
A bipartide network adjacency matrix is represented here by B. A Disease weighted net-
work that is constructed from theB network is defined asD and its index are represented by
o and p.
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3.3 The use of networks in biological sciences
Recent applications of complex network analysis methods have provided important new
knowledge of the function and interactions of genes at the systems level69;71–73. Favourites
amongst biologists include Protein-Protein Interactions (PPI) networks74;75, metabolic net-
works76;77, and co-expression networks44;50.
In PPI networks, the nodes represent proteins and they are connected by a link if they
physically interact with each other78. Typically, these interactions aremeasured experimen-
tally, for instancewith Yeast-Two-Hybrid systems, but interactions can also be inferred com-
putationally based on sequence similarity79. PPI can be used to infer gene functions and the
association of sub-networks to diseases74. Gene duplication and sequence divergence can
shape such networks over time. For example, the PPI network of Saccharomyces cerevisae
showed that the evolutionary older a particular protein is, the more connections it has with
time80. Interaction networks of some eukaryotic Transcription Factors (TFs) became more
and more complex due to the duplication of genes encoding for TFs of these networks81.
Results of both studies can be related to the phenomena known as preferential attachment,
which states that nodes that already have many links will attract more new links over time
thanothernodes82. Duplicationof single genes or ofwhole genomeshas alsobeenproposed
to be the driving force of gene regulatory networks83;84. The preferential attachment has also
been observed in metabolic networks85. This process can directly affect the formation of
more complex protein structures and pathways and lead to the evolution of more complex
organisms. In a metabolic network the nodes describe the metabolites (biomolecules) and
the links represents enzymes (proteins) that are able to catalyse a biochemical reaction86.
This network type contains the stoichiometry of the reactions necessary for the synthesis
and degradation of basic metabolites or complex compounds such as proteins87;88.
To describe metabolic processes,metabolic networks have proved to be valuable. In a
metabolic network, the nodes describe the metabolites (biomolecules) and the links repre-
sent enzymes (proteins) that are able to catalyse a biochemical reaction86. These networks
contain the stoichiometry of reactions necessary for the synthesis and degradation of ba-
sic metabolites or complex compounds such as proteins87;88. With the availability of an-
notated genomes, it became possible to construct genome-scale metabolic networks. They
combine inferredormeasuredgene-protein-reaction relationships, transport reactions, and
an estimated biomass composition89;90. These reconstructions have been successfully used
in biotechnological applications, mainly targeting the over-production of metabolites91;92.
The computational approach for analysing this kind of networks is, in general, a constraint-
based analysis89;93.
A different way of investigating evolutionary changes of gene networks was proposed by
Andreas Wagner with his, so-called, genotype-phenotype maps94;95. In these networks, the
nodes represent sequences, e.g. genes or binding sites, and they are linked if they only differ
in one position of their sequence. It can then be analysed whether neighbouring sequences
encode for the same phenotype, e.g. the same gene function or binding of the same factor.
These analyses revealed that these gene networks show a certain level of evolvability and
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robustness: while changed sequences can still lead to the same phenotype (robustness),
it is also possible that evolutionary changes of single sequence positions can create new
phenotypes. For these networks, both genotype and phenotype information needs to be
available.
In co-expression networks, a pair of nodes is typically connected by a link if the genes
they represent a significantly correlated expression pattern across a set of biological sam-
ples of interest. They can be built from RNA sequencing or microarray data52;62;96. Often the
links have aweight, which canbe estimated from the correlation and represents the strength
of a gene-pair association. The sign of the link canbe indicative ofwhether a gene pair is reg-
ulated in the same direction or oppositely controlled52;96. Most of the methods for building
co-expression networks are based on a similarity measure, such as mutual information or
correlation (Pearson, Spearman, Bicor, etc)97–99. Co-expression networks are an example of
undirected and weighted networks. To reduce noise, one can choose to represent the TO
of nodes instead of each interaction. The TO expresses how similar two nodes are in their
set of neighbours, such that a link is drawn between two nodes if they share many interac-
tions68;100. A comparison of those methods for building networks is presented in Chapter 4.
3.4 Measuring the changes in a network
Co-expression networks are constantly changing. Biologists are often interested in com-
paring them between a healthy and diseased status or among tissues, or in comprehending
changes in the gene co-expressionduringdevelopmentor evolution. Inmany studies, global
network features are compared, such as the degree of a node, degree distribution, central-
ity, modules and pinpointing hubs. However, these measures do not have a real biological
meaning. Instead, rewiring in the topology of the co-expression networks, including identi-
fying which nodes have altered links andwho changed the neighbours givemuchmore bio-
logical insights. That information cannot be obtained using other approaches such as gene
Differential Expression (DE). Consequently, amethod that classifies nodes and links accord-
ing to the concepts of being present, different or absent in some networks is essential for
understanding how different phenotypes are affected by the gene regulatory processes52;101.
Evolutionary analyses of co-expression networks are relatively new because compara-
ble transcriptome datasets from different species are still rare. My method, Co-expression
Differential Network Analysis (CoDiNA)52 (Chapter 5) has been recently applied to unravel
changes in co-expression network topology during development and differentiation of neu-
rons from induced pluripotent stem cells. In addition, CoDiNA could pinpoint at which
time point of the differentiation process the knock-out of the micro RNA (miRNA) 124 has
the biggest effect on network rewiring58 (Chapter 7). Another study compared the weighted
Topological Overlap (wTO) networks of the prefrontal cortex of humans, chimpanzees and
rhesus macaque to infer their ancestral networks and species-specific links102.
A comparison of methods for comparing networks is shown in Chapter 5.
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II
Development of methods for




Building and combining highly accurate
networks
“Let me interact
How can I connect?
Let me interact
How can I connect?”
– Human Connect To Human, Tokio Hotel
N
ETWORK ANALYSES, such as of gene co-expression networks, metabolic networks
and co-occurrence networks became an important approach for the systems-level
study of biological data. Several software and libraries exist for constructing and in-
vestigating such networks. In a gene regulatory process a particular gene can up- or down-
regulate other genes, or in ecology, in a co-occurrence network, two species can compete
for the same energy source or can live in symbiosis. In both examples, it is important to
explicitly consider both positive and negative interactions. It is also required that the rep-
resented networks have high accuracy, it means that the interactions found have to be rel-
evant and not found by chance or background noise. Another issue derived from building
co-expressionnetworks is the reproducibility of those. When constructing independent net-
works for the same phenotype using different expression datasets the output network can
be remarkably distinct due to biological or technical noise in the data. In this chapter, I will
present how I improved the weighted Topological Overlap (wTO) methodology by calculat-
ing probabilities associatedwith the randomness of a particular link, I alsowill compare this
wTO approach with other state-of-art methods. Afterwards, I will show a novel method that
allows the calculation of a network that reduces the noise by combining multiple indepen-
dent networks into one Consensus Network (CN). The application of the wTO method will
follow on Chapter 7 and Chapter 8. The application of the CN will follow on Chapter 8.
This chapter is based onmy following publications.
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• D. M. Gysi, A. Voigt, T. M. Fragoso, E. Almaas and K. Nowick. “wTO: an R package for
computing weighted topological overlap and a consensus network with integrated vi-
sualization tool”. BMC Bioinformatics, 19(1), 392, 2018. https://doi.org/10.1186/
s12859-018-2351-7.
• D. M. Gysi, A. Voigt, T. M. Fragoso, E. Almaas and K. Nowick. “wTO: Computing
Weighted Topological Overlaps (wTO) & Consensus wTO Network". 2017. Retrieved
from https://cran.r-project.org/package=wTO.
This methodology is publicly available on the Compreensive R Archive Network (CRAN)
as an R package, called wTO. A well-described manual can be found on Appendix A and
https://deisygysi.github.io/rpackages/Pack-1.
4.1 Motivation
The analysis of interactions has been enabled in a system level of genes or species by re-
cent applications of complex network analyses methodologies69;71–73. Within the biological
network field, the analysis of co-expression40;41 and co-occurrence networks103–107 have re-
ceived much attention in the complex-systems levels. In these particular areas, genes or
species are represented by nodes and a pair of nodes is typically connected by a link if its
nodes show a significant association expression pattern. Links can be represented as a bi-
nary relationship, where 1 denotes the presence and 0 the absence of a particular link, or
alternatively, the link may have a numeric value (often called weight). The weight is a mea-
sure of association derived from a similarity measure analysis such as correlation orMutual
Information (MI) (Figure 4.1a). In a co-expression network, the strength of a gene-pair as-
sociation can be represented by the link weight, and the sign as indicative of the type of
associated gene interaction (Figure 4.1b): i) positive if the genes are co-regulated; ii) neg-
ative if they are oppositely controlled96. While in a co-occurrence network, the strength of
association represent interactions among species: positive interactionsmight indicate com-
mensalism ormutualismwhile negative interactions represent that the species compete for
the same energy source or predator-prey interaction.
In many implementations of co-expression network analyses, one might primarily be
interested in a priori defined subset of genes with a specific set of properties (Figure 4.1c).
Examples include Transcription Factor (TF), non-coding RNA (ncRNA), genes with known
orthologs in a set of organisms of interest or disease-associated genes108;109. For these situ-
ations, oftentimes the choice is made to only take into account direct interactions between
thegene-subset of interest, insteadof including the full set of interactions. Amajordrawback
of such an approach is that relevant information contained in interaction patterns among
excluded genes that would affect network topology and link strength values, is not incor-
porated in the network. The loss of such information is not only undesirable but may also
lead to biased results. To reduce the noise and bias, a solution is to represent the Topolog-
ical Overlap (TO) of nodes instead of each interaction. The TO expresses how similar two
nodes are in their set of neighbours, such that a link is drawn between two nodes if they




































































FIGURE 4.1: Graphical representation of the topological overlapmethod: (a) represents a network, where
the weight represents the association of a a node-pair. In this network all kinds of nodes can be connected;
(b) shows a network where the association does not have only a weight but also a sign. The sign represents if a
particular connection occurs in the same or opposite direction; (c) displays a TO network. In this network the
interest lies in a subset of nodes (the red nodes). The interactions are weighted by the shared commonalities
of those nodes and take into account the information that the grey links carry, however, because the interest
lies only in the red nodes, only links between them are drawn (green and purple links).
share many interactions68;100. Figure 4.1 shows the graphical representation of the method.
Just the calculating of the TOdoes not remove false associations of genes, therefore, a proba-
bilitymeasure has to be associatedwith each link. The improvement of themethod is shown
on Subsection 4.2.1.
Networks differwhen investigating independent networks derived from similar datasets,
e.g. from a repeated experiment or independent studies on a similar subject54. These differ-
encesmay arise from several sources: i) technical differences, such as the platformonwhich
the expression data was measured, the facility where data was collected and prepared, or
howdatawasprocessed; ii) biological differences fromconfounding factors, suchas sex, age,
and geographic origin of the individuals measured. In both cases, the network is different
due to non-controllable or observable variables. Therefore, it is desirable to obtain an in-
tegrated network that considers all independently derived networks as biological replicates
and systematically identifies their commonalities and is able to filter out the background
noise. I developed a novel method to compute the network that captures all this informa-
tion; I denote this as Consensus Network (CN). Details on that are presented on Section 4.3.
4.2 Methods for constructing co-expression networks
A variety ofmethods currently exist to analyse gene co-expression networks. Most are based
on similarity measures. In a nutshell, we can split the similarity measures into two cate-
gories, the ones based on correlation (Sparse Partial Correlation Estimation (SPACE)110 and
TO methods such as Weighted Gene Co-Expression Network Analysis (WGCNA)98;111 and
weighted Topological Overlap (wTO)55) and the ones based on MI (Algorithm for the Re-
construction of Accurate Cellular Networks (ARACNe)99;112). Thesemethods rest on amulti-
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tude of different mathematical principles, particularly with respect to how co-expression is
quantified. However, co-expression networks based on the TOhave been shown to compare
favourably against other methods113.
SPACEselects all partial correlationsdifferent fromzeroandfits a sparse regressionmodel.
This method allows for the identification of gene-hubs that can be further annotated or as-
sociated to the phenotype under study. ARACNe method builds the network using the MI
and removing links that are indirect interactions usingData Processing Inequality (DPI) and
only for not independent pairwise correlation. The wTO builds the adjacency matrix using
the raw correlation, ρ, of all pairwise interactions and later computes the TO as
ωi,j =
∑
u ai,uau,j + ai,j





A = [ai,j] =
{
ρi,j i 6= j
0 i = j.
(4.2)
The WGCNA general framework consists of first calculating the pairwise correlations of
the expression values of genes and applying a soft threshold on the correlation and has three
options to calculate the adjacency matrix i) a signed version; ii) a hybrid version and iii)
unsigned. In all three cases the weight values resulting from the TO are given by
ωi,j =
∑
u ai,uau,j + ai,j
min{ki, kj}+ 1− ai,j
, (4.3)
which lies on unit interval, since the adjacencymatrix inWGCNA is defined only for positive
values.
There are three possible adjacency matrix for this approach. The first one is the signed







where β is an integer that forces a network to fit into a power-law. The second one is a hybrid




β forρi,j > 0
0 forρi,j 6 0,
and the last one is an unsigned version, that considers only a soft threshold
aunsignedi,j = [ρi,j]
β.
In contrast toWGCNA,wTOuses the raw correlation as the adjacencymatrix for building
the Topological OverlapMatrix (TOM)114;115. Where the weight of a gene-gene interaction is
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then an average across all its neighbours. For both, wTO and WGCNA, the ωi,j = 1 if both
the conditions are satisfied for the node with fewer links: i) all its neighbours are the same
of the other node and ii) they are connected. However, ωi,j = 0 if they have no neighbours
in common or are not connected.
Different fromthemethodsabove, Bayesiannetworks assume that thegene relationships
are causal and adirectionof the regulatory process canbe captured in an acyclic graph. Each
interaction takes into account all other possible gene interactions116;117. The main problem
in using this method is the extremely long running time.
4.2.1 Weighted Topological Overlap calculation
Zhang et al.118 first described the wTO method in 2005. The representation of interactions
between a set of nodes by this method takes into account the overall commonality of all the
links a node has, instead of basing the analysis only on calculating raw correlations among
the nodes115;118;119. It thus provides amore comprehensive understanding of how two nodes
are related. Therefore, it is expected that a network build from this method contains more
robust informationabout the connections amongnodes thanwhatwould result fromsimply
taking direct correlations into account55;118.
The wTO can be computed based on a similarity matrix, where the link weights are cal-
culated using Pearson’s product moment correlation coefficient or the Spearman Rank cor-
relation. The first one measures the linear relationship between two genes. Note that, the
Pearson’s correlation coefficient is sensitive to extreme values, and therefore it can over or
underestimate the strength of an association. The Spearman Rank correlation is recom-
mended when data are monotonically correlated, skewed or ordinal, and it is less sensitive
to extreme outliers than the Pearson coefficient120–123.
Nowick et al.55 improved themethod by allowing themethod to explicitly accommodate
both positive and negative correlations. Later, I improved the method for allowing it to es-
timate if the ωi,j value found is different from zero by calculating a p−value for each link.
This calculation allows the final network to be filtered using a probability measure in each
link instead of an overall correlation measure for all links.
I use the same notation defined in Section 3.2. Let N be a set of n nodes,
N = {N1, . . . , Nn} and ρi,j a correlation between a pair of nodes i and j. The adjacency
matrixA = [ai,j] is defined as in Equation 4.2.
Assuming that nodes i and j represent a sub-set of factors (e.g genes) of particular in-
terest selected from the n nodes, the wTO (ωi,j) is calculated55 between nodes i and j as
presented in Equation 4.1.
Note that, this expression (Equation 4.1) explicitly includes both positive and negative
correlations, and thus allows for ωi,j to take both positive and negative values. Other soft-
warepackages calculating theωi,j have implementeddefinitionsof theTOmethod that does
not allow for negative values98, making my version more valuable for gene regulatory net-
work analysis. The wTO package also calculates the unsigned network, and for that, it takes
as an input the absolute correlation values (|ρi,j|).
Since (Equation 4.1) explicitly allows ai,j 6 0, therefore, is important to be aware of the
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limits of this expression. Consider three nodes i, j and u, and assume that aij 6 0. All
the terms in the numerator of (Equation 4.1) will be negative if aiuauj 6 0 for all nodes u.
However, if aiuauj > 0, then at least some contributions to the sumwill cancel out. The same
rationale applies for the case of aij > 0.
To systematically assess the potential effect of term cancellation in (Equation 4.1), I cal-
culated the absolute wTO, |ω|, which uses the absolute value of the correlations (ai,j = |ρi,j|)
as input for (Equation 4.1). In this case, the sign of the correlation is excluded from the analy-
sis and only themagnitude of the link-strength is taken into account. Consequently, by gen-
erating a scatter plot of the signed andunsignedweights, it is possible to assess atwhichωi,j-
values term cancellations start affecting the results. Thus, for values of interest, the closer
the plot of ω vs. |ω| is to the classic y = |x|, the better.
However, by just computing the wTO network all spurious correlations are not avoided.
To overcome this issue, my package estimates the probability of eachω being zero by testing
the hypothesis {
H0 : ωi,j = 0
Ha : ωi,j 6= 0,
of the null hypothesis (H0) of no association against the two-sided alternative (Ha) of non-
zero association. This can be computed by using a bootstrap approach124.
Bootstrap is a method to measure the accuracy of statistical measures, such as mean,
standard deviation, correlation etc. But it can also be used formore complexmeasures, such
as the wTO. The idea behind the bootstrap is very simple. Assume that we have the gene ex-
pression of Gene A (G) measured inm different individuals, it means, G = {G1, . . . , Gm}.
The process starts by generatingmultiple independent samples of sizem with replacement,
each resampling realisation is in theB∗ bootstrap sample, {G1∗ , . . . ,GB∗}. For each realisa-
tion, you compute the statistic f(xB∗) of interest, such as themean, median, standard devi-
ation. With this collection of values, it is straightforward to derive an empirical distribution
for the statistic under study. A visual representation of themethod is onFigure 4.2. When the
dataset is composed of correlated observations, such as time series and repeatedmeasures,
this naive independent sampling with replacement must be modified to sampling that al-
lows for suchparticularities. Theblockedbootstrap, as thenamesuggests, buildsblocks that
controls for the high dependency on data and each block is considered to be one individual.
The approximation of the weights’ empirical distribution can be done by resampling the
individuals with replicates and the probability that an observedweight is sufficiently distant
from zero can be easily calculated. Each bootstrap realisationB∗ estimates a ω∗i,j .
The absolute difference of ωi,j and each ω∗i,jis bounded by a fixed confidence interval of
δ − ωi,j 6 ω∗i,j 6 δ + ωi,j . This means that, the smaller δ is, the stronger the confidence is in
a particular ωi,j . By default, the wTO package sets the δ to 0.2.
In short: for the ω case, I have drawnB∗ new samples of sizem with replacement from
the original dataset. For each link, calculate the ω∗i,j , derive the empirical distribution for
each one of the links. Define an interval of interest, δ, and estimate the proportion of ωB∗i,j
outside the predefined interval.
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FIGURE 4.2: Schematic representation of the bootstrap method: Each B∗ bootstrap sample is generated
from the dataset. Each bootstrap sample containsm elements from the original data, with replicates. These
samples are used for estimating the f(x∗) statistics of interest. The result from each B∗ statistics computed
are used to build the empirical distribution.
Calculating networks for repeatedmeasure and time series data
One advantage of the wTO package is its application in the analysis and construction of net-
works for time series and repeated measures data. For that, the implementation of blocked
bootstrap resampling124 is needed. This type of resampling is necessary mainly because
there are two correlation components structures in these samples: the node’s correlation
and the autocorrelation (individuals or time). For the individual, the autocorrelation is given
by the same individual beingmeasuredmultiple times and its measures can be very similar,
and thus, inflate (or deflate) the nodes correlation. While for a time series there is a tendency
of consecutive values to be correlated. An important benefit of the presence of autocorre-
lations is that we may be able to identify patterns inside a time series, such as seasonality
(patterns that repeat themselves at a periodic frequency). A way to measure the time de-
pendency is by using a lag. Those are particularly helpful in time series analyses and can be
chosen using a partial correlation of the time per sample. In both cases, the resampling is
followed by calculating the wTO for a time series where the observations are not indepen-
dent of each other.
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4.2.2 Comparing wTO to other state-of-art approaches
In order to quantitatively compare the performance of wTO, WGCNA and ARACNe, I down-
loaded a gene expression dataset from E. coli from http://systemsbiology.ucsd.edu/
InSilicoOrganisms/Ecoli/EcoliExpression2125–128. The data consist of 213 Affymetrix
microarray gene expression profiles, corresponding to multiple different strains under dif-
ferent growth conditions, and contains gene expressiondata for 7, 312distinct probes. Qual-
ity control of the probes was performed and log2 normalised previous tomaking the dataset
available. Unspecific probe-set were removed and genes that werematched frommore than
one probe were combined using the mean of all its probes. The resulting dataset contained
4, 356 expressed genes.
To assess the capability of the three tools in identifying true TF-TF interactions, I used
the RegulonDB129 database, which contains experimental data from E. coli, as a reference.
I define as True-Positive interactions those that are described in RegulonDB, and as True-
Negatives all interactions that could not be experimentally validated in that dataset. For
comparison, I also calculated networks using only Pearson’s correlation without any modi-
fication. We generated the network for WGCNA following the steps described by the authors in
the Tutorial118;130 and used the functions pickSoftThreshold() and
pickHardThreshold() for defining the power of the soft-threshold and for choosing the
hard-threshold, respectively. The power was defined as 4 and the hard-threshold was set
to 0.3.
The ARACNenetworkwas built using the Pearson correlationwith build.mim and ARACNe
functions in the minet R package131. The wTO networks were built using 1, 000 simulations,
Pearson correlation and filtered for Benjamini-Hochberg adjusted p−value (BH)132 6 0.01
and the 90% quantile. One wTO network was constructed using a δ of 0.2, the default of the
wTO package, and another network was built using a δ of 0.1. All networks were filtered to
only contain TFs with information in the RegulonDB. To measure accuracy of the methods,
the Receiver Operator Curve (ROC) curve was calculated using the pROC R package133 (see
Figure 4.3). The ROC curve is plotted, using different thresholds, the True Positive Rate, sen-
sitivity, against the False Positive Rate, specificity. It is a plot of the power in function of the
type I error.
ARACNe was able to better identify the number of true positives compared to WGCNA
andwTO, but performsworsewhen finding true negatives, thus resulting in a larger number
of false positives. (Figure 4.3, Table 4.1). WGCNA is better at finding true negatives, but
does not identifymany true links. ThewTOmethodperforms better thanWGCNA in finding
true positives and better than ARACNe in finding true negatives. It also finds fewer false
positives than ARACNe. In general, even when using a large δ, that can be interpreted as a
wide confidence interval, wTO performs better than the two other methods, as seen in the
Area Under the Curve (AUC), the closer it is to unity, the better. This demonstrates that the
use of thewTOmethod further reduces false effects coming from incorrectly assigned linked
genes (false positives) when compared to ARACNe and raw correlations.
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True Negative 7234 2259 2633 7092 6520 5235
False Negative 0 216 245 321 318 288
False Positive 0 4975 4601 142 714 1999
True Positive 328 112 83 7 10 40
Total 7562 7562 7562 7562 7562 7562
4.3 Amethod for combining networks
Constructing independent co-expression networks for the same trait using different data
leads todifferentnetworks. Therefore, it iswell known that co-expressionnetworks cancarry
background noise due to: i) biological differences, such as age, sex, gender etc; ii) techni-
cal differences such as the platform used for measuring the gene expression, facility. Those
differences cannot be measured or be controlled when the network is constructed. This
background noise that is intrinsic to each network leads to distinct networks for the same
phenotype. Because of that, methods that are able to combine multiple networks into one
network with reduced false positive rates and noise levels are required.
Berto et al.54 described a consensus network based on gene-expression data from pri-
mates’ frontal lobes by applying a Wilcoxon test on the links. It assumes that there are a
sufficient amount of independent networks in two groups to be compared and therefore,
combine the networks. However, there are not always a substantial amount of networks to
be combined. Thus, amethod that is able to build aCN fromat least twonetworks, re-weight
the links and compute a probability for them is needed.
TheCNmethodology I developed allows combing twoormore networks, each generated
from different and independent datasets, into a single CN. This method, penalises the links
with opposite signs and also links that does not exist in all networks. According to the same
rationale, links with the same sign among the multiple wTO-networks, will have their link
weight values (ω) closer to the largest |ωi,j| of the link in all k networks. In order to obtain the
CN, the first step is to remove nodes that were not measured in all networks. Consequently,
if a node is absent in at least one network, it is not possible to compute a consensus of the
links that belong to that node (Figure 4.4). It is particularly important for avoiding the false
associations of factors that were not measured in all networks.
In order to obtain a single integrated network derived from multiple independent wTO
networks, we calculate a CN using the following approach.
Assume a setw of k independent networksW = {W1, . . . ,Ww} replicated networks, the


















1.0 ARACNE, AUC: 0.5485
WGCNA, AUC: 0.4759
WTO (Delta = 0.1), AUC: 0.6744
WTO (Delta = 0.2), AUC: 0.6349
Correlation, AUC: 0.3775
FIGURE 4.3: ROC curves for the comparison of methods. Overall, the wTO method performs better than
ARACNe, WGCNA and raw Pearson correlations. ARACNe is better in finding true positives, while WGCNA is more






A threshold can be applied to remove links with ωi,j values close to zero, thus should not
be included in the consensus network. To join networks that were generated with the wTO





which can be used because i) the networks are independent; ii) Uniform distribution is as-
sumed for the ω p−values.
A visual representation of the CN methodology is shown in Figure 4.4. The thicker the
link between two nodes is, the stronger the correlation between them. The signs are repre-
sented by the colours green and violet, respectively. If a link has different signs in the net-
works, the strength of the link in the CN is close to zero. When all links agree to the same
value or show little deviation, the strength of the resulting CN value is closer to the deter-
mined absolute maximum value. If a node is absent in at least one network, it is removed.
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FIGURE 4.4: A schematic example of theCNmethod: Three independent networks are shown in (a), (b) and
(c) to be combined into one CN. Note that the rightmost network does not have the right bottom pink node;
(d) is the resulting CN. Note that, the pink node node is present in the CN but does not contain any link. Also,
only links that do not change sign between networks are present in the CN. For example, the link between the
red and the yellow nodes is removed, because it has different signs in networks.
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4.4 A package for constructing and combining networks
In order to make the wTO and CN methods available, an R package called wTO was devel-
oped. wTO is open source and freely available from CRAN https://cran.r-project.org/
web/packages/wTO/ under the GPL−2 Open Source License, and it is platform indepen-
dent.
4.4.1 Input data
The wTO R package can handle a wide range of input data. Data can be discrete or contin-
uous values. However, it is recommended that the input data should be previously cleaned
using the common steps for quality control and normalisation prior to the network con-
struction. This step avoids background noise. For RNA sequencing (RNA-seq) data, wTO can
handle normalised quantification, for example Reads Per Kilobase Million (RPKM), Frag-
mentsPerKilobaseMillion (FPKM)andTranscriptsPerKilobaseMillion (TPM). Formicroar-
ray data, log2, RobustMulti-array Average (RMA) orMicroArray Suite 5 (MAS5) values can be
used. For metagenomics data, for instance for analysing co-occurrence networks, the rec-
ommendednormalisation for the abundance data are per day/sample orHellinger distance.
4.4.2 Functions
The function wTO() calculates theweights for all links according to (Equation 4.1) between a
set of nodes for a given input dataset. A user that isnot interested in having a highly accurate
network can run this function.
To test whether the calculated ωi,j is different than a random expectation and to decide
on a suitable hard-threshold value for including linkweights, the functions wTO.Complete()
and wTO.fast() are implemented. Both this functions calculates theω∗i,j anumber of times,
specified by the user, by using either the method_resampling as (“Bootstrap”), or for time
series or repeated measures data case (“BlockBootstrap”). In the last case a lag or an ID
is required. The user may specify the correlation method (Pearson or Spearman) that this
function should use, the Pearson correlation is the default choice.
Because resamplingmethods, such as bootstrap and permutations, are computationally
expensive, the wTO.Complete() can also run in parallel over multiple cores to reduce the
wall clock time. For running in parallel, the user may specify a given number of k computer
threads to be used in the calculations. To implement the parallel function, the R package
parallel18 was used.
The execution of the wTO.Complete() function returns two outputs: i) a diagnosis set of
plots (Figure 4.5) and ii) a list consisting of the following three objects:
• $Correlation is a data.table containing the Pearson or Spearman correlations be-
tween all the nodes, not only the set of interest. The ωi,j values for the set of nodes of
interest are based on these correlations. The default of this output is set to FALSE.














































































































































































































































































































































































FIGURE 4.5: wTO R package diagnosis plot: The diagnosis plot shows the quality of the resampling (first two
plots). The closer the purple line to the black line, the better. The ωi,j vs |ωi,j | shows the amount of ωi,j being
affected by cancellations on the heuristics of the method, the most similar to a smile plot, the better. Note
that for both ω and |ω| when the p−value is lower than 0.05, the ω is closer to the diagonal line where the
values are not affected by the signal cancellation of themethod. The last two plots show the relationship of the
p−values and the ωi,j . It is expected that higher ω will have lower p−values.
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• $wTO is a data.table containing the nodes, the ωi,j values (signed and unsigned),
the p−values and the adjusted p−values computed using both signed and unsigned
correlations.
• $Quantile is a table containing the quantiles for the empirical distribution, computed
using the bootstrap and the quantiles for the real data: 0.1%, 2.5%, 10%, 90%, 97.5%
and 99.9%. Those empirical values can be used as a threshold for the ω values when it
is not desired to visualise small ωi,j .
The set of plots on Figure 4.5 indicates the quality of the resample: the closer the den-
sity of the resampled data is to the real data, the better. Another generated plot is the scat-
terplot of the ωi,j vs |ωi,j|, as discussed in Subsection 4.2.1. The scatter plot of p−values
against the ωi,j and |ωi,j| is also plotted along with suggested threshold values that are the
quantiles based on the empirical distribution. Note that the values on the diagonal of this
plot, have in most of the cases, low p−values, it shows that the implementation of the boot-
strap per se can alleviate the sum problem presented before.
The wTO.Consensus() computes the CN. This function allows the user to give a list of
networks in a data.frame (edge.list) format with: Node 1, Node 2, the link weight and
the p−value. The output is a data.table containing the two nodes’ names and the consen-
sus weight, and the combined p−value. This allows the user to filter out the links that were
not significant in part of the network.
The wTO R package also includes options to visualise the resulting networks. The func-
tion NetVis() generates an interactive graph using as input a list of links and their corre-
spondingweights. Theanalysis functionswTO.Complete()andwTO.Consensus()bothgen-
erate network data-structures (edge.list) that can be visualised with this function. The
user needs to choose a relevant ω-threshold (the quantiles resulting from the bootstrap),
p−value cut-off and/or padj−value to select the set of links to be plotted. Additionally, the
usermay choose a layout for the network visualisation from those available in the igraph135
package. By default, the threshold value is set to 0.5, and the network layout-style is set to
layout_nicely. To avoid false positives, we recommend to filter the data according to the
desired significance p−value and to choose thewTO-threshold according to the computed
empirical quantiles. The size of the nodes is relative to their degree. My package further in-
cludes an option for making clusters from the nodes; if allowed, nodes are coloured accord-
ing to the cluster they belong to. The user can choose themethod to create the clusters. The
width of a link is relative to theωi,j , and its colour is respective to its sign (if a signed network
was calculated). Nodes can have different shapes, allowing for labelling nodes of different
classes, for example, target genes or protein-coding and non-protein coding genes. Further-
more, the user may also zoom in and out of the network visualisation, drag nodes and links,
edit nodes and links, and export the image as .html or .png. The package provides example
datasets and an example of nodes of interest aswell. Theworkflowof the data-analysis using
the wTO package can be seen in Figure 4.6.
One important difference between the wTO package and the WGCNA package, is that wTO
only use significant links for cluster (modules) network representation oposed to the full set
of co-expressions, as in the WGCNA package.
















































FIGURE 4.6: The wTO package workflow: Gray boxes refer to inputs, red boxes refer to content of the wTO
package, yellow boxes are functions included in the package, blue boxes are outputs of those functions, and
green boxes refer to methods internal to the package. wTO package can deal with multiple kinds of data, for
example, RNA-seq counts or normalised values, microarray expression data, abundance data coming from
metagenomic studies, and many more. All input data should be pre-processed with the quality control and
normalisationmethods recommended for each respective type of data. The function wTO.Complete() calcu-
lates thewTO values, asmany times as desired. As output, the user will obtain an object containing the signed
and absolute wTO values for each pair of nodes, p−values and padj−values for multiple testing. This output
can be used for the construction of a CN from independent networks using the function wTO.Consensus().
Outputs from thewTO and CN networks can be used as an input for NetVis(), which is an integrated tool for
plotting networks. As an interactive tool, it also allows the user to modify the network.
Relative to WGCNA, wTO provides three major additions: the determination of p−values
(determined by bootstrapping) for each pairwise wTO value; the calculation of a consensus
network, and the ability to visualise the topological overlapnetwork (alongwithnode group-
ing according to a choice of nine algorithms). While WGCNA provides a variety of tools for vi-
sualising the hierarchical tree forming the network, as well as for rendering the correlation
matrix in heatmap form, it does not provide a node-and-edge type view of the co-expression
network (but does allow for exporting networks into Cytoscape, in which network views are
possible). Additionally, the consensus network as defined in Equation 4.5 differs from the
consensus TOM defined in WGCNA, which simply assigns to each edge of the consensus net-
work theminimal value of the topological overlap across the input conditions. This is a strict
version of consensus (unanimity), in that it will discard any gene pair if the overlap is weak
in even a single network. In contrast, while Equation 4.5will remove contributions fromnet-
workswhere the TO isweak (orwhere the sign of theω is in conflictwith the other networks),
an edge may still be included if it is sufficiently present across the other networks.
Further additions inwTO include thepossibility of choosing the Spearman correlation as
thebasis ofA (whileWGCNAprovidesbiweightmidcorrelation, or bicor for short; bothprovide
Pearson), aswell as reducing computation timeby the option of restricting the calculation of
wTO scores to a set of genes of interest (while still including the adjacency to genes outside
this set in each inter-set wTO score).
For an unweighted network, where ai,j = 0 or ai,j = 1 for all (i, j), this approximates to
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ωii ≈ 1 for large ki. However, this is not the case for weighted networks. WGCNA differs from
the wTO package in that wi,i = 1 is explicitly set for all i, while the wTO package retains the
score as defined by Equation 4.3.
A brief comparison of the main R packages for constructing networks can be found on
Table 4.2.
TABLE 4.2: Comparison of key differences between wTO, WGCNA and ARACNe.
Method wTO WGCNA ARACNe
TO Yes Yes No
Signed TO Optional No No
Consensus TO Weighted sum Minimumweight (strict) No
Pairwise p−values Yes No Used to filter MI
Network view Native Exported to Cytoscape Exported to Cytoscape
Soft threshold No Optional (on by default) No
Correlation Spearman Bicor Spearman, Pearson
choices Pearson Pearson Kendall
Deal with Yes No Notime series
Deal with Yes No Norepeated measures
4.4.3 Algorithm compute time with varying system size
Normally, when running the wTO, the interest lies on a subset of nodes of interest. In Fig-
ure 4.7, we show the run-time for different network sizes, and different proportions of nodes
of interest. When running the wTO for all expressed genes coding for TF being the genes of
interest, we have around 14% of nodes of interest. Using a standard laptop computer, it’s
possible to compute the wTO for a full network with 20, 000 nodes in 20 milliseconds per
link. This shows that it is quite feasible to compute the full wTO for a realistic gene expres-
sion network.






























































FIGURE 4.7: Computational time for the calculation of wTO for each link for different sizes of networks
and proportions of sets of nodes of interest: The run time of the ωi,j calculation increases with increasing
proportion of nodes of interest. The graph presented here shows the time for computing each link for different
sizes of nodes and proportions of subsets of nodes of interest.
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5
Comparing highly accurate networks
“Six degrees of separation doesn’t mean that everyone is linked to everyone else in
just six steps. Itmeans that a very small number of people are linked to everyone else
in a few steps, and the rest of us are linked to the world through those special few.”
– The Tipping Point: How Little Things CanMake a Big Difference,Malcolm
Gladwell
B
IOLOGICAL AND MEDICAL sciences are increasingly recognising the relevance of gene
co-expression-networks for the analysis of complex systems, phenotypes or dis-
eases. Typically, complex phenotypes are investigated under varying conditions.
While approaches for comparing two networks exist, this is not the case for multiple net-
works, although many studies consist of more than two datasets, for example, multiple tis-
sues, treatments, time points, or species. In this Chapter, I present amethod for the system-
atic comparison of an unlimited number of networks: Co-expression Differential Network
Analysis (CoDiNA). In particular, CoDiNAdetects links andnodes that are common, specific
or different among the networks. CoDiNA includes a statistical framework to normalise be-
tween these different categories of common or changed network links and nodes, resulting
in a comprehensive network analysis method, more sophisticated than simply comparing
the presence or absence of network nodes.
In this Chapter, I will present how I developed the CoDiNA, a classifier method for links
and nodes in a set of co-expression networks. I also will compare qualitatively my CoDiNA
approach with other state-of-art methods.
ApplyingCoDiNA to aneurogenesis studywe identified candidate genes involved inneu-
ronal differentiation. Experimentally overexpressing one candidate resulted in a significant
disturbance in the underlying gene regulatory network of neurogenesis (Chapter 7), more-
over, applying CoDiNA to different mental disorders showed gene candidates that seem to
be involved in modules involved with those disorders (Chapter 8).
This chapter is based onmy following publications.
44 5. Comparing highly accurate networks
• D. M. Gysi, T. M. Fragoso, V. Busskamp, E. Almaas and K. Nowick. “Comparing multi-
ple networks using the Co-expression Differential Network Analysis (CoDiNA)”. Sub-
mitted. 2018.
• D.M.Gysi, T.M. Fragoso, E. Almaas andK.Nowick. “CoDiNA: Co-ExpressionDifferen-
tial Network Analysis”. CRAN. 2018. htps://cran.r-project.org/web/packages/
CoDiNA/.
This methodology is publicly available on the Compreensive R Archive Network (CRAN)
as an R package, called CoDiNA. A well-describedmanual can be found on Appendix B and
https://deisygysi.github.io/rpackages/Pack-2.
5.1 Motivation
Complex systems, exemplifiedbybiological pathways, social interactions, andfinancialmar-
kets, can be expressed and analysed as systems of multi-component interactions136. In sys-
tems biology, it is necessary to develop a thorough understanding of the interactions be-
tween factors, such as genes or proteins. Gene co-expression networks have been especially
effective in identifying those interactions69;71–73, and as mentioned the sign of the interac-
tion may suggest an up- or down-regulation of one factor by the other96. It has been shown
that different conditions have distinct underlying regulatory patterns and thereforewill lead
to dissimilar networks even for a single system54;62;136.
Differential network analyses are able to capture changes in gene relationships and are
thus exceptionally suitable for understanding complex phenotypes and diseases73. And this
cannot be done using aDifferential Expression (DE) approach. Severalmethods for pairwise
networks comparisons exists101;137–145. However, it is often of great interest to comparemore
than just two networks simultaneously, such as gene co-expression networks arising from
different species, tissues or diseases, or co-existence networks fromdifferent environments.
Unfortunately, the comparative method for more than two networks that account for both
links and nodes were missing.
Toovercome this issue, researchershavebeencontouring thisusingdifferent approaches.
For instance, an evolutionary study conducted pairwise comparisons between humans,
chimpanzees (Pan troglodytes) and rhesus macaques (Macaca mulatta) to uncover similar-
ities and differences in the Prefrontal Cortex (PFC)102. In a recent medical study, the au-
thors compared enriched gene functions using the Gene Ontology40 instead of comparing
the networks of themultiple cancers. Another study generated a network that involved only
differentially expressed genes146 extracted from theirmultiple networks. Fewproblems arise
from this: i) the lack of statistical power; ii) the accuracy is reducedbymultiple comparisons.
Therefore, these studies could have profited extensively from applying amethod capable of
systematically comparing multiple networks simultaneously.
Kuntal et al.136 proposed amethod, CompNet, that may address the comparison ofmul-
tiple networks. However, the focus of CompNet is on the visualisation of the union, inter-
sections and exclusive links of the analysed networks. ConMOd147 has recently been devel-
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oped to find conserved functional modules across multiple biological networks. However,
a method that is capable of comparing both links and nodes of any number of networks is
still lacking.
Here, I present a novel method for that purpose, Co-expression Differential Network
Analysis (CoDiNA), implemented as an R package, CoDiNA, that also includes an interactive
tool for network visualisation similar to the one presented in the wTO R package Chapter 4.
5.2 Comparing CoDiNA to other state-of-art approaches
Evaluating multiple co-expression network methodologies for comparing networks is con-
siderably challenging due to the lack of a gold standard network for multiple conditions148,
of which all links are experimentally validated. Therefore, we are able to identify theoreti-
cal similarities and differences among themethods, and that is how I compare themethods
here.
Few other tools, CompNet136 and ConMod147, allows for the comparison of more than
two networks. The focus of CompNet is on the visualisation of pairwise Jaccard-similarities
from the union, intersections and exclusive links of those networks. It includes features such
aspie-nodes and links to allow theuser to identify key elements of thenetwork. Elements are
identifiedbyprovidingadistributionof global graphproperties, suchas thenetworknumber
of nodes, number of links, density, clustering coefficient, average path length and diameter.
Even thoughbuilding a visualisation tool is not the focusofCoDiNA,wealso incorporated an
interactive tool for visualisation of the final network, and CoDiNA provides summary statis-
tics of the network, such as the total number of links and nodes, degree of the nodes, as
well as how many links and nodes have been classified as common, different or specific to
each category. Other network statistics can be easily obtained using the igraph135. Con-
Mod focuses on finding only commonmodules of different networks by building a consen-
sus network from layering different networks and from that, selects nodes for building the
conserved modules. Unlike CoDiNA and CompNet, ConMod does not perform an actual
comparison.
Lichtblau et al.148 compared ten differential network analysis methods that are able to
perform a pairwise comparison. The authors split the methods into two main categories:
Local search and Global search. Global methods focus on changes in the network topol-
ogy while local methods search for changes in the nodes. CoDiNA combines both: it first
searches for changes in the topologyof thenetworks and then for the specificity of thenodes.
This allows investigating both features with one powerful tool. Changes in network topol-
ogy indicate alterations in affected pathways or regulatory relationships, while changes con-
cerning specific nodes can evaluate the importance of genes for the network and suggest
genes that might be responsible for the topology differences. Together, the local and global
changes are crucial for understanding the functional effects of network changes.
As previouslymentioned,mostmethods for distinguishing networks allow only pairwise
comparisons, but few approaches distinguish multiple conditions. For a systematic com-
parison of links or nodes several methods can be considered: CoDiNA, CoXpress139, Comp-
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TABLE 5.1: Methods for comparing co-expression networks: Amount of networks to be compared; Statis-
tical methodology used in the method; Focus on nodes or links; Output network of the method: Integrated













Full network Yes R package




Links Full network Yes GUI
CoXpress 2 Hierarchical cluster











Links Full network No In-house
software
DiffCorr 2 Fisher’s z-test Links Full network Yes R package







Links Full network Yes Web-
based
MIMO 2 Sub-graph match-
ing
Nodes Sub-graph No In-house
software









QNet 2 Computes graph
similarities from
trees for the nodes
based on colouring
graph theory
Nodes Full network No In-house
software











Net136, CSD101, DiffCorr145;149, Gain144, MIMO143, NetAlign138, SAGA140 and QNet142. From
5.3 CoDiNA in a nutshell 47
those, only the CoDiNA and CompNet aremethods that were developed for the comparison
of two or more networks simultaneously. Table 5.1 describes briefly the main methods for
differential network analysis. However, as mentioned before, it is difficult to quantitatively
evaluate the accuracy of any of these approaches, because a set of gold standard experimen-
tally validated networks does not exist148.
5.3 CoDiNA in a nutshell
I will first describe briefly the idea behind themethod, and in Subsection 5.3.1 I describe the
algorithm and the method in details.
To perform a comparison of co-expression networks, CoDiNA requires as input a set of
networks to be assessed (Figures 5.1a, 5.1b, 5.1c). The networks can be constructed using
a correlation method, but should only contain links that are statistically significant given
a predefined p−value threshold, links that are not significant should have its weight set to
zero.
In order to avoid false associations, i.e. the incorrect inference that a particular gene
is associated with a specific condition, the method requires that all investigated nodes are
present in allnetworks: If a node is absent in at least onenetwork, all of its links are removed
from the networks in which it is present. This does not apply to nodes that are present but
have no significant links. In this case, it is assigned a (weight) value of zero, thus allowing
all measured node to be included in the analysis, even when they only have non-significant
links.
The weight value of the link between the genes i and j, denoted by ρi,j , is defined within
the interval [−1, 1] (Figure 5.1d). To denote links as positive, negative, or neutral this interval
is divided into three (equal) parts (Figure 5.1e). To compare networkswhose intervalsmight
vary, one option is to normalise the data inside the interval to [−1, 1]; I refer to this approach
as stretch. This step is particularly important to compare networks that were not measured
under identical and therefore comparable experimental conditions.
Each link is classified into one of three Φ categories based on its weight:
1. A link is classified as α if it is present in all networks with the same sign, i.e., it is an
interaction that is common to all networks. In gene co-expression networks, it means
that if the same interaction exists across all networks under comparison, probably,
would be a high cost for changing this regulatory process (Figure 5.2a);
2. A link is called β if it is present in all networks but with different signs of the link’s
weight, i.e., it represents a different kind of interaction in at least one network. The bi-
ological interpretation of this category is that a particular gene changed its function so
that a gene that up-regulates another gene in one condition down-regulates the same
gene in another condition (or vice-versa). This is one of the most important interac-
tions one should look for. Changes in the regulatory process might indicate a change
of the gene function (Figure 5.2b);














































































































































(E) Divide the intervals.
FIGURE 5.1: Visual representation of the CoDiNAmethod for a 3-network comparison: Areas definition.
5.1a, 5.1b and5.1cdisplay three independent networks to be compared; violet links represent positively corre-
lated gene-pairs, and green links negatively correlated ones. Node-size is relative to node strength. 5.1d shows
the geometrical representation of CoDiNA: a 3D scatter-plot that is derived from plotting the weights of each
link in the three networks. 5.1e displays the slices on the cube based on τ .
3. A link is considered a γ link, if it is present in some networks but not all, regardless
of the sign of the link’s weight, i.e., this link is specific to at least one network. This
category pinpoints rewiring on the network topology, meaning that genes can start
or stop regulating another gene and might indicate changes in metabolic pathways
(Figure 5.2c).
To further characterisehow a particular link is different or specific, a subcategory have to
be assigned, Φ̃ (Figure 5.2d). This subcategory clarifies to which condition a link is specific
or in which condition it has changed.
After all links are classified, they receive a score that is used tofilter thenetworks for back-
ground noise (Figure 5.3a and Figure 5.3b). After applying the filter to the network (Figure
5.3c), the nodes have to be classified. This is done for each gene by testing the hypothesis
































































































































































































































































(D) All categories and subcategories.
FIGURE 5.2: Visual representation of the CoDiNAmethod for a 3-network comparison: Categories defi-
nition. 5.1e displays the slices on the cube based on τ . 5.2a represents where the α links lie on the 3D space;
similarly, 5.2b represents the β and 5.2c, γ. The fullΦ and Φ̃ positions can be seem on 5.2d.
of the frequency of links in eachΦ and Φ̃ categories are different than expected by chance,
using a χ2 goodness-of-fit (Figure 5.3d).
5.3.1 How themagic works
The notation used here is the same as previously presented in Section 3.2. For a set of nodes
N,N = {N1, . . . , Nn}, where the indices in the nodes are denoted by: i or j. The total num-
ber of nodes in a network isn.W is a set of independentnetworksW = {W1, . . . ,Ww}. The
index for the networks is k and the total number of networks is w. Each links has a specific
link weight, ρij,k ∈ [−1, 1], connecting nodes i and j in a network k. If the compared net-
works have different link-weight ranges, these may be normalised by using a multiplicative













































































































































(D) CoDiNA network: Nodes classified.
FIGURE5.3: Visual representationof theCoDiNAmethod for a 3-network comparison: Scores definition.
The scores are shown in∆∗ 5.3a and∆ρ̃ 5.3b. The filtered network only for strong andwell-classified links are
displayed in 5.3c. Finally, the network where the nodes and links are classified is represented in 5.3d.
(stretch) parameter. This parameter forces the ρij,k values to be inside this interval. This is
particularly important for comparing networks constructed from different and not directly
comparable measures.
In order to avoid false associations, an important step to be aware of is that anode should
bepresent in all networks; if a node is absent in at least onenetwork, we remove all of its links
in the networks where this node is present (Algorithm 1). This step is implemented to pre-
vent the erroneous inference that a particular node is associated with a specific condition,
when in fact that specific node possibly was not measured in the other conditions. If a link
weight is found not to be significant, we assign it a (weight) value of zero, thus allowing all
measured nodes to be included in the analysis even when only some of its links are signifi-
cant.
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Algorithm 1Description of the RemoveNodes procedure
Input: Set ofN nodes that belongs to the each network from the setW
Output: Set of common nodes to all w networks






Next, the linkweight in eachnetwork is categorised. Bydefault, the interval is partitioned
into three equal parts (τ = 1/3), which will be denoted as corresponding to a positive link,
negative link or neutral link (Algorithm 2). Each link is categorised as
ρ̃ij,k =

−1 if ρij,k < −τ
1 if ρij,k > τ
0 otherwise,
where ρ̃ij,k is an integer transformation of the link weight based on the threshold, and τ . If a
particular link categorical weight ρ̃ij,k is zero in all thewnetworks, this link is removed from
posterior analyses.
Algorithm 2Description of the links categorisation algorithm
Input: Set ofW networks withN nodes (w > 2;n > 2)
Output: Links weight categorised into−1, 0 or 1
1: Set τ > 0;
2: By default τ ← 1/3;
3: procedure ASSIGNCLASSES
4: for ρij ← 1 to e do
5: for ρij k ← 1 to w do
6: if ρij,k < τ then
7: ρ̃ij,k← −1;








After the correlation values are coded into the categorical variables ρ̃ij,k, each link is as-
signed to an additional subcategory, Φ̃, that shows inwhich condition the link is present and
what is its sign, if present.
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k=1 |ρ̃ij,k| = w ∧ |
∑w
k=1 ρ̃ij,k| = w
β if
∑w
k=1 |ρ̃ij,k| = w ∧ |
∑w
k=1 ρ̃ij,k| < w
γ otherwise.
The Algorithm3 describes this process. Each link receives a subcategory, Φ̃, based on the
pattern of networks inwhich that link exists. Thismakes itmore straightforward to interpret
the links in each of theΦ categories, and as a result, this improves our ability to identify links
that are specific or it has a different behaviour to a subset of networks. This classification
step is particularly important for links that are classified as β or γ type, because it is a clear
identification inwhich network(s) the link is specific or different. Moreover, a group is given.
The group gives the exact sign for a link in all networks. The maximum number of group is
(3w − 1). Note that, the group where all categorical values are equal to zero is removed from
analyses.
Algorithm 3Description of the Φ algorithm
Input: Set ofW networks withN nodes (W > 2;N > 2)
Output: Network with links categorised into α, β or γ
1: Set τ > 0;
2: procedure PHILINKS
3: for ρ̃ i← 1 to e do
4: for ρ̃i,j k ← 1 to w do
5: if
∑w






j ρ̃ij,k = w then
8: Φij← α;









14: Calculate the penalised Euclidean Distance ∆∗ij (Equation 5.1).




To illustrate the concept of subcategory, assume the following ρ̃ of a particular link in 3
networks: NetworkA = 1; NetworkB = 1 andNetworkC = 1. Because the value 1 is common
in the threenetworks, thisΦ category is clearlyα, andno further explanation isneeded. Now,
take as a second example, NetworkA = 1; NetworkB = −1 and NetworkC = 1. Its Φ class
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is β, but this class cannot help us understand where the change occurs, therefore, the Φ̃ is
needed. Its Φ̃ class is βνB . Important to note is that CoDiNA assumes the first network to
be the reference network. And ν is a vector with all networks that the value is different from
the reference network, in this case, NetworkA. As a final example, assume that the ρ̃ weight
of the three networks are 0, 1 and 1 for Networks A, B and C, respectively. This link does
not occur in network A, so it is a γ links, that is specific to networks B and C. But this is
not possible to understand only by reading that its category is γ, therefore, its Φ̃ category is
γνB.C .
Let,L, be the set of linksL = {L1, . . . , Ll} and l the amount of links inL. When allL links
are assigned a Φ category and further subcategorised as Φ̃, it is necessary to score the links
to identify those that are stronger. For every link i = 1, . . . , l, we interpret the array of link
weights (ρ1i, . . . , ρwi) as a point in a w-dimensional Euclidean space. In particular, as each
link weight is bounded, all points are contained in the cube determined by the Cartesian
product [−1, 1]w.
As such, a link that is closer to the centre of the w-dimensional cube is weaker than a
link closer to the links. Based on that, the Euclidean distance,∆, to the origin of the space is
calculated for all linksEij as
∆ij =
√





However, since links closer to cornerswill triviallyhavea larger∆ compared to theothers,
all distances are penalised by the maximum theoretical distance a link can assume in its








which lies in the unit interval.
A second step it to normalise the resulting values in eachΦ and Φ̃ categories. I refer to it
as∆∗∗. Normalising the distance can be away to overcome the challenge of some categories





Three different approaches may be applied to the normalisation:
• Normalise all the links together: Here, it is not considered if a complete cluster is situ-
ated near the surface or closer to the centre of the cube;
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• Normalise links according to theirΦ and Φ̃ class: In this alternative, all the categories
are a part of the final output. This means that if one of the Φ groups lies inside the
cube closer to its centre compared to the other Φ categories, it will be possible to see
links that belong to this category in the final network.
Another important score calculated by CoDiNA, called internal Score, denoted by ∆ρ̃,
measures the distance from the link ij to the theoretical best well-clustered link in that par-
ticular Φ̃ category. In other words, if a link is considered an α with all positive links, we
calculate its distance to the point (1, 1, 1). This score allows us to identify links that aremost
well defined for each Φ̃ category.
Because the two scores ∆∗∗ and ∆ρ̃ are highly negatively correlated, the ratio between
them also gives us a measure of the very best well-defined links. For a well defined not
stretched CoDiNA network, this ratio should be greater or equal than 1.
Knowing only the links classification is not sufficient to describe a network; we are also
interested in thenodes’ classification. Todefine theΦ categoryof aparticularnode,wemake
a frequency table of howmany times each node had a link in eachΦ category and Φ̃ subcat-
egory. Using a χ2 goodness-of-fit test the hypothesis that the links of a node are distributed
equally in all categories are tested. If the null hypothesis is rejected, theΦ -category with the
maximum number of links is assigned to that particular node. Similarly, the same is done
for the Φ̃ (Algorithm 4).
Algorithm 4Description of the node-categorisation algorithm
Input: Set ofN nodes with L links (l > 2; n > 2)
Output: Node classified as α, β or γ type
1: procedure PHINODES
2: for i← 1 to n do
3: Φα = Count α;
4: Φβ = Count β;
5: Φγ = Count γ;
6: Test if Φα 6= Φβ 6= Φγ
7: end for
8: end procedure
Algorithm 5 shows the complete pseudocode for the CoDiNA method.
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5.4 A package to compare multiple networks
To make the proposed methodology publicly available, an R package, called CoDiNA, where
all the presented steps are implemented. The R package also includes an interactive visual-
isation tool, similar to the one presented in Chapter 4, its workflow analysis is presented in
Figure 5.4. The functions included in the package are:
• normalize(): Normalises a variable according to Equation 5.2;
• OrderNames(): Reorder the names of the nodes for each link in alphabetical order;
• MakeDiffNet(): Categorise all the links intoΦ, Φ̃ and also the group. It also computes
the normalised scores;
• plot: Classifies the nodes into Φ and Φ̃ following a user-defined cutoff for the cho-
sen distance and plots the network in an interactive graph, where nodes and links can
be dragged, clicked and chosen according to its group or classification. The size of a
node is relative to its degree. Nodes and links that belong to theα (common) group are
coloured in shades of green; Nodes belonging to the β (different) group are coloured
in shades of red; Nodes of the γ (specific) group are coloured in shades of blue; Nodes
have a category for group and Φ or Φ̃, according to a χ2-goodness of fit test as de-
fined above. If a node is group-undetermined and it is grey coloured. The user can
also choose a layout for the network visualisation from those available in the igraph
package135. It is further possible to cluster nodes, using the parameter MakeGroups,
and the user may select among the following clustering algorithms: “walktrap”150,
“optimal”151, “spinglass”152–154, “edge.betweenness”155;156, “fast_greedy”157,
“infomap”158;159, “louvain”160, “label_prop”161 and “leading_eigen”162. These al-
gorithms are implemented in the igraph package135;
The CoDiNA package also contains three datasets for illustrative purposes.
• The AST data.table contains the nodes and the weighted Topological Overlap (wTO)
of Transcription Factors (TFs), from GSE4290163 for astrocytomas;
• TheGLIdata.table contains thenodesand thewTOofTFs, fromGSE4290163 for glioblas-
tomas;
• TheOLI data.table contains the nodes and the wTO of TFs, fromGSE4290163 for oligo-
dendrogliomas;
• And the CTR data.table contains the nodes and the wTO of TFs, from GSE4290163 for
controls.
CoDiNA is open source and freely available from CRAN https://cran.r-project.org/
web/packages/CoDiNA/under theGPL−2Open Source License, and it is platform indepen-
dent.
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FIGURE 5.4: Workflow process of the CoDiNA R package. Input data for the CoDiNA R package can be any
network, filtered for containingonly significant links. Edge list is a list containingall the links and itsweights. To
links forwhich thep−value isnot significant, theuser canassignaweightof zero. The functionMakeDiffNet()
clusters the links into theΦ and Φ̃ categories, calculates and normalises the scores. Its output is used as input
for clustering the nodes into categories by the function ClusterNodes(). The plot() function can be used
on the output from MakeDiffNett() and automatically calls the function ClusterNodes().
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Makeme Rich
“I don’t need no money
As long as I can feel the beat
I don’t need no money
As long as I keep dancing”
– Cheap Thrills, Sia
A
FTER CONSTRUCTING and comparing a set of networks it becomes natural to under-
stand andmake inference whether the transcripts associated with a particular phe-
notype are found by chance. Therefore an enrichment analysis is necessary. In this
Chapter, I will present a robust and efficient approach that aims to find enrichment of gene-
sets describedas associatedwithdisorders, Gene-DiseaseAssociations (GDA). Thismethod-
ology is publicly available as an R package, RichR that contains a dataset, Gene-to-Disorder
(g2d), that was manually curated and combines information from the five most up-to-date
studies on GDA into one.
Thismethodology is publicly available on the CRAN as an R package, called RichR. A pub-
lication regarding this methodology is under preparation.
• D.M.Gysi andK.Nowick. “MakemeRichR: anRenrichment package”. In preparation.
2019.
6.1 Motivation
A functional enrichment analysis canhelp to characterise large lists of candidate genes asso-
ciated with functions, diseases, biological processes among others. In general, this analysis
consists of comparing the gene-set against a background list and testing if there is a signifi-
cant difference in gene functions164.
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The functional annotation can be retrieved from several databases such as Gene Ontol-
ogy (GO), that returns information on molecular and biological functions (GO), metabolic
pathway (Kyoto Encyclopedia of Genes and Genomes (KEGG)165, WikiPathways166), exper-
imental databases (Encyclopedia of DNA Elements (ENCODE)167). When a set of genes in-
volved in the same function is also significant in the candidate list, it is more likely to be a
relevant function in the candidate list.
The same rationale can be applied for a disease enrichment. In one hand many tools
are able to make the enrichment analysis for GO (e. g. EasyGO168, GOrilla169, topGO170,
GSEA171) on the other very few are able to deal with disorders (DisGeNET172, GS2D164 and
PsyGenNET173). Even though these tools are able to correct for the background, all have
the background fixed and defined by the genes each database contains and it cannot be
changedby theuser. It becomes aproblemwhendealingwith a subset of transcripts, such as
expressed genes, TranscriptionFactors (TFs), non-codingRNA (ncRNA) or a set of orthologs.
Therefore, a tool that allows the user to define its own background set is necessary.
6.2 Construction of a curated dataset of Gene-Disease as-
sociation
I constructed andmanually curated a database that associates genes to disorders usingmul-
tiple tools andpublication that incorporates information on genes and associated disorders.
The datasets combined here collects information about genes and disorders from PubMed,
Mesh and GenomeWide Association Study (GWAS) studies.
6.2.1 Data collection
Data of association of genes to disorders were retrieved from multiple tools. Those are the
fourmost up-to-date and complete tools that combines information fromGene-Disease As-
sociations (GDA): Gene Set to Disease (GS2D)164, Disease to Genes Network (DisGeNET)172,
Berto201654 and Psychiatric disorders Gene association NETwork (PsyGeNET)173. Another
important dataset is eDGAR174 that could be included, however, it does not allow multiple
searches and the download of a formated table.
TheGS2D164 is availableonline fromhttp://cbdm-01.zdv.uni-mainz.de/~jfontain/
cms/?page_id=605 and contains data fromNational Center for Biotechnology Information
(NCBI), PubMed andMeSH. All genes are identified by official Entrez Gene IDs, and the dis-
eases are identified by MeSH C terms. The Disease-related citations are retrieved from an-
notations in PubMed. I filtered this dataset in order to retain only genes that had at least
two publications that associated it with the same disease. Because this tool by its own may
not reflect themost current and accurate biomedical/scientific data available fromNational
Library of Medicine (NLM), I also included data from other datasets.
From DisGeNET, I used the curated data, that integrates data from UniProt, PsyGeNET,
ClinVar, Orphanet, the GWAS Catalog, CTD (human data) andHuman Phenotype Ontology.
This database is homogeneously annotated with controlled vocabularies.
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Berto et al.54 made available a list containing GDA for mental disorders and brain de-
velopment. For Autism Spectrum Disorder (ASD) his list was constructed using SFARI gene
database175–177 and a genome-wide differential expression study178. For other Gene Regula-
toryFactors (GRFs) associatedwithParkinson’sdisease, Alzheimer’sdisease, andSchizophre-
nia theyused results fromGWASstudies179–182 and independentpublications183–188, thebrain
development genes were manually selected from independent publications181;189 and On-
line Mendelian Inheritance in Man (OMIM).
PsyGeNET is a tool that collects data for GDA of psychiatric diseases. This database has
been developed by automatic extraction of information from the literature using the text
mining tool BeFree and contains updated information on depression, bipolar disorder, al-
cohol use disorders and cocaine use disorders, and has been expanded to cover other psy-
chiatric diseases of interest: bipolar disorder, schizophrenia, substance-induced depressive
disorder and psychoses and cannabis use disorder.
The overlap of those databases is very small (0.004%), the biggest share of genes and
diseases associations that is reported in only one database (95.98%) (Figure 6.1). This shows
that it is important to consider all datasets inorder toobtain amore robustGene-to-Disorder
(g2d) dataset. This lack of overlap is due to the different platforms andmethods used by the
different tools to retrieve data. Moreover, each tool collected the gene-disorder association
from different sources.
6.2.2 Curating the data
The final database was filtered for diseases that had more than 4 genes associated with it;
this step is important to assure that the final database contains only polygenic diseases.
The next stepwas to collect only the gene name, its associated diseases and the source of
thedata. The sourceof thedata refers to theoriginal database that contains this information.
In all five databases, it is possible to retrieve the publications that identified the association
of the gene to the disease.
Genes had all their namesmatched to Entrez IDusing the BioMart Rpackage190;191. Dis-
eases kept the name it appeared in the original dataset, however, the same disease might
have different orthography in the five databases. Thus, similar terms weremerged into one.
For example: Major Depression and Major Depression Disorder were considered to be the
same disorder. After assuring that the same disorder would have the same term in all dis-
eases, each gene-disorder pair was marked with the datasets that had this information.
In total, the new (cleaned) g2d database contains 13, 028 genes associated to 5, 295 dis-
eases.
6.3 Enrichment function
In order to calculate the disease enrichment of a set of genes, I wrote the function
Enrichment(). This function tests thehypothesis, for eachdisease, that thenumberof genes
found is different than random. Genes are first corrected for the background gene list, given
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FIGURE 6.1: Overlap of Gene-Diseases in the four databases: The barplot shows the frequency of gene and
diseases that repeats on the datasets, after curating diseases names. It becomes clear that the overlap of the
information of gene and diseases is quite small, therefore, combining all the information into one dataset is
desired.
by the user. Correcting for the background allow us, to identify disease enrichment even in
a smaller subset of genes, for example, using only TFs.
Thehypothesis test is doneusingaproportion test andFisher’sExact test. Bothp−values are
returned and its p−values are corrected using Benjamini-Hochberg adjusted p−value (BH).
The raw p−values are combined into one, using Fisher’s method for combining p−value.
Previously presented in Equation 4.6.
This tool is used in Chapter 8 to define gene enrichment for mental disorders.
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“Once you begin to appreciate the structure of the mind, there’s no reason anything
about us can’t be changed. Pain can be destroyed. The mind can be solved.”
– Maniac, James Mantleray
N
ON CODING RNAS can regulatemanybiological processes, including theoneof anun-
specialized cell differentiating itself in a neuron, known as neurogenesis. The brain-
enriched miR−124, a particular micro RNA (miRNA), is assigned as a key player of
neuronal differentiation via its complex, but little understood, regulation of thousands of
annotated targets. To systematically understand its regulatory functions, I used Clustered
Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 human stem cells where
all the six miR−124 alleles were edited and disrupted to construct, analyse and compare its
regulatory network. Under neuronal induction, miR−124-deleted cells experienced neuro-
genesis and became functional neurons, even though it had altered morphology and neu-
rotransmitter specification. I performed a Transcription Factor (TF)-network analysis and
revealed indirect miR−124 effects on apoptosis and neuronal sub-type differentiation. The
results emphasise the need for combined experimental- and systems-level analyses to com-
prehensively untangle and reveal miRNA functions, including their involvement in the neu-
rogenesis of diverse neuronal cell types found in the human brain.
The results presented in this Chapter are based onmy shared first authorship paper pub-
lished in Cell Systems.
• L. K. Kutsche∗, D. M. Gysi∗, J. Fallmann, K. Lenk, R. Petri, A. Swiersy, S. D. Klapper, K.
Pircs, S. Khattak, P. F. Stadler, J. Jakobsson, K. Nowick, and V. Busskamp. “Combined
experimental and system-level analyses reveal the complex regulatorynetworkofmiR-
124 during human neurogenesis”. Cell Systems, 7(4), 438–452, 2018.
∗Both authors contributed equally.
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7.1 Motivation
The human brain is constituted of more than 300 cell types of neurons, with an undeter-
mined number of subtypes. Their underlying developmental features are essentially un-
known. Up-to-date, micro RNAs (miRNAs) have been identified as playing a relevant role
in the neurogenesis192. These miRNAs bind in a sequence-specific way to messenger RNA
(mRNA) transcripts and negatively interfere with the concomitant translation of multiple
target transcripts by annealing predominantly at the 3′ Untranslated Region (UTR).
In the brain, themiR−124 is one of themost abundantmiRNAs, and it is associated with
processes such as neurogenesis193;194, cancer195;196, the control of synaptic functions in ma-
ture neurons in health197–199 and disease200;201 including cognitive impairment40;202. It is still
not clear how, and at which developmental stages, miR−124 affects neurons. For instance,
miR−124 has been shown to be involved in the initiation of neuronal differentiation203–210,
as well as in the maturation and survival of the differentiated neurons211–216. miR−124 dif-
ferent functions have been extensively studied in diverse model systems, such as mouse,
chicken, frog, and human immortalised cell lines, with partially contradictory results about
miR−124’s importance in neurogenesis199;204;205;207;208;212;214;215;217–225.
Despite previous knockout studies in mouse models were incomplete because not all
three miR−124 paralogs, six alleles in total, coding for identical mature miRNAs were si-
multaneously removed214. There is also a high heterogeneity of neuronal ancestor cells in
vivo, impeding studies ofmiR−124 in defined cell types226. Poolingheterogeneous cell types
that differ in their coding and non-coding transcriptome likely results in incomplete views
on miR−124’s complex regulatory role: there are 4, 024 computationally predicted human
transcripts with miR−124 binding sites, as well as further potential non-canonical bind-
ing events227;228. So far, most studies have experimentally validated only single or very few
miR−124 targets at once. It remains unclear how many miR−124 targets are simultane-
ously regulated within a cell and what their composed impact is – direct and also indirect
– via gene regulatory cascades. Therefore, it is essential to investigate miR−124’s functions
in a well-defined, homogeneous, and complete Knock Out (KO) model system. The data
used was obtained from human induced Pluripotent Stem Cell (hiPSC)-based model sys-
tem tomimic theneurogenesis of bipolar neuronsunder controlled and reproducible condi-
tions229. A completemiR−124 KO (∆miR−124) was generated using CRISPR/CAS9 genome
editing230–232, where all the six alleles were deleted. By forced Transcription Factor (TF) in-
duction, the neuronal differentiation in Wild Type (WT) and ∆miR−124 cells was rapidly
and robustly induced. Performing an in-depth molecular, cellular, and physiological char-
acterisation of the ∆miR−124 and isogenic WT lines revealed altered morphological and
functional features, neurotransmitter specification, and decreased long-term viability. 98
miR−124-regulated targets were identified by the RNA-Interaction Protein Immunoprecip-
itation and subsequent sequencing (RIP-seq)223;233 by capturing active miRNAs and their
mRNA targets bounding to Argonaute-2 (AGO2).
Since my interest lied in functional differences between TF networks in WT and the
∆miR−124neurons, these networkswere constructed using theweightedTopologicalOver-
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lap (wTO) method, presented in Chapter 4, that distinguishes positive and negative corre-
lations54;55 and includes a p−value62 followed by the comparative method I presented in
Chapter 5, Co-expression Differential Network Analysis (CoDiNA)52. Using this computa-
tional approach, I was able to detect similarities and specific differences in WT and
∆miR−124 neurogenesis at the level of genes and their regulatory connections including
the impacts on neurogenesis of the uncharacterised TF ZNF787. This results highlights the
complexity of the downstream effects of experimental miRNAs manipulations.
7.2 Methods
HiPSCs, generated from fibroblasts, were reprogrammed to become neurons according to
protocols described in Kutsche et al.58. Before the neurogenesis was induced, the six alle-
les that codes for the miR−124 were removed. With that, two cell lines were originated and
followed-up for transcriptomic analysis for the next four days and fourteen for morpholog-
ical and physiological analysis. The cell line where it was KO for the miRNA under study is
called ∆miR−124 and the cells that did not undergo this process are called WT. Both cell
colonies had its morphology and physiology analysed to ensure that the final cells were in-
deed neurons. For details of these experiments, please refer to the original paper.
Seven replicates were collected for each one of the 4 days of the neurogenesis induction
for each group: WT and ∆miR−124. The complementary DNA (cDNA) was sequenced; I
processed the Fasta and controlled for quality as using with FASTQC31 (v0.11.4, accessed
2016 − 09 − 10), reads were mapped to the human genome assembly hg38/GRCh38 using
Segemehl (v0.2.0 − 418,34–36). I extracted only uniquely mapped reads for further analysis.
Counts were computed using rnacounter38 using Reads Per Kilobase Million (RPKM) and
raw counts, from the v25 gencode annotation234. Differential Expression (DE) was calcu-
lated usingDESeq2with raw counts235. The contrast I usedwas∆miR−124 versusWT. Nor-
malised Fold Change (nFC) of the significant genes132 (Benjamini & Hochberg padj−value<
0.05) were used to construct the time series analysis. Z-scores were used to visualise expres-
sion analysis per gene. For the ZNF787-associated genes, counts were log-transformedwith
DESeq2 prior to standardisation.
TFs that were differentially expressed at all timepoints from 1 to 4 days post induction
(dpi) were clustered according to their nFCpattern over time using the Self OrganisingMaps
(SOM) algorithm236, implemented in R using the package SOM237. I increased the number of
clusters until the q−error of each group was reduced, with the average distortion measure
under 10. The membership of the genes to each SOM cluster was used to colour the genes
in the (target-) TF-TF network analysis.
I used my R package wTO62;238, presented in Chapter 4, to calculate the wTO of the
(target-) TF-TF networks. The correlation between a set of genes was corrected using all the
other genes present, thus reducing the noise and the false positives, and taking into account
the commonalities of those genes. For each one of the ten networks built (for both WT and
∆miR−124 from day 0 to 4 dpi), the parameters used in this calculationwere Pearson corre-
lation coefficient and 1, 000 bootstrap resampling. The final results were filtered to a proba-
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bility of 0.10 for randomwTO. The wTO was calculated based on RPKM values. Genes with
RPKM < 5 for each day were removed. From the total of 56, 269 mapped transcripts from
the RNA sequencing (RNA-seq) dataset, 39, 275 are considered to be expressed. Only TFs
fromthe target list (assembled fromtheGeneRegulatoryFactor (GRF)Catalogue54werecon-
sidered for the network analysis. The information for GRF Catalogue proteins was sourced
from the most seminal studies in the area of human GRF inventories239–245 and manually
curated: these are associated with gene ontology terms for regulation of transcription,DNA-
dependent transcription, RNA polymerase II transcription co-factor and co-repressor activity,
chromatin binding,modification, remodelling or silencing, among others. The wTO R pack-
age was used to visualise the interactive plots and igraph135 and network246 R packages
were used to visualise the steady developmental network. Human or primate specificity was
judged according to the Uniprot database247.
Later, the networks for each day were compared using CoDiNA, presented in Chapter 5.
Where links and nodes are classified according to Φ categories, to its commonalities, dif-
ferences and specificities. links are considered to be common (α) if they belong to a set of
networks (WT and ∆miR−124 for each dpi) with the same sign and similar strength. If the
sign changes fromone network to another, the link is considered different (β). If a particular
link belongs to one network only, it is considered to be specific to this network (γ). α and
β categories are intersections of correlated genes between WT and ∆miR−124; γ links are
exclusive for one condition. The classification of the interactions according to these con-
cepts is central to understand how the∆miR−124 networks are affected in their TF interac-
tions during the time course. Links were scored as previously described. Only links with a
normalisedΦ distance greater than 0.5were kept for further analysis. In order to define the
category a TF belongs to, a χ2 goodness-of-fit test was used to test if the distribution of the
links is different than 1/3 for each category (padj−value < 0.05). Each TF is classified using
the link category (Φ) and subcategory (Φ̃) that appears most frequently for that particular
TF. Later, the correlation between TFs and genes wasmeasured using a Pearson correlation
coefficient. Only absolute correlations above 0.9were considered for the following analyses.
CoDiNA was computed separately for each day. In order to compare WT and ∆miR−124
networks, the TFs were distinguished according to a category; the names of the genes cor-
related with each TF were retrieved.
In order to verify if any gene function was enriched in any of the DE genes,Φ and Φ̃ Co-
DiNA groups, Gene Ontology (GO) enrichment analysis was conducted using the topGO170
R package using all expressed genes (average RPKM > 10) as background for each day. Se-
mantic clustering was performedwith Reduce + Visualise Gene Ontology (ReViGO)248 using
the Semantic similarity scores (SimRel) measure and allowed similarity of 0.9.
7.3 Results
The overall changes in gene expression in the absence ofmiR−124was studied by analysing
differential gene expression patterns betweenWTand∆miR−124 over neurogenesis course
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FIGURE 7.1: Extended transcriptome analysis Venn diagram for differential gene expression over the time
course of differentiation (0− 4 dpi) comparing WT and∆miR−124with associated GO terms.
15, 196, and at 4 dpi 15, 731 (padj−value < 0.05; Figure 7.1). These genes showedGO enrich-
ment for differentiation, cell adhesion,morphogenesis, and cell division.
Because miRNAs repress gene expression, it is expected that direct miR−124 targets
would show increased mRNA levels after miR−124 KO. It remains inconclusive to use com-
putational predictions ofmiRNA target genes,mainly due to the unspecificity ofmiRNAs. In
general, they can bind to thousands of targets andmost of themRNAs havemultiplemiRNA
binding sites. Just for the miR−124 there are 4, 024 genes with possible binding sites an-
notated249–252. Using AGO2-RIP-seq for the identification of active miRNAs targets, it was
identified 98 high-confidence active miR−124−targets (from those, 81 were validated) out
of the 4, 024 annotated targets in inducible-Neurogenin Cell Line (iNGN) neurons.
The 98 high-probability targets were analysed to assess their involvement in biological
processes using a GO term analysis Figure 7.2b. The GO enriched terms were associated
with synaptic maturation and apoptosis at 4 dpi (Figure 7.2b).
7.3.1 A network of transcription factors is influenced bymiR-124
A significant fraction of the identified miR−124 targets (24%, m = 98, p−value< 0.05; χ2-
test) coded for TFs, suggesting that miR−124 exerts much of its impact via influencing gene
regulatory cascades involving many TFs. Measuring indirect miRNA effects is not trivial253,
but essential to understand the full spectrum of miRNA regulation. Therefore, I conducted
a time series network analysis focusing on the 24 miR−124 targets coding for TFs to under-
stand themiR−124 regulatory network that underlies the neurogenesis in humans. For each
timepoint and, separately, forWTand∆miR−124 cells (m= 7 for each timepoint), the genes
that correlated with the 24 TFs-targets were identified. Correlated genes represent potential
target genes or interaction partners of each TFs.
To reveal how similar TFs were to their correlated target genes, the wTO networks were
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(B) GO enrichment analysis.
FIGURE 7.2: Differential Expression and GO enrichment analysis 7.2a Differentially expressed genes were
filteredas shown in theVenndiagram. Transcriptswith less30UTRsignal inAGO2-IPdata inmiR−124 samples
were intersected with significantly upregulated transcripts in the whole-cell samples. 127 transcripts over-
lapped, of which 98 were annotated miR−124 targets. And 98 high-probability miR−124 targets filtered for
30 UTR peak signal decrease (left) and increase in expression (right). Data are presented as mean± log2-fold
change standard error. Experimentally validated targets according tomiRTarBase are indicated in red. 43 addi-
tional targets were validated by luciferase reporter assays; color code indicates relative luciferase signal reduc-
tion upon miR−124 overexpression. 7.2b GO term enrichment analysis of filtered miR-124 targets indicating
their involvement in apoptosis and synaptic maturation.
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FIGURE 7.3: Time course network: Expression correlation (as weighted topological overlap, wTO) between
TFs that were differentially expressed on at least one day between 1 dpi and 4 dpi, but not on 0 dpi. Differ-
ences in interaction (|wTOWT − wTO∆miR−124| > 0.2) are shown in the top panel. Every panel shows the
development of the network during differentiation for the difference (top), WT (middle), and∆miR−124 (bot-
tom). The opacity of the line indicates the wTO value. Coloured gene names represent a specific SOM cluster
as shown in Figure 7.4a. Underlined TFs are miR-124 targets (Figure 7.2a).
constructed for all expressed TFs for each timepoint for WT and∆miR−124 cells separately
(Figure 7.3). In thesewTO networks, nodes represent TFs, and they are connected by a link if
they share a significant number of correlated genes, i.e., are likely working concomitantly in
regulating their target genes. As mentioned in Chapter 4, the benefits of Topological Over-
lap (TO) networks is that they result in more robust definitions of connections and inter-
actions among genes than simple correlation networks, by the reduction of false positive
inferences55;62;115;118;119. In contrast to the widely-used Weighted Gene Co-Expression Net-
work Analysis (WGCNA)98;254, the wTO network that I presented here accommodates both
positive and negative correlations, which is essential for analysing TFs as they have both en-
hancing and repressing functions55;62. Furthermore, this method also specifies p−value to
each link, resulting in a high-accuracy network based on seven replicates, which is essen-
tial for comparing networks with high confidence62. At 0 dpi, WT and ∆miR−124 networks
were identical. Differences on the networks started to appear from 1 dpi, peaked at 3 dpi,
and decreased at 4 dpi, Figure 7.3.
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To acknowledge the contrast between the WT and ∆miR−124 networks, the wTO of
∆miR−124 from the wTO of WT were subtracted, resulting in differential networks (Fig-
ure 7.3). Interesting to note is that, in the WT wTO networks, a parcel of links were reac-
tivated at different timepoints, while in the ∆miR−124 cells most links were unique, sug-
















































WT − total TFs ∆miR-124 − total TFs
WT − active TFs ∆miR-124 − active TFs
(C) Average degree.
FIGURE 7.4: SOM classification, nodes activation 7.4a depics the Loess regression from Self Organising
Maps calculated on the basis of normalised fold changes of permanently (1 − 4 dpi) differentially expressed
TFs. Colour code represents the SOM categories. 7.4b shows the nodes activation of the network depicted
gene relationships reappearing on different days. 7.4c presents the degree of nodes for each network for active
genes and full set of genes over time, as a measure for network strength.
In the following step, I classified the differentially expressed TFs (14.95%, m = 3, 145)
using a SOM algorithm (Figure 7.4a). The SOM categories with a steady increase in DE over
time were considered to be the best candidates for also being influenced by miR−124, as
they were expected to be upregulated in the absence of the negative regulator (Figure 7.4a).
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(A) Correlation network. (B) wTO network.
FIGURE 7.5: Targets of ZNF787: 7.5a is an illustration of a miR−124 target-specific correlation subnetwork
showing TF nodes at 3 dpi. Coloured lines indicate negative or positive correlations of underlying associated
genes. 7.5b is an illustration of the subnetwork shown in 7.5a, including underlying associated genes.
MostmiR−124 targets obtained suggested in by the analysis appeared in themonotonically
increasing SOMcategories, which is in linewith the lack of repressingmiR−124 (Figure 7.2a
and Figure 7.4a): the targets previously described included PTBP1, which was identified as
an important factor within the co-expression network (Figure 7.3). Nodes including GLIS2,
SERTAD3, andTP73 appeared tobe very important, as these genes fulfilled all criteria: i) they
were filtered and validated targets (Figure 7.2a); ii) were top hits in the network analysis; iii)
followed a rising trend in the SOM clustering.
Because most of the network difference was detected to happen at 3 dpi, it became the
centre for the subsequent analysis (Figure 7.3, Figure 7.5a and Figure 7.5b). I also detected
some miR−124 targeted TFs with unknown functions (ZNF787) and a indirectly targeted
human-specific (ZNF138) within the dense 3 dpi network of the ∆miR−124 samples240;247.
For example, themiR−124 target ZNF787 connects to ZNF138 viaUBE2 (Figure 7.5a). Other
correlated genes (Figure 7.5b) were extracted from thewTO analysis. This visualisation em-
phasises how integrated the ZNF787waswithin the gene regulatory network uponmiR−124
depletion at 3 dpi.
The importance of ZNF787 was evaluated experimentally by perturbating the ZNF787
node by Over Expressing (OE) ZNF787 in WT iNGN cells (Figure 7.6a). The WT-ZNF787-
OE cells underwent neurogenesis and were positive for the neuronal marker MAP2. I per-
formed GO term analyses on DE genes between WT and WT-ZNF787-OE (m= 3 biological
replicates, 4 dpi). Particularly, concentrating on downregulated genes, many neuronal bio-
logical processes were significantly repressed (Figure 7.6b). Hence, the data indicated that
ZNF787 acts as aneuronal feature repressor. Thiswas in linewithZNF787 containing aKRAB
domain255 that leads to transcriptional repression256. Looking at ZNF787-correlated genes
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(A) Quantification of ZNF787OE. (B) GO enrichment analysis.
FIGURE 7.6: Overexpression of ZNF787 and its GO enrichment: 7.6a Quantification of ZNF787 overexpres-
sion (OE) efficiency in WT neurons over time. m = 3 biological replicates. Significance was assessed with un-
paired Student’s t tests with Holm-Sidak correction for multiple comparisons with ∗ ∗ ∗p−value 0.001. Data
are represented as mean± SEM; 7.6b shows the GO term enrichment analysis of significantly downregulated
transcripts (padj−value < 0.05, log2-fold change < 1) upon ZNF787 overexpression indicating its impact on
repressing neuronal differentiation andmaturation.
derived fromourwTO analysis, corresponding expression levelsmassively differed between
WT, ∆miR−124 and WT-ZNF787-OE (Figure Figure 7.8). Specifically, 51 out of 78 ZNF787-
associated genes showed a similar expression trend for ∆miR−124 and WT-ZNF787-OE in
comparison to WT (Spearman correlation, ρ = 0.498; p−value < 0.01; Pearson correlation,
ρ = 0.277; p−value < 0.01). Hence, ZNF787 behaves as one mediator of miR-124 activity.
This highlights ZNF787’s regulatory influence on the gene regulatory network when its
expression was enhanced due to miR−124 depletion or when OE. These variations could
lead to the detected downregulation of maturation-associated genes (Figure 7.6b) since
known neurogenesis-regulating factors, such as PTBP1, SP1 and HES5, were
upregulated207;257–259.
FIGURE 7.7: Semantic clustering of GO terms reveals shared anddifferent biological processes at 3dpi in
WTand∆miR−124 cells: Co-expressiondifferential network analysis of sharedfirst graphWT-specificmiddle
graph, or∆miR−124-specific last graph regulated genes at 3 dpi. Underlying biological processes are grouped
and highlighted.
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However, ZNF787OEdoesnot impedeneurogenesisper se as the cells are still positive for
MAP2. In summary, the wTO analysis suggested that the TF networks were globally altered
and differentially connected, especially at 3 dpi upon miR−124 depletion. In addition, my
analysis identified uncharacterised TFs - of which ZNF787 was experimentally validated -
having regulatory functions during neurogenesis.
7.3.2 Enrichment analysis of wTO network nodes reveals indirect miR-
124 functions
Later, I investigated which biological functions were controlled by the TF networks of WT
and ∆miR−124 cells at each timepoint, particularly which functions were common or dif-
ferent between the networks. For that, I usedCoDiNA52;260 and classified eachωi,j value into
common or specific networks (Figure Figure 7.7, Figure 7.4c), followed by GO enrichment
tests for the categories to report the biological processes.
GO groups that were common between the WT and ∆miR−124 networks at 0 dpi in-
cluded, for example, mRNA processing, cell division, and mitotic cell cycle (Figure 7.7). In
particular, WT and∆miR−124 networks shared the groups regulation of asymmetric cell di-
vision and regulation of extracellularmatrix disassembly at 1 dpi, and synapse assembly, reg-
ulation of synapse organization, and positive regulation of neurological system process at 4
dpi, indicating that aspects of neurogenesis were also present in ∆miR−124 cells.
Groups that were specific to WT network were also found. For example, the GO terms
layer formation in cerebral cortex and pyramidal neuron development at 1 dpi, regulation
of exit from mitosis and positive regulation of long-term neuronal synaptic plasticity at 2
dpi, positive regulation of dendritic cell differentiation at 3 dpi, and severalmRNA processing
groups at 4 dpi were different, detailed information can be found in S1 in the publication.
Metabolic terms and cell signalingpathways (Wnt signaling at 3dpi)were also specific toWT
cells (Figure 7.7), indicating that functions related to cell-cycle control and neuronal differ-
entiation started to be differentially controlled right from the beginning of neurogenesis.
∆miR−124 groups differed in ion incorporation and diverse metabolic processes at 1
and 2 dpi, and signal transduction resulting in induction of apoptosis, positive regulation
of long-term neuronal synaptic plasticity, regulation of dendritic spine morphogenesis, and
striatal medium spiny neuron differentiation at 3 dpi (Figure 7.7). In contrast to Wnt sig-
naling in WT, phosphatidylinositol 3-kinase signaling was detected in ∆miR−124 groups.
In particular, the GO term striatal medium spiny neuron differentiation was in line with the
BrainSpan analysis (more details in the paper). Our analysis further suggested that the dif-
ferences in cell fate regulation weremediated by the alteredmiR−124−disregulated TF net-
works in ∆miR−124 cells at 3 dpi. The regulatory network analysis of the TFs, which are
direct miR−124 targets, revealed clear differences in network architecture betweenWT and
∆miR−124 samples: these increased until the cells become post-mitotic. These complex
relationships, i.e. indirect miR−124 functions, would have been impossible to detect by
miR−124 target analysis alone. Furthermore, biological functions underlying these regula-
tory network differences are in linewith the phenotypic differences observed in∆miR−124.
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FIGURE 7.8: ZNF787-associated genes reappearing in target-wTO networks: Heatmap of ZNF787-
associated genes reappearing in target-wTO networks for WT, ∆miR−124, and WT-ZNF787-OE (RNA-seq, z
scores from rlog-transformed counts, m = 3 biological replicates). Arrows indicate similar expression trends
for∆miR−124 versus WT andWT-ZNF787 overexpression versus WT.
8
Understanding the human cognition
using TF-networks
“My whole brain was out of tune
I don’t know how to tune a brain, do you?
Went in to a brain shop
They said they’d have to rebuild the whole head
I said well, do what you gotta do
When i got my brain back, it didn’t work right
Didn’t have as many good ideas
Haven’t really have a good idea since i got it fixed”
– My brain,Morphine
C
OGNITION IS A GROUPofmental processes that includeattention,memory, producing
andunderstanding of language, learning, reasoning, problem-solving, and decision
making. Many of these mental processes take place in the Prefrontal Cortex (PFC).
The closest living relatives of humans, the chimpanzees and bonobos, display a rich
repertoire of higher cognitive functions, such as usage and production of tools, they teach
others how to make tools, they communicate to hunt cooperatively, and they can deceive
others. They further have some understanding of numbers and syntax, have a sophisti-
catedmemory, and seen to occasionally plan for the future261–263. Humans are distinct from
other apes by having amore complex communication systemand an extraordinary ability to
learn from others. They acquire knowledge faster and maintain newly acquired knowledge
over generations264. Genetic changesmust have facilitated the evolution of human-specific
cognitive skills. Several genes that are important for cognitive functions have been iden-
tified through research on cognitive disorders, such as Autism Spectrum Disorder (ASD),
Schizophrenia (SCZ) or Alzheimer’s Disease (AD). Many of these disorders share a common
genetic basis, that is characterised by overlapping sets of genes implicated in these disor-
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ders, and overlapping phenotype and symptoms. Knowing that, this Chapter has two main
objectives: i) define a Consensus Network (CN) wTO for the PFC of humans in some cogni-
tive diseases, such as ASD, AD, Bipolar Disorder (BD), Major Depression Disorder (MDD),
Parkinson Disease (PD) and SCZ and compare them with healthy individuals, and ii) com-
pare the CN of healthy humans with healthy apes.
The results of this Chapter are being prepared for a publication.
• D. M. Gysi and K. Nowick. “Evolution of gene-co-expression networks implicated in
cognitive functions in primates. In preparation. 2019.
8.1 Motivation
The adult human brain is not only composed bymany types of neurons, as we saw in Chap-
ter 7, but it is also arranged in many regions, each responsible for different functions, func-
tional connectivity patterns and distinct distribution of cell types59. Even though there is a
range of differences in connectivity between regions across individuals, a considerable part
of transcripts is conserved across the human population59. However, changes on the levels
of gene expressionmight lead to abnormal function265 such as psychiatric illness, for exam-
ple Autism Spectrum Disorder (ASD)266–269,Bipolar Disorder (BD)270–273, Major Depression
Disorder (MDD)46;47;272;274, Schizophrenia (SCZ)50;188 or neurodegenerative disorders such
as Alzheimer’s Disease (AD)180;275–277 and Parkinson Disease (PD)182;278–280.
ASD is a developmental disorder and is characterised by deficits in social communica-
tions, restricted and repetitive behaviours281;282. It has a high familiar recurrence283. It is
highly polygenic andmany genes that increase the risk for ASD has been identified284;285.
BD is a severe psychiatric disorder and is characterised by recurrent alternating episodes
of mania and depression270, neuropsychological shortfalls, immunological and physiolog-
ical changes286;287. It is also associated with high rates of premature mortality from suicide
and medical comorbidities288. BD is a complex disorder, with both environment and ge-
netic components270;289. However, many genes have been implicated to this disorder it is
still unknownmuch about it270.
MDD is another important psychiatric illness290. This is a disease that affects how the
person relates, feel and interacts with the world, to themselves and with other individuals.
In general, they lose interest in their daily activities, on their lives, feel worthless and lose the
capacity to feel pleasure290;291. Moreover, patients also show changes in biological processes
that regulate sleep, appetite, sexual activity, autonomic function, and neuroendocrine activ-
ity282;290. As ASD and BD, MDD is also highly polygenic and a complex disorder, where the
environment plays a big role292.
SCZ is a severe mental disorder that affects 1% of the population, and similar to BD has
also a high rate of premature mortality188. This disorder has different symptoms types, is
multidimensional and heterogeneous. And its symptoms are divided as positive and neg-
ative. The positive symptoms include ideas of reference, delusions and magical thinking,
while negative includes social withdraw293;294. It also is a polygenic complex phenotype.
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Theheritability for thosemental disordershasbeenestimatedasbeingaround80%295–297,
which is quite similar to type I diabetes298, but is greater than breast cancer299. AD has an
estimated heritability of 74%300 and PD, on the other side, 41%301;302.
ASD, BD, MDD and SCZ share signs, symptoms, clinical features303 and some genes are
similarly differentially expressed in those disorders272;304. AD and PD are also complex and
polygenic200;275;300–302;305;306.
In general, differently, from the previous disorders that start to be symptomatic in early
age, AD and PD tend to appear later in life. AD is a severe disorder that is characterised
by episodic memory loss accompanied by progressive impairment of other cognitive do-
mains305. AD affects different areas of the brain differently and not simultaneously275. PD is
a severe progressive neurodegenerative disorder and is a common cause of disability. There
are no therapies that can decrease disease progression. This disorder is characterised by
the presence of Lewy bodies and heavy damage of dopaminergic neurons in the substantia
nigra302.
8.1.1 A network of symptoms
It is common in psychometrics to explain a set of correlated measures, such as the joint oc-
currenceof psychological symptoms, as causedby anunobservable variable, suchas general
intelligence or depression307;308. However, the causation structure assumed by these mod-
els implies that the unobservable variable is the unique cause of correlations between ob-
servations. This assumptionmight not be reasonable in clinical and psychiatric setting309 in
which symptomsmight cause andmodify other symptoms. As an example, lack of sleep and
fatigue are associated with depression. However, it is reasonable to assume that sleep prob-
lemsmight cause some fatigue for physiological reasons not necessarily related to the pres-
ence of depression. Therefore, network approaches to investigate the interaction of symp-
toms have been proposed in the literature.
Those networks are assembled considering each symptomas a node and the association
strength as the edge’s weight310. For MDD and Generalised Anxiety Disorder this network
resulted in two well-defined clusters, one associated with each disease with some bridge
symptoms between both diseases, such as sleep problems, restlessness and concentration
problems, which give a possible explanation for the comorbidity of both diseases. In addi-
tion, the strength of each node provided insights into which symptoms are more dominant
to each separate diagnosis310;311. Similarly, the symptoms network of ASD and Obsessive-
Compulsive disorder312 was investigated.
Using similar methods, also the entire disease structure of the DSM-IV catalogue282 has
been investigated311. This is a comprehensive manual of 439 symptoms, criteria and lan-
guage for the classification of mental disorders. Two symptoms were connected if they are
used as diagnostic criteria for the samedisease. This network revealed one large component
comprising almost half (47.4%) of the symptoms, a high degree of clustering and high con-
nectivity. These properties give the network a small world nature, predicting the observed
pattern ofmultiple symptoms interacting inmultiple disorders and the observedprevalence
rate for comorbidity.
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8.2 Anetwork of genes involved inmental disorders reveals
overlaps
Based on the same rationale as presented in the symptoms network, I wanted to under-
stand the overlap of genes to mental disorders, using the Gene-to-Disorder (g2d) database
presented in Chapter 6. For that, I constructed a bipartide network, B, where the first set of
nodes is given by the disorders and the second set is given by the genes. A disorder has a link
to a gene only if the gene is associated with that particular disorder. The visual representa-
tion of this network is presented in Figure 8.1. It is quite interesting how the genetic basis
overlap of those disorders can be verified. As in the symptoms networks that BD, MDD and
SCZ shares symptoms, they also have a big overlap on the genes. On the other hand, ASD,
impaired cognition and intellectual disability are also closer in the network since they have
a higher gene overlap. Important to note here is that because ASD is amultidimensional dis-
order, there is a plurality of completely different symptoms, and probably, with a different
genetic basis.
The bipartide network was transformed into a weighted disease to disease network, D
based on how the gene amount two diseases share, this can be easily calculated bymultiply-
ing the adjacency Bmatrix by its transpose, i.e. D = B Bᵀ. However, having the proportion
of shared genes instead of the absolute number, give us a better insight of their overlap. The
proportion of shared genes of any two disorders, o and p, can be easily calculated as




It gives us the adjacencymatrix of the estimated proportion of shared genes in two disor-
ders, represented byD∗. The visual representation of this network is presented in Figure 8.2.
This network enables us to describe better how the genetic basis of the mental disorders is
related. The same pattern as seen in the bipartide graph can be visualised here. Moreover,
a triangle from BD, SCZ and MDD appears. This means that those three disorders have,
indeed, a higher set of overlapping genes than other disorders. ASD is the middle of the
triangle, also sharing many connections with those three disorders.
However, because not all classes of genes are able to regulate the expression process, my
interest lies on the ones thatmight be responsible for the rewiring in the networks, the Tran-
scription Factors (TFs). With the result from this network, I hypothesise that the TF-TF net-
work of the i) neurodegenerative disorders might have few similar patterns of deregulation
compared to healthy controls. Because it has the highest overlap with brain development
than the other disorders, I also want to compare it to the infant TF-TF network; ii) ASD, BD,
MDD and SCZ have similar patterns of gene co-regulation. I expect to find genes that are
highly specific for each one of those mental disorders, those genes are also referred to as
signature genes.
An overlap of genes specific to humans that are also involved in those disorders was sug-
gested54. Therefore, another question is to understand the patterns of co-expression in hu-
mans and other primates, such as Chimpanzee (CMP) and Rhesus macaque (RH).
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































MOOD DISORDERSMAJOR DEPRESSIVE DISORDER
FIGURE 8.1: Gene and mental disorders bipartide network: Genes are represented in green and diseases
in purple. The layout used for this visualisation is Distributed Recursive (Graph) Layout (DrL), that allows
us to better visualise the clusters of gene-disease interactions. The size of the nodes is proportional to the
node degree. It is clear that brain development does not share many genes with the other disorders, it is not
surprising that impaired cognition and intellectual disability share genes. ASD seens to have a big overlapwith
other disorders. However, SCZ and BD have a higher overlap. Similarly, dementia, AD and PD have a higher
overlap than the other disorders.
8.3 TF-TF co-expression network analysis
Because of this huge overlap in the symptoms and the genes that are involved with men-
tal disorders I wanted to understand if the patterns of gene co-regulation were similar in
those disorders. For that, I collected available data from the Gene Expression Omnibus
(GEO). Performed quality control and normalised the datasets. Later, using the method-
ologies described previously in Chapter 4, Chapter 5 and Chapter 6, I constructed the in-
dependent weighted Topological Overlap (wTO) networks for each disorder, combined into
oneConsensusNetwork (CN), compared thenetworks usingCo-expressionDifferentialNet-
work Analysis (CoDiNA) and finally performed a enrichment using GeneOntology (GO) and
RichR.







































FIGURE 8.2: Weighted Disease-to-Disease network shows modules of diseases: Link thickness are pro-
portional to the link weight, the stronger the red, the higher the proportion of shared genes the two disorders
share, the lighter the blue, the fewer genes the two disorders share. As expected, BD, MDD and SCZ forms a
triangle where some genes overlap; in the centre of this triangle, we find ASD, that also overlaps highly with
those disorders, as discussed in the literature. On the other hand, the neurodegenerative disorders share a lot
with dementia but not as much with each other.
8.3.1 Database selection
Data was collected fromGEO. The data used originated from studies that contained at least
8 samples from the same brain tissue and disorder. The platform used for measuring the
gene expression should not have been designed for a subset of genes. In total, I collected
expression data from 4399 samples, divided into 39 studies, using 15 platforms, from 5 brain
regions (Cerebellum (CER), Ganglia (GAN), Hippocampus (HIP), Prefrontal Cortex (PFC),
Temporal Cortex (TC)) and 28, 901 different transcripts. A description of the datasets can be
found onAppendix C. A table of the number of datasets per tissue can be found onTable 8.1.
Not all diseaseshavedata available for all tissues, and fewdonothavemore thanonedataset.
However, because my interest lies in cognition, it is natural to only use the data that comes
from the brain area responsible for that, that is the PFC. The brain areas that are not PFC are
used only to help understand how the individuals’ cluster in Subsection 8.3.2 but not carried
on for the network analysis.
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TABLE 8.1: Number of expression datasets for each tissue and phenotype used to construct the networks. The
diseases collected for humans are: Autism SpectrumDisorder (ASD), Alzheimer’s Disease (AD), Bipolar Disor-
der (BD),MajorDepressionDisorder (MDD), Schizophrenia (SCZ) andParkinsonDisease (PD).Moreover, data
was collected for Chimpanzee (CMP) and Rhesus macaque (RH). Healthy human adults (CTR5) and healthy
human infants are (CTR0) are also presented.
Phenotype Cerebellum Ganglia Hippocampus Prefrontal Cortex Temporal Cortex
AD 0 0 1 3 1
ASD 1 0 0 2 1
BD 1 0 1 5 0
MDD 1 3 1 5 0
PD 0 3 0 2 0
SCZ 2 0 1 3 1
RH 1 2 4 2 0
CMP 1 0 0 2 0
CTR0 3 0 2 5 2
CTR5 12 12 8 28 7
Normalisation and quality control
After the selection of the datasets, all datasets went through a quality control step. Because
each study is independent of each other this step has to be done separately. The controls
samples were normalised among themselves, and the diseases were normalised against the
controls. Somegeneexpressionsweremeasuredusingmicroarrays, and thosewereanalysed
using the R environment18 and Bioconductor313 packages. For themicroarray sets that were
from Illumina, I used the package lumi21, for the ones from Affymetrix, the package affy19.
The probe expression levels (Robust Multi-array Average (RMA) expression values) and
MicroArray Suite 5 (MAS5) detection p−values were computed and only probesets signifi-
cantly detected in at least one sample (p−values < 0.05) were considered. Probes that were
not specific for only one gene were deleted. Average expression was computed for those
genes mapped by more than one probe. All datasets with low quality were removed. Only
datasets that survived this step are presented here.
For the datasets that weremeasured using RNA sequencing (RNA-seq), I made the qual-
ity control using FASTQC314, mapped the reads to the human genome assembly
hg38/GRCh38315 using Segemehl34. Uniquelymapped readswere extracted for further anal-
ysis and counted using rnacounter38. Genes with less than 5 Reads Per Kilobase Million
(RPKM) in total were removed.
Transcription Factor list
Similarly to the study presented in Chapter 7, only TFs from the target list (assembled from
the Gene Regulatory Factor (GRF) Catalogue54 were considered for the network analysis.
8.3.2 Multivariate analysis
In order to verify how did the individual cluster, I used a Principal Component Analysis
(PCA). The PCAwas constructed using the function princomp() in R, using only TFs instead
of the whole set of expressed genes. Similarly, a heatmapwas also performed, using the cor-
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FIGURE 8.3: PCA and correlation heatmap of the 4399 individuals: 8.3a is a 3D scatter-plot that shows
that the individuals clusters into the study, platform, brain region, disease and age. Similarly, 8.3b represents
the individuals correlations. The same colour code is used as before, negative correlations are represented in
green and positive correlations are in purple.
relation of the individuals. In both analyses, five levels of disturbance can be detected on
the data: Study and Platform are the stronger, however, the brain region, the disease and age
also showed to cause differences on the levels of expression. Thus, it was necessary to con-
struct the wTO networks from 129 different datasets, each containing data from the same:
study, platform, disease and age group.
8.3.3 Constructing the networks
Networks were constructed independently for the PFC for each combination of study, plat-
form, disease and age. I constructed the networks using the wTO methodology presented
in Chapter 4. For each network, the parameters for the wTO used were Bootstrap, Pearson
correlation and a 1000 replicates, using TFs for the Topological Overlap (TO).
8.3.4 Combining the networks
Networks were combined according to the combination of each disorder and age. For that,
I used the CN methodology, presented in Chapter 4. Because not all transcripts were mea-
sured in all networks, I considered the interaction of all TFs that had not been measured to
have awTO value of 0 and the padj−value to be 1. This approach penalises all links that were
not measured in all networks, however, if this link existed in the majority of the networks
with low padj−value, it is still present in the CN.
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For the final CN, links were considered to be significant only if its padj−value < 0.05. All
links that did not fulfil this criterion had its wTO value set to 0. This allows all genes to be
present in the comparison network.
8.3.5 Comparing the networks
In the previous sections, I discussed that the gene overlap of the mental disorders treated
here is quite big. Therefore, it is ofmajor importance to detect genes that canbe identified as
signatures. Those genes can be later used for improving and developing new treatments for
those disorders. It is also important to understand if exists an overlap of TFs that are active
during the brain development and the neurodegenerative disorders, however, are inactive
during adulthood. Psychological disorders have an immense overlap of deregulation in the
expression of the gene, however, it is not clear if there are patterns of deregulation in its co-
expression. Humans and other primates share many similarities and differences. It is also
of major interest to understand the specificities of each species.
In order to understand if there are patterns of co-expression on the neurodevelopmen-
tal disorders, I compared the CN derived from the PFC of patients with AD and PD with the
adult (CTR5) and infant (CTR0) healthy controls. Similarly, to understand co-expressionpat-
terns in psychiatric disorders, I compared the co-expression network of ASD, BD,MDD and
SCZ against healthy adult controls. To identify patterns on the co-expression on the PFC of
primates, I compared the CN of healthy adult controls, chimpanzee (Pan troglodytes) and
rhesus macaque (Macaca mulatta).
I filtered the CoDiNA network to contain only well defined, clustered and strong similar-
ities or differences by filtering for the scores ratio, as proposed in Chapter 5 (∆∗∗/∆ρ̃> 1).
Genes were categorised into a Φ category and Φ̃ subcategory using the ClusterNodes()
function.
The Φ categories in R are shown as a for α, b for β and g for γ. Links classified as a
are common to all networks under comparison, b had a signal change, by default, the first
network is considered to be the reference level, in all comparisons shown here, the adult
humans are taken as reference and are represented as CTR5. g links (or nodes) are specific to
at least one category, the abbreviation g.AD means that that particular link (or node) exists
only in AD, but not in other phenotypes, similarly g.CTR5.CTR0 means that it exists only in
the adult and young controls.
8.3.6 Disease enrichment
Each Φ̃ was tested for thedisorder andGOenrichment,whichwasperformedusingtopGO170.
The geneset of the background was only TFs co-expressed in the networks. Filtering for this
background allows that the enrichment is not biased towards this class function. The Gene-
Disease Associations (GDA) enrichment was performed using RichR presented in Chapter 6
andfiltered for bothFisher’s exact test or proportion test padj−value< 0.05. I usedonly genes
associated with mental disorders and the TF as the background of expressed genes.
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8.4 The co-expression network of the prefrontal cortex in
neurodegenerative disorders
To find specific genes to neurodegenerative disorders and test if there are genes involved
in brain development and those disorders I compared the AD and PD networks with the
controls from adult and infant individuals. In total, the differential network of AD, PD and
the controls (adults, CTR5, and infants, CTR0), was able to classify 1, 153, 949 interactions
from 2, 514 TF. The link distribution according to the Φ̃ can be seen in Table 8.2 and the
distribution of TFs classified in each Φ̃ is shown in Figure 8.4a. Interesting to note is that
AD hasmore specific genes than PD, it also has genes that are shared with the infant’s brain.
Suggesting that there are TFs that behaves similarly to the ones found in brains that are still
under development. Another important thing to note here is that ADhas a higher part of the
genes being shared with both controls when compared to PD. This is quite interesting and
shows that PD has less TFs being co-expressed. Another important result is that there are
many genes specific only to the controls, but absent in the disorders. This might indicate a





































































































(B) Chord graph of TF-TF interaction.
FIGURE 8.4: CoDiNA TFs specificity distribution and interaction for neurodevelopmental disorders Fig-
ure 8.4a displays the nodes distribution classified in each one of the CoDiNA Φ̃ subcategories. g. means
specific TFs, a are genes with common pattern of co-expression. U are TFs that could not be classified. In
Figure 8.4bwe can see a chord graph of the Φ̃ TFs for neurodegenerative disorders. Colour code is the same as
in the barplot. If a link starts in one category andmoves to another, it crosses the circle. The Figure 8.4b shows
that most of the interactions happens inside the same category instead of genes interacting with distinct Φ̃.
This category dependent interactions might be interpreted as changes on big blocks of regulation.
Of note is how those genes interact in the CoDiNA network. In Figure 8.4b we can see
that most of the TF-TF interactions occur in the same Φ̃ category, This is quite important to
understand that the deregulation of a TF in these disorders disrupts a whole set of genes.
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TABLE 8.2: Links distribution in the neurodegenerative co-expression network. α represents links that are
common to all networks, γ are links that specific to at least one condition. The networks compared here are:


























Regarding the enrichment analysis for each subcategory of the neurodegenerative disor-
ders, I found 29 (out of 114) genes involved in the brain development for genes classified as
specific to AD, showing enrichment for this (padj−value Fisher’s exact test and proportion
test< 0.05). Impaired cognition also presented itself as significant, with 5out of 67 genes be-
ing present in AD, PD and adults. Meanwhile, the GO enrichment showed important terms
for PD, for example, beta-catenin destruction complex, that is known to be affected in this
disorder316;317. A full table of the enrichment can be found in Appendix D.
The genes found to be hubs in this network are ZMYM2, that is a gene classified as com-
mon to all phenotypes, it is associated to regulation of transcription by RNApolymerase II 318.
The TFs SLF1, SRSF2, ZFP90, SRSF10, ZNF772 andZNF845 are specific to the controls (CTR5
and CTR0) and are involved with RNA splicing 318.
The set of genes HSF2, PIAS2, MYEF2, HCFC2, UBE3A, RBMX, ZMYM6, ZNF131, ZNF25,
ZNF420 and ZNF84 are specific to both controls and AD, however, it is not to PD. Those hubs
are enriched for regulation of transcription, DNA-template, intracellular steroid hormone re-
ceptor signalling pathway and regulation of nucleic acid-template transcription.
8.5 The co-expression network of the prefrontal cortex in
psychiatric disorders
To find specific genes to psychiatric disorders that can be later used as signatures of those
mental disorders, I compared the ASD, BD, MDD and SCZ networks with the healthy adults
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as a control. Although exists links that are classified asα to all conditions under comparison,
no gene has enough connections to be considered significant to this category. In total, 2, 379
TFs were classified into the Φ̃ categories. There were 797, 531 links on the final CoDiNA
network, those links were distributed according to Table 8.3.
TABLE 8.3: Links distribution in the psychiatric co-expression network. γ represents links that specific to
at least one condition. The networks compared here are: Autism Spectrum Disorder (ASD), Bipolar Disorder







































As discussed previously, the overlap of genes found to be associatedwith psychiatric dis-
orders is quite big. With this, we aim to find genes that are specific to each category individ-
ually, those genes could be useful in finding signatures for identifying psychiatric disorder
and could potentially be helpful for identifying new specific treatments. However, in Figure
8.5a the majority of genes are specific to controls, it means that they are not regulated in
the sameway in themental disorders, showing that, indeed, a big overlap on the patterns of
co-expression can be found. ASD has also a big share on γ genes and some shared only with
the controls. This is, again by exclusion, deregulated TFs in BD, MDD and SCZ.
Differently than the neurodevelopmental disorders, the mental ones have a big overlap
also on the co-expression patterns and how genes interact (Figure 8.5b). The TFs classified
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TABLE 8.4: RichR enrichment for mental disorders. γ represents links that specific to at least one condition.
The categories presented here are: Autism SpectrumDisorder (ASD), Bipolar Disorder (BD),Major Depression
Disorder (MDD), Schizophrenia (SCZ). Healthy human adults (CTR) were used as controls.
Φ̃ Disease Genes Expected Genes Observed weight
γ SCZ ATTENTION DEFICIT HYPERACTIVITY DISORDER 29 2 0.0132
γ SCZ IMPAIRED COGNITION 61 3 0.0068
γ CTR.SCZ ATTENTION DEFICIT HYPERACTIVITY DISORDER 29 1 0.0015
γ CTR.MDD INTELLECTUAL DISABILITY 192 3 0.0000
γ CTR.BD COGNITION DISORDERS 45 3 0.0000
γ CTR.BD DEMENTIA 43 2 0.0247
γ CTR.ASD.BD IMPAIRED COGNITION 61 1 0.0020
γ CTR INTELLECTUAL DISABILITY 192 94 0.0153
γ BD MAJOR DEPRESSIVE DISORDER 116 7 0.0049
as specific to the healthy humans mainly interact among themselves, it can indicate that
there is a rewiring in the metabolic pathways and biological processes that underlie that
networks. Part of the interactions occurs from one Φ̃ to another. It might indicate that there
is not complete rewiring in the network, but only sub-parts of the pathways become active
or inactive.
The CoDiNA network for the mental disorders showed that not many hubs appear in all
Φ̃. The majority of genes with high connections are related to the controls and does not
appear in the diseased brains. However, ASD shared specific genes with control, and it can
be used as a signature to define the other two disorders. The genes that specific to controls
and ASD are KMT5B, EXOC2, ORC2, GTF3C3, ZRANB2, ELP2, ZNF776 and SMARCAD1 and
are involvedwith 5S class rRNA transcription fromRNA polymerase III type 1 promoter, tRNA
transcription and histone H4 deacetylation. The controls specific hubs are ZNF597, ZFP90
and ZNF420. Those genes are enriched for transcriptional repressor activity.
The RichR enrichment, displayed in Table 8.4, shows that there is an enrichment for cog-
nition disorders and dementia in controls and BD, meaning that those genes are absent in
the other networks. Interestingly, BD also showed enrichment forMajor Depression Disor-
der, this result was quite expected, mainly due to the huge overlap of symptoms and genes
of both disorders. Of note, controls are enriched for intellectual disability, it indicates that
those genes are being co-expressed in healthy controls, but lack regulation in the psycho-
logical disorders.
The GO enrichment for each category showed that there is an enrichment for cellular
response to lithium ion in SCZ that is in line with literature319, more terms can be found in
Appendix E.
8.6 The evolution of the co-expression network of the pre-
frontal cortex
To find specific genes to humans, chimpanzees and rhesus macaque, I compared the net-
works of healthy human adults with the ones fromhealthy chimpanzees and healthy rhesus
macaque.



















































































































(B) Chord graph of TF-TF interaction.
FIGURE 8.5: CoDiNA TFs specificity distribution and interaction for psychiatric disorders: Chord graph
of the Φ̃ genes for psychiatric disorders: Figure 8.5a displays the nodes distribution classified in each one of
the CoDiNA Φ̃ subcategories. g. means specific TFs,U are TFs that could not be classified. Controls have the
biggest number of TFs that have an specific pattern of co-expression, however, ASD also shares many genes
with the Controls. In Figure 8.5b we can see a chord graph of the Φ̃ TFs for psychological disorders. Colour
code is the same as in the barplot. If a link starts in one category and moves to another, it crosses the circle.
The Figure shows that most of the interactions of controls occurs inside the same category instead of with TFs
from distinct Φ̃. This category dependency of interactionsmight indicate that there are big blocks TFs that are
specific to each category.
The CoDiNA network for the primates had, in total, 906, 735 links, from 2, 892 TFs. The
distribution of the links classification can be seen in Table 8.5. For this network, healthy
adult humans are considered to be controls.
TABLE 8.5: Links distribution in the primates co-expression network. α represents links that are common
to all networks, γ represents links that specific to at least one network. The networks tested are: Chimpanzee












When comparing the co-expression network of TFs of humans and other primates, we
can see that humanshavemoreTFswithhuman-specific links, thushavebeencharacterised





































(B) Chord graph of TF-TF interaction.
FIGURE 8.6: CoDiNA TFs specificity distribution and TF-TF interaction for the evolution in the PFC:
Figure 8.6a displays the nodes distribution classified in each one of the CoDiNA Φ̃ subcategories. g. means
specificTFs,U are TFs that couldnot be classified. Humanshave the biggest number of TFs that have a specific
pattern of co-expression, however, RH also has many specific TFs. The Figure 8.6b displays a chord graph of
the Φ̃ TFs for evolution. Colour code is the same as in the barplot. If a link starts in one category andmoves to
another, it crosses the circle. This Figure shows that most of the interactions of controls occur inside the same
category instead of genes interacting with distinct Φ̃. This category dependency of human-specific TFs shows
that those TFs are interacting mostly with other human-specific TFs rather than primate-specific TFs.
in by CoDiNA as human-specific, when compared to CMP and RH ( 8.6a). This is quite sur-
prising that humans havemuchmore specific TFs when compared to other primates. Many
TFs have a co-expression pattern specific to RH, is expected that humans and chimpanzees
have a closer co-expression pattern of the PFC, due to their evolutionary distance. However,
even that not many, humans and RH share some gene patterns that are not present in CMP.
The RichR enrichment for the primates did not find any disorder enriched in either TFs
categorised as shared or specific. Whichmakes total sense, because the networks were con-
structed only using healthy individuals. However, GO terms were found to be enriched, for
example, RH showed enrichment for walking behaviour. The hubs found in this network
are all classified by CoDiNA as having a majority of links in the human-specific network,
the hubs are: THAP12, ZNF280D, ZNF131, ZFP90, ZNF420, ZNF772 and ZNF534 and are en-
riched for transcriptional repressor activity.
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8.7 Psychologicaldisorders sharepatternsof co-expression
with other primates
The combination of wTO, CN andCoDiNA revealed TFs and signatures for each of the disor-
ders. At the beginning of this chapter, I discussed the gene and symptoms overlap of those
disorders. The hypothesis was that the neurodevelopmental disorders would share its ge-
netics basis with brains under development. For that, I compared the PFC co-expression
network from healthy adult controls and infant brains with the one derived from patients
diagnosed with AD and PD. In those networks, I identified TFs that are involved with each
disorder, butmostly, two categories of TFs draw our attention: i) TFs that are present only in
controls (independent of the age)might be TFs that plays an important role in the PFC func-
tions and ii) TFs that are inactive in the adult PFC but active in the infants and the PFC with
the disorders. The Venn diagram showing the amount of TFs in each one of these categories
is displayed in Figure 8.7. Other studies already pointed out some evidence that neurode-






FIGURE 8.7: Venn diagram of the TFs overlap from the neurodegenerative disorders and healthy PFC
shows that there are two important categories of TFs. In the first, some are present only in controls (inde-
pendent of the age), can be related to TFs that play an important role in the PFC functions. The second is
represented by TFs that are inactive in the PFC of adults (CTR5), however, are active in the infants (CTR0) and
the PFC with the disorders, that might indicate that there are TFs that regulates other genes in a brain in de-
velopment and in the neurodegenerative disorders.
Similarly, wewanted to understand the genetic overlap of the TFs in psychological disor-
ders. Another study321 showed that genes associated with ASD might also be involved with
the primate evolution. In Figure 8.8 it is displayed the Venn diagram of TFs identified in
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each category and its overlap. It is possible to identify that ASD and RH have TFs identified
as specific to both categories. It is also interesting to visualise that MDD and SCZ have the
majority of their TFs also associated with BD. Of note is that TFs that specific to CMP is also








FIGURE 8.8: Venn diagram of the TFs overlap from the psychological disorders and healthy PFC: It is
displayed the overlap of the TFs in the psychological disorders. MDD and SCZ have their majority of genes
overlapping with BD. CMP and RH also have a part of genes specific to these three mental disorders.
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9
Conclusion and future perspectives
I
N Chapter 4 I presented weighted Topological Overlap (wTO) method for construct-
ing networks and how I improved this pre-existing method by attributing a proba-
bility to each link and allowing the method to be used to time series data when the
interest lies in a single network for the whole time-frame. In the same chapter, I introduced
the Consensus Network (CN), a method that can be used to find links that are common to a
set of independent networks. The wTOmethod also showed to bemore efficient than state-
of-art methods in detecting experimentally validate genes.
In the next Chapter, I introduced a novel methodology, Co-expression Differential Net-
workAnalysis (CoDiNA), that allows formultiple comparisonsof independent co-expression
networks. CoDiNA applications clearly demonstrate the successful detection of genes asso-
ciated with specific phenotypes. Moreover, CoDiNA can also be used for comparing any
number of networks other than co-expression networks, for example, metabolic, protein-
interaction, or ecological networks.
At the last methodological Chapter, I introduced RichR, an enrichment tool that enables
tofindenricheddisorders ina set of genes. This is particularlyuseful in combinationwith the
two previous methods. This methodology differs from the other Gene-Disease Associations
(GDA) enrichment tools because the user can define both the background list of genes and
also the Gene-to-Disorder (g2d) dataset.
The combination of wTO and CoDiNA shed light in the characterisation of genes in-
volved in the neurogenesis, Chapter 7 and in mental disorders Chapter 8. In neurogenesis,
CoDiNA pinpointed genes that were candidates to be involved in themiR-124 pathway. The
Zinc Finger, ZNF787 tested showed affecting extensively the process of neuron differentia-
tion.
In the second application showedhere, it becamemore clear that the combination of the
methods I developed can be helpful to identify novel genes involved in cognition andmen-
tal disorders. That can be used to find potential new therapies. This is an important topic,
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mainly because, as presented in this dissertation, there is a huge overlap in the network of
genes associated with those disorders. It is of major importance to identify signature genes
(and regulatory patterns) that can, in the future, enable better andmore accurate diagnosis
and treatment for those disorders. It is quite interesting to see that humans have a higher
amount of TFs where the interactions occur specifically in the human network when com-
pared to other primates. However, it is much more interesting and surprising that the psy-
chological disorders that I presented here have an overlap with some chimpanzee-specific
TFs.
The methodologies presented here can be used to help researches to understand other
complex systems. For example, I used the combination of those tools to understand the
co-infection of HIV and Tuberculosis in children and adults. CoDiNA was able to success-
fully identify enrichment of known genes associated with HIV infections among the specific
nodes, providing support for the ability of CoDiNA to retrieve biological meaningful results.
Importantly, I was also able to pinpoint modules of genes related to each one of the co-
infections.
In addition, in another study, not presented here, but can be found on the publication
list, the focus was to identify similarities and specificities of different cancer types. There I
identified several Transcription Factors (TFs) specifically associated with Astrocytoma that
were not previously linked to this type of cancer. Some of themwere previously described as
associated to neoplasms and neoplasm metastasis 164. The most strongly differentiated TFs
associated with oligodendroglioma that were not assosiated to this disease are associated
to neoplasm invasiveness and neoplasic cellular transformation164. The new TFs CoDiNA
identified for glioblastoma are described as associated with other neoplams 164.
This suggests that the methods that I developed have biologically meaningful results.
More importantly, I was able to propose new candidate genes as associated with particular
phenotypes or disorders and their interactions. I also expect that these tools will be helpful
formanydiverse studies for building, combing and comparing network data generated from
multiple conditions, such as different diseases, tissues, species or experimental treatments.
Furthermore, wTO and CoDiNA are not limited to the analysis of co-expression networks
but can be applied to comparing any type of network.
In another application of wTO, the aimwas to understand how the fungi in amarine en-
vironment interacted. Those interactions can be a fungi-fungi interaction, fungi and biotic
factors (such as fish eggs) and abiotic factors (such as temperature and pH) through awhole
year. For this aim, data was collected once a week, using metagenomics, the abundance of
each Operational Taxonomic Unit (OTU) was measured. I was able to detect interactions
of the fungi by using the time series version of the wTO. A publication with this analysis is
being prepared.
In summary, my contribution to the scientific communities presented here was the de-
velopment of two methods for high-quality network analysis and comparison. The first
one, wTO, performs substantially better than other well-knownmethods. The second, CoD-
iNA, represents a completely novelmethod that enables the simultaneous comparison of as
manynetworks as desired. It does not classify only links, but also nodes. The combination of
thosemethods was used to better understand the role of miR-124 for the neuronal develop-
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ment, it allowed the identification of ZNF787, a therefore uncharacterised TF that was now
shown to be involved in neuronal development. Also, combining the methods I developed
gives support for a better understanding of complex brain disorders, including molecular
relationships that explain similar symptoms in many disorders, but also TFs and links that
could distinguish the disorders, and the potential relationship between the evolution of the
human brain and its disorders
However, it is still necessary to constructmodels and approaches that enable the integra-
tion of multiple data types into one model. This could be achieved, for instance, by tighter
integration of co-expression data with data on long non-coding RNAs, miRNA, transcrip-
tion factor binding sites, taken from CHIP-seq data or databases, such as Jasper, Transfac
and Encode. CHIP-seq has already been combined with TF expression data to predict the
activation status of regulatory elements using a statistical Paired Expression and Chromatin
Accessibility (PECA)model322, those results should also be later experimentally validated147.
Although some integration exists, it still has to be optimised to be able to includemore data
types. The integration of multiple data sources could be understood as amultilayer system,
where each layer is one omic and the integration among layers can be given by experimen-
tal data. However, it is still challenging to integratemultiple omics data into one network323.
Moreover, it is still necessary to have accessible platforms, software andmodels that can in-
tegrate different layers on thosemultilayer networks. Such integrated networks would allow
for better prediction of diseases. In the sense of mental disorders, the data derived from
the multi-omics multilayer network can also be enriched by the use of functional Magnetic
resonance imaging (fMRI) for a better linking of symptoms to brain regions.






Overlaps (wTO) & Consensus wTO
Network
A.1 wTOManual
The wTO package computes the Weighted Topological Overlap with positive and negative
signs (wTO) networks55 given a data frame containing the mRNA count/ expression/ abun-
dance per sample, and a vector containing the interested nodes of interaction (a subset of
the elements of the full data frame).
It also computes the cut-off threshold or p−value based on the individuals bootstrap or
the values reshuffleper individual62. It also allows the constructionof a consensusnetwork,
basedonmultiplewTOnetworks. Thepackage includes a visualisation tool for thenetworks.
The package can be downloaded from CRAN using:
install.packages('wTO')
A.1.1 Input data
The wTO package, can be used on any kind of count data, but we highly recommend to use
normalised and quality controlled data according to the data type such as RMA, MD5 for
microarray, RPKM, TPM or PKM for RNA-seq, sample normalised data for metagenomics.
As an example, the package contains three datasets, two from microarray chips
(Microarray_Expression1 and Microarray_Expression2), and one from abundance in
metagenomics (metagenomics_abundance).
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A.1.2 wTO
The wTO method is a method for building networks based on pairwise correlations nor-
malised and corrected by all shared correlations. For this reason, the user can choose a set
of factors of interest, called hereOverlaps, those are the nodes thatwill be corrected andnor-
malised by all other factors in the dataset. Those factors can be Transcription Factor, long
non coding RNAs, a set of species of interest etc.
Genomic data
The wTO package contains 2 datasets that were obtained using expression arrays
(Microarray_Expression1 and Microarray_Expression2), they were previously
normalised and the quality control was done. We will use it to build the wTO network using
the different methods implemented in the package.
First we are going to inspect those datasets.
require(wTO)
#> Loading required package: wTO
require(magrittr)





#> [1] 268 18
dim(Microarray_Expression2)
#> [1] 268 18
Microarray_Expression1[1:5,1:5]
#> ID1 ID2 ID3 ID4 ID5
#> FAM122B 5.325653 5.039814 5.099828 5.053185 5.213816
#> DEFB108B 2.038747 1.965599 1.925807 1.977435 2.079381
#> CCSER2 4.973347 4.865783 4.818910 5.024392 4.697314
#> GPD2 5.453287 5.595471 5.223886 5.130226 5.370672
#> HECW1 4.350837 4.279759 4.218375 4.472152 4.408025
Microarray_Expression2[1:5,1:5]
#> ID1 ID2 ID3 ID4 ID5
#> FAM122B 5.532142 6.395654 5.159082 5.806040 5.339848
#> DEFB108B 2.456210 1.993044 2.251673 2.440018 2.493610
#> CCSER2 5.164945 4.923511 4.979691 5.080116 5.014569
#> GPD2 5.742455 5.649180 5.430411 6.007418 5.662126










Please, note that the individuals are in the columns and the gene expressions are in the
rows. Moreover, the row.names() are the names of the genes. The list of genes that will be
used for measuring the interactions are in ExampleGRF. There should always be more than
2 of them contained in the expression set. If there are no common nodes to be measured,
the method will return an error.
sum(ExampleGRF$x %in% row.names(Microarray_Expression1))
#> [1] 168
Running the wTO We can run the wTO package with 3 modes. The first one is running the
wTOwithout resampling. For that we can use the wTO(). The second one, wTO.Complete(),
gives you the whole diagnosis plot, hard-threshold on the ωi,j , the ωi,j , |ωi,j| values and
p−values. The last mode, wTO.fast(), just returns the ωi,j values and p−value.
Using the wTO() function: To use the wTO() function, the first step is to compute the
correlation among the nodes of interest using CorrelationOverlap() and then use it as
input for the wTO(). In the first function the user is allowed to choose the method for cor-
relation between Pearson (‘p’) or Spearman (‘s’). The second function allows the choice be-
tween absolute values (‘abs’) or signed values (‘sign’). Please, keep in mind that the result
of the wTO() function is a matrix, and it can be easily converted to an edge list using the
function wTO.in.line().
wTO_p_abs = CorrelationOverlap(Data = Microarray_Expression1,
Overlap = ExampleGRF$x, method = ’p’) %>%
wTO(., sign = ’abs’)
wTO_p_abs[1:5,1:5]
#> ZNF333 ZNF28 ANKRD22 ZFR TRIM33
#> ZNF333 0.352 0.237 0.269 0.242 0.241
#> ZNF28 0.237 0.287 0.209 0.206 0.239
#> ANKRD22 0.269 0.209 0.299 0.199 0.252
#> ZFR 0.242 0.206 0.199 0.328 0.258
#> TRIM33 0.241 0.239 0.252 0.258 0.361
wTO_p_abs %<>% wTO.in.line()
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head(wTO_p_abs)
#> Node.1 Node.2 wTO
#> 1: ZNF333 ZNF28 0.237
#> 2: ZNF333 ANKRD22 0.269
#> 3: ZNF28 ANKRD22 0.209
#> 4: ZNF333 ZFR 0.242
#> 5: ZNF28 ZFR 0.206
#> 6: ANKRD22 ZFR 0.199
wTO_s_abs = CorrelationOverlap(Data = Microarray_Expression1,
Overlap = ExampleGRF$x, method = ’s’) %>%
wTO(., sign = ’abs’) %>%
wTO.in.line()
head(wTO_s_abs)
#> Node.1 Node.2 wTO
#> 1: ZNF333 ZNF28 0.236
#> 2: ZNF333 ANKRD22 0.258
#> 3: ZNF28 ANKRD22 0.215
#> 4: ZNF333 ZFR 0.264
#> 5: ZNF28 ZFR 0.187
#> 6: ANKRD22 ZFR 0.193
wTO_p_sign = CorrelationOverlap(Data = Microarray_Expression1,
Overlap = ExampleGRF$x, method = ’p’) %>%
wTO(., sign = ’sign’) %>%
wTO.in.line()
head(wTO_p_sign)
#> Node.1 Node.2 wTO
#> 1: ZNF333 ZNF28 -0.099
#> 2: ZNF333 ANKRD22 -0.185
#> 3: ZNF28 ANKRD22 0.076
#> 4: ZNF333 ZFR -0.117
#> 5: ZNF28 ZFR -0.077
#> 6: ANKRD22 ZFR -0.036
wTO_s_sign = CorrelationOverlap(Data = Microarray_Expression1,
Overlap = ExampleGRF$x, method = ’s’) %>%
wTO(., sign = ’sign’) %>%
wTO.in.line()
head(wTO_s_sign)
#> Node.1 Node.2 wTO
#> 1: ZNF333 ZNF28 -0.064
#> 2: ZNF333 ANKRD22 -0.143
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#> 3: ZNF28 ANKRD22 0.029
#> 4: ZNF333 ZFR -0.164
#> 5: ZNF28 ZFR -0.011
#> 6: ANKRD22 ZFR 0.024
Using the wTO.Complete() function: The usage of the function wTO.Complete() is
straight-forward. No plug-in-functions are necessary. The arguments parsed to the
wTO.Complete() functions are the number k of threads that should be used for computing
the ωi,j , the amount of replications, n, the expression matrix, Data, the Overlapping nodes,
the correlationmethod (Pearson or Spearman) for themethod_resampling that should be
Bootstrap,BlockBootstrap orReshuffle, the p−value correctionmethod, pvalmethod (any
from the p.adjust.methods), if the correlation should be saved, the δ is the expected differ-
ence, expected.diff, between the resampled values and the ωi,j and also if the diagnosis plot
should be plotted.
wTO_s_sign_complete = wTO.Complete(k = 5, n = 250,
Data = Microarray_Expression1,
Overlap = ExampleGRF$x, method = ’p’,
method_resampling = ’Bootstrap’, pvalmethod = ’BH’,
savecor = TRUE, expected.diff = 0.2, plot = TRUE)
#> There are 168 overlapping nodes, 268 total nodes and 18 individuals.
#> This function might take a long time to run. Don’t turn off the computer.




The diagnosis plot (Figure A.1) shows the quality of the resampling (first two plots). The
closer the purple line to the black line, the better. The ωi,j vs |ωi,j | shows the amount of ωi,j
being affected by cancellations on the heuristics of the method, the more similar to a smile
plot, the better. The last two plots show the relationship between p−values and the ωi,j . It
is expected that higher ω’s presents lower p−values.
The resulting object from the wTO.Complete() function is a list containing:
• wTOan edge list of information such as the signed andunsignedωi,j values its raw and
adjusted p−values.
• Correlation values, also as an edge list.
• Quantiles, the quantiles from the empirical distribution and the calculated omega’s
from the original data, for both signed and unsigned networks.
wTO_s_sign_complete
#> $wTO
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FIGURE A.1: Diagnosis of the wTO resampling
#> Node.1 Node.2 wTO_sign wTO_abs pval_sig pval_abs Padj_sig
#> 1: ZNF333 ZNF28 -0.099 0.237 0.168 0.004 0.3607366
#> 2: ZNF333 ANKRD22 -0.185 0.269 0.188 0.016 0.3607366
#> 3: ZNF333 ZFR -0.117 0.242 0.180 0.012 0.3607366
#> 4: ZNF333 TRIM33 0.007 0.241 0.136 0.008 0.3607366
#> 5: ZNF333 RIMS3 -0.325 0.409 0.144 0.000 0.3607366
#> ---
#> 14024: ANAPC2 SBNO2 -0.147 0.298 0.156 0.000 0.3607366
#> 14025: ANAPC2 ZNF528 -0.142 0.222 0.152 0.016 0.3607366
#> 14026: TIGD7 SBNO2 -0.297 0.354 0.128 0.004 0.3607366
#> 14027: TIGD7 ZNF528 -0.099 0.219 0.212 0.032 0.3607366
















#> Node.1 Node.2 Cor
#> 1: FAM122B DEFB108B 0.366857931
#> 2: FAM122B CCSER2 0.278870911
#> 3: DEFB108B CCSER2 -0.252482453
#> 4: FAM122B GPD2 -0.005649124
#> 5: DEFB108B GPD2 -0.107064848
#> ---
#> 35774: TRIM23 ZNF528 0.054249174
#> 35775: ZNF559 ZNF528 -0.218309729
#> 35776: ANAPC2 ZNF528 -0.013821370
#> 35777: TIGD7 ZNF528 0.011807143
#> 35778: SBNO2 ZNF528 0.092317502
#>
#> $Quantiles
#> 0.1% 2.5% 10% 90% 97.5% 99.9%
#> Empirical.Quantile -0.56 -0.46 -0.34 0.37 0.48 0.56
#> Quantile -0.50 -0.40 -0.28 0.32 0.43 0.52
#> Empirical.Quantile.abs 0.21 0.24 0.27 0.47 0.53 0.57
#> Quantile.abs 0.17 0.19 0.21 0.41 0.47 0.53
Using the wTO.fast() function: The wTO.fast() function is a simplified version of
the wTO.Complete() function, that doesn’t return diagnosis, correlation, nor the quantiles,
but allows the user to choose the method for correlation, the sign of the ω to be calculated
and the resampling method should be one of the two Bootstrap or BlockBootstrap. The
p−values are the raw p−values and if the user desires to calculate its correction it can be
easily done as shown above.
fast_example = wTO.fast(Data = Microarray_Expression1,
Overlap = ExampleGRF$x, method = ’s’,
sign = ’sign’, delta = 0.2, n = 250,
method_resampling = ’Bootstrap’)
#> There are 168 overlapping nodes, 268 total nodes and 18 individuals.
#> This function might take a long time to run. Don’t turn off the computer.
#> Done!
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head(fast_example)
#> Node.1 Node.2 wTO pval
#> 1: ZNF333 ZNF28 -0.064 0.264
#> 2: ZNF333 ANKRD22 -0.143 0.236
#> 3: ZNF28 ANKRD22 0.029 0.188
#> 4: ZNF333 ZFR -0.164 0.232
#> 5: ZNF28 ZFR -0.011 0.256
#> 6: ANKRD22 ZFR 0.024 0.264
fast_example$adj.pval = p.adjust(fast_example$pval)
Metagenomic data
Along with the expression data, the wTO package also includes a metagenomics dataset that
is the abundance of some OTU’s in bacterias collected since 1997. More about this data can
be found at https://www.ebi.ac.uk/metagenomics/projects/ERP013549.
The OTU (Operational Taxonomic Units) contains the taxonomy of the particular OTU













#> Week1 Week2 Week3 Week4 Week5 Week6 Week7 Week8 Week9
#> 2 1 6 0 0 0 1 0 1 0
#> 3 0 0 0 0 0 0 0 5 0
#> 4 0 0 0 0 0 0 0 0 0
#> 5 0 1 0 0 0 0 0 0 0
#> 6 0 0 0 0 0 0 0 0 0
#> 7 0 1 0 0 0 0 0 1 0
#> 8 0 0 0 0 0 0 0 1 0
#> 9 0 0 0 0 0 0 0 1 0
#> 10 0 1 0 0 0 0 0 7 0
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Beforeweare able todefine thenetwork, wehavefirst tounderstand thepatterns of auto-
correlation of each species, and then define the lag, that will be used for theBlockBootstrap
resampling in the wTO.Complete() or fast.wTO() functions. To define the lag, we use au-




for ( i in 1:nrow(metagenomics_abundance)){
acf(t(metagenomics_abundance[i,]))
}
FIGURE A.2: Auto-correlogram of the OTUs
Becausemost of them have only a high autocorrelation with itself or maximum 2weeks,
we will use a lag of 2 for the blocks used in the bootstrap.
The functions wTO.fast() and wTO.Complete() are able to accommodate the lag pa-
rameter, therefore, they will be used here. Similarly to the previous analysis, the Figure A.3
represents the diagnostic of the resampling.
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Meta_fast = wTO.fast(Data = metagenomics_abundance,
Overlap = row.names(metagenomics_abundance),
method = ’p’, sign = ’sign’, n = 250,
method_resampling = ’BlockBootstrap’, lag = 2)
#> There are 67 overlapping nodes, 67 total nodes and 98 individuals.
#> This function might take a long time to run. Don’t turn off the computer.
#> Done!
Meta_Complete = wTO.Complete(k = 1, n = 250, Data = metagenomics_abundance,
Overlap = row.names(metagenomics_abundance),
method = ’s’ , method_resampling = ’BlockBootstrap’, lag = 2 )
#> There are 67 overlapping nodes, 67 total nodes and 98 individuals.
#> This function might take a long time to run. Don’t turn off the computer.





From the expression data-sets, we are able to draw a Consensus Network. For that, the
function wTO.Consensus() can be used. This function works in a special way, that the user
should pass a list of data.frames containing the Nodes names and the wTO and p−values.
We show an example above.
Let’s calculate the networks the same way we did in the Subsection A.1.2.
wTO_Data1 = wTO.fast(Data = Microarray_Expression1,
Overlap = ExampleGRF$x, method = ’p’, n = 250)
#> There are 168 overlapping nodes, 268 total nodes and 18 individuals.
#> This function might take a long time to run. Don’t turn off the computer.
#> Done!
wTO_Data2 = wTO.fast(Data = Microarray_Expression2,
Overlap = ExampleGRF$x, method = ’p’, n = 250)
#> There are 168 overlapping nodes, 268 total nodes and 18 individuals.
#> This function might take a long time to run. Don’t turn off the computer.
#> Done!
Now, let’s combine both networks in one Consensus Network.





FIGURE A.3: Diagnostic plot of wTO in a time series approach
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pval = wTO_Data1$pval)





#> Joining by: Node.1, Node.2
#> Joining by: Node.1, Node.2
#> Joining by: ID
#> Total common nodes: 168
Or using the wTO.Complete():
wTO_Data1C = wTO.Complete(Data = Microarray_Expression1,
Overlap = ExampleGRF$x, method = ’p’, n = 250, k = 5, plot = F)
#> There are 168 overlapping nodes, 268 total nodes and 18 individuals.
#> This function might take a long time to run. Don’t turn off the computer.




wTO_Data2C = wTO.Complete(Data = Microarray_Expression2,
Overlap = ExampleGRF$x, method = ’p’, n = 250, k = 5, plot = F)
#> There are 168 overlapping nodes, 268 total nodes and 18 individuals.
#> This function might take a long time to run. Don’t turn off the computer.




Now, let’s combine both networks in one Consensus Network.











#> Joining by: Node.1, Node.2
#> Joining by: Node.1, Node.2
#> Joining by: ID
#> Total common nodes: 168
head(CN_expression)
#> Node.1 Node.2 CN pval.fisher
#> 1 ZNF333 ZNF28 -0.1191288 0.06006662
#> 2 ZNF333 ANKRD22 -0.1400000 0.13016905
#> 3 ZNF333 ZFR -0.1091659 0.10147819
#> 4 ZNF333 TRIM33 -0.0240000 0.11707440
#> 5 ZNF333 RIMS3 -0.2798101 0.10797662
#> 6 ZNF333 ZNF595 0.1542850 0.11529832
A.1.4 Visualisation
The wTO package also includes an interactive visualisation tool that can be used to inspect
the results of the wTO networks or Consensus Network.
The arguments given to this function are the Nodes names, its wTO and p−values. Op-
tional are the cutoffs that can be applied to the p-value or to the wTO value. We highly rec-
ommend using both by subsetting the data previous to the visualisation. The layout of the
network can be also chosen from a variety that are implemented in igraph package, for the
theMake_Cluster argumentmany clustering algorithms that are implemented in igraph can
be used. The final graph can be exported as an html or as png.




cutoff = list(kind = ’pval’, value = 0.001),
MakeGroups = ’louvain’, layout = ’layout_components’)
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wTO = CN_expression_filtered$CN,
pval = CN_expression_filtered$pval.fisher,
cutoff = list(kind = ’pval’, value = 0.001),
MakeGroups = ’louvain’,
layout = ’layout_components’, path = ’Vis.html’)






The usage of the Co-expression Differential Network analysis has been growing by the Bio-
logical andMedical science for the analysis of complex systems or diseases. We have devel-
oped amethod that is able to compare as many networks as desired, by characterising both
links and nodes that are common, different or specific to each network.
You can download the package from CRAN using:
install.packages(’CoDiNA’)
B.1.1 Input data
The input data for CoDiNA is a list of data.frame, containing: Node.1, Node.2 and value. It
is important tomentionhere that themethodology should be employed only forundirected
graphs. The value is the strength of the link between Node.1 and Node.2 andmust any real
number between -1 to 1. This value canbe re-normalisedby thepackageusing the argument
stretch = TRUE (by default the values are normalised).
As an example, the CoDiNApackage contains 4 datasets fromaCancer study, GSE4290163.
Each one of this datasets was previously normalised, the control quality was done for the
genes and the networks were calculate using the wTO package62. Each dataset consists of the
Gene names and the weight only for the significant interactions and filtered for a wTO value
of |0.3|.
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Using the wTO output for CoDiNA
The output from the wTO package can be easily used as input for CoDiNA.
require(wTO)
#> Loading required package: wTO
require(CoDiNA)
#> Loading required package: CoDiNA
require(magrittr)
#> Loading required package: magrittr
wTO_out = wTO.fast(Data = Microarray_Expression1, n = 100)
#> There are 268 overlapping nodes, 268 total nodes and 18 individuals.
#> This function might take a long time to run. Don’t turn off the
#> computer.
#> Done!
wTO_filtered = subset(wTO_out, p.adjust(wTO_out$pval) < 0.05,
select = c(’Node.1’, ’Node.2’, ’wTO’))
B.1.2 Creating the Differential Network
To generate the differential network one can use the MakeDiffNet() function.
This functionwill return theΦ and Φ̃ classification for eachoneof the links. Connections
that are assigned to α (a) are in agreement in all networks and it means that all networks
possess that particular linkwith the same sign. Links classified as β (b) are the ones that also
exist in all networks but at least one network contains it with a different sign. The category
γ (g) contains links that does not exist in all networks, meaning that they are specific to at
least one network.
This function also assigns the link into a sub-category. It is important mainly for the
β and γ links to understand its differences or specificities. It is important to note that the
first network is considered to be the reference for β and γ links.
The output from this function is a data.frame containing the nodes, the original weights
(or normalised), the Phi and Phi_tilde categories, a Group, which describes the sign or ab-
sence of the link, the Score_center (raw score), Score_Phi (normalised score by Φ),
Score_Phi_tilde (normalised score by Φ̃, Score_internal (score of the link to its theoretical
category). The first 3 scores, should be closer to 1, while for the last one, the closer to 0 the
better.
DiffNet = MakeDiffNet(Data = list(CTR, OLI, AST),
Code = c(’CTR’, ’OLI’, ’AST’))
#> Starting now.
#> CTR contains 17471 edges and 1022 nodes.
#> OLI contains 64791 edges and 1697 nodes.
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#> AST contains 3384 edges and 1002 nodes.
#> Total of nodes: 442
#> Total of edges: 82558
#> Coding correlations.
#> Total of edges (inside the cutoff): 15950
#> Starting Phi categorization.
#> Coding the groups.







#> Node.1 Node.2 CTR OLI AST Phi Phi_tilde Group
#> 1 CTCF NKX6-3 -0.8861789 -0.7756813 0 g g.CTR.OLI -CTR,-OLI,NoAST
#> 2 IRF3 NKX6-3 -0.8520325 0.0000000 0 g g.CTR -CTR,NoOLI,NoAST
#> 3 NKX6-3 TDG -0.9040650 -0.8385744 0 g g.CTR.OLI -CTR,-OLI,NoAST
#> 4 BUD31 NKX6-3 -0.8016260 -0.7484277 0 g g.CTR.OLI -CTR,-OLI,NoAST
#> 5 HMGN3 NKX6-3 -0.8878049 -0.8364780 0 g g.CTR.OLI -CTR,-OLI,NoAST
#> 6 NKX6-3 PUF60 -0.9479675 0.0000000 0 g g.CTR -CTR,NoOLI,NoAST
#> Score_center Score_Phi Score_Phi_tilde Score_internal
#> 1 0.8327648 0.5467547 0.5235928 0.17786809
#> 2 0.8520325 0.5989745 0.5937500 0.14796748
#> 3 0.8719348 0.6529143 0.6723478 0.13278127
#> 4 0.7754832 0.3915083 0.3060555 0.22654014
#> 5 0.8625233 0.6274069 0.6366059 0.14022695
#> 6 0.9479675 0.8589800 0.8571429 0.05203252
B.1.3 Clustering the nodes into Φ and Φ̃ categories
Because exclusively the information about the links is not enough to define a network, it is
necessary to define the nodes accordingly to its Φ and Φ̃ categories. To do so, the function
ClusterNodes() can be used. The input for this function is DiffNet, that is the output from
the MakeDiffNet(), besides the external and internal cutoffs. The external cutoff is applied
to the normalised Φ̃ Score, while the internal cutoff is applied to the internal Score.
The suggested values for the internal and external cutoffs are themedian or the first and
third quantiles of the internal and Φ̃ scores, depending on how conservative the network
should be.
Using the median:
int_C = quantile(DiffNet$Score_internal, 0.5)
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ext_C = quantile(DiffNet$Score_Phi, 0.5)
Nodes_Groups = ClusterNodes(DiffNet = DiffNet,
cutoff.external = ext_C, cutoff.internal = int_C)
table(Nodes_Groups$Phi_tilde)
#>
#> g.AST g.CTR g.CTR.OLI g.OLI g.OLI.AST U
#> 11 213 2 125 1 66
Using the first and third quantile:
int_C = quantile(DiffNet$Score_internal, 0.25)
ext_C = quantile(DiffNet$Score_Phi, 0.75)
Nodes_Groups = ClusterNodes(DiffNet = DiffNet,
cutoff.external = ext_C, cutoff.internal = int_C)
table(Nodes_Groups$Phi_tilde)
#>
#> g.AST g.CTR g.OLI U
#> 8 188 64 80
B.1.4 Plotting the network
The visualisation of the final network can be quickly done with plot. The layout of the
network can be also determined from a variety that is implemented in igraph package, the
Make_Cluster argument allows the nodes to be clustered according to many clustering al-
gorithms that are implemented in igraph can be used. The final graph can be exported as an
HTML or as png. The argument path saves the network in the given path.
The plot returns the nodes and its information.
int_C = quantile(DiffNet$Score_internal, 0.25)
ext_C = quantile(DiffNet$Score_Phi, 0.75)









#> Loading required package: igraph
#>
#> Attaching package: ’igraph’
#> The following objects are masked from ’package:CoDiNA’:
#>
#> as.igraph, normalize
#> The following objects are masked from ’package:stats’:
#>
#> decompose, spectrum
#> The following object is masked from ’package:base’:
#>
#> union
plot(g, layout = layout.fruchterman.reingold(g), vertex.label = NA)
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C
Datasets for the mental disorders study
Table showing the studies used for themultivariate analysis. From thebrain regionsCerebel-
lum (CER), Ganglia (GAN), Hippocampus (HIP), Prefrontal Cortex (PFC) and Temporal Cor-
tex (TC). The diseases collected for humans are: Autism Spectrum Disorder (ASD),
Alzheimer’s Disease (AD), Bipolar Disorder (BD), Major Depression Disorder (MDD),
Schizophrenia (SCZ) and Parkinson Disease (PD). Moreover, data was collected for Chim-
panzee (CMP) and Rhesus macaque (RH).
TABLE C.1: Datasets used to construct the networks for the mental disorders study.
Study Platform Disorder Tissue Age Genes TFs m
GSE28521 GPL6883 ASD CER Adult 9005 2117 10
GSE35974 GPL6244 BD CER Adult 20252 3154 37
GSE22569 GPL6244 CMP CER Adult 20366 3154 5
GSE28521 GPL6883 Control (CTR) CER Adult 9005 2117 11
GSE2164 GPL91 CTR CER Adult 4840 1339 13
GSE22569 GPL6244 CTR CER Adult 20366 3154 15
GSE22570 GPL6244 CTR CER Adult 16563 2741 15
GSE2164 GPL8300 CTR CER Adult 5896 1617 17
GSE4036 GPL570 CTR CER Adult 15031 3042 18
GSE25219 GPL5175 CTR CER Adult 18345 2760 22
GSE25219 GPL5188 CTR CER Adult 18333 2753 22
GSE35974 GPL6244 CTR CER Adult 20252 3154 50
GSE45642 GPL17027 CTR CER Adult 9298 2426 79
GSE60862 GPL5175 CTR CER Adult 22134 3153 130
GSE60863 GPL5188 CTR CER Adult 22134 3153 130
GSE22570 GPL6244 CTR CER Infant 16563 2741 9
GSE25219 GPL5188 CTR CER Infant 18333 2753 24
GSE25219 GPL5175 CTR CER Infant 18345 2760 25
GSE35974 GPL6244 MDD CER Adult 20252 3154 13
GSE22569 GPL6244 RH CER Adult 20366 3154 8
GSE4036 GPL570 SCZ CER Adult 15031 3042 10
GSE35974 GPL6244 SCZ CER Adult 20252 3154 44
GSE11512 GPL6879 CTR GAN Adult 13408 3154 9
GSE7621 GPL570 CTR GAN Adult 13140 2979 9
GSE8397 GPL96 CTR GAN Adult 8137 2268 11
GSE8397 GPL97 CTR GAN Adult 4876 934 11
GSE44593 GPL570 CTR GAN Adult 13928 3003 14
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TABLE C.1: Datasets used to construct the networks for the mental disorders study.
Study Platform Disorder Tissue Age Genes TFs m
GSE54566 GPL570 CTR GAN Adult 14866 3070 14
GSE54564 GPL6947 CTR GAN Adult 18658 3083 21
GSE45642 GPL17027 CTR GAN Adult 9383 2480 62
GSE60862 GPL5175 CTR GAN Adult 22115 3153 101
GSE60863 GPL5188 CTR GAN Adult 22115 3153 101
GSE60862 GPL5175 CTR GAN Adult 22110 3153 129
GSE60863 GPL5188 CTR GAN Adult 22110 3153 129
GSE44593 GPL570 MDD GAN Adult 13928 3003 14
GSE54566 GPL570 MDD GAN Adult 14866 3070 14
GSE54564 GPL6947 MDD GAN Adult 18658 3083 21
GSE7621 GPL570 PD GAN Adult 13900 3029 16
GSE8397 GPL96 PD GAN Adult 8580 2353 24
GSE8397 GPL97 PD GAN Adult 5305 994 24
GSE42581 GPL3535 RH GAN Adult 10048 2201 12
GSE42581 GPL3535 RH GAN Adult 10363 2241 12
GSE1297 GPL96 AD HIP Adult 8854 2410 22
GSE53987 GPL570 BD HIP Adult 16008 3108 18
GSE1297 GPL96 CTR HIP Adult 8326 2324 9
GSE36980 GPL6244 CTR HIP Adult 16500 2752 11
GSE53987 GPL570 CTR HIP Adult 16008 3108 18
GSE25219 GPL5188 CTR HIP Adult 18287 2751 19
GSE25219 GPL5175 CTR HIP Adult 18243 2728 20
GSE45642 GPL17027 CTR HIP Adult 9678 2515 108
GSE60862 GPL5175 CTR HIP Adult 22112 3153 122
GSE60863 GPL5188 CTR HIP Adult 22112 3153 122
GSE25219 GPL5188 CTR HIP Infant 18287 2751 30
GSE25219 GPL5175 CTR HIP Infant 18243 2728 31
GSE53987 GPL570 MDD HIP Adult 16008 3108 17
GSE13824 GPL3535 RH HIP Adult 10336 2234 9
GSE13824 GPL3535 RH HIP Adult 10339 2228 9
GSE11697 GPL3535 RH HIP Adult 10183 2209 11
GSE11697 GPL3535 RH HIP Adult 10345 2226 12
GSE53987 GPL570 SCZ HIP Adult 16008 3108 15
GSE53697 RNAseq AD PFC Adult 17133 2685 9
GSE36980 GPL6244 AD PFC Adult 16544 2753 15
GSE33000 GPL4372 AD PFC Adult 15348 2813 310
GSE28521 GPL6883 ASD PFC Adult 9005 2117 16
GSE59288 RNAseq ASD PFC Adult 20684 3040 34
GSE5392 GPL96 BD PFC Adult 9179 2466 10
GSE12654 GPL8300 BD PFC Adult 6328 1757 11
GSE53987 GPL570 BD PFC Adult 15951 3105 15
GSE5388 GPL96 BD PFC Adult 9630 2515 30
GSE5392 GPL96 BD PFC Adult 9321 2482 30
GSE22521 GPL6244 CMP PFC Adult 20338 3154 7
GSE59288 RNAseq CMP PFC Adult 6383 1261 39
GSE2164 GPL91 CTR PFC Adult 4861 1372 4
GSE53697 RNAseq CTR PFC Adult 18720 2877 8
GSE5392 GPL96 CTR PFC Adult 8861 2405 11
GSE54570 GPL96 CTR PFC Adult 9230 2452 13
GSE54567 GPL570 CTR PFC Adult 14743 3071 14
GSE12654 GPL8300 CTR PFC Adult 5864 1664 15
GSE18069 GPL6244 CTR PFC Adult 16534 2747 15
GSE20168 GPL96 CTR PFC Adult 8704 2378 15
GSE22521 GPL6244 CTR PFC Adult 20338 3154 15
GSE22570 GPL6244 CTR PFC Adult 16534 2747 15
GSE54568 GPL570 CTR PFC Adult 14715 3072 15
GSE28521 GPL6883 CTR PFC Adult 9005 2117 16
GSE36980 GPL6244 CTR PFC Adult 16532 2751 18
GSE53987 GPL570 CTR PFC Adult 15951 3105 19
GSE17612 GPL570 CTR PFC Adult 12923 2942 22
GSE25219 GPL5175 CTR PFC Adult 18290 2746 23
GSE25219 GPL5188 CTR PFC Adult 18290 2769 23
121
TABLE C.1: Datasets used to construct the networks for the mental disorders study.
Study Platform Disorder Tissue Age Genes TFs m
GSE11512 GPL6879 CTR PFC Adult 14296 3045 26
GSE2164 GPL8300 CTR PFC Adult 6009 1641 26
GSE5388 GPL96 CTR PFC Adult 9630 2515 31
GSE5392 GPL96 CTR PFC Adult 9104 2452 31
GSE51264 RNAseq CTR PFC Adult 20551 3015 38
GSE53890 GPL570 CTR PFC Adult 14318 3052 41
GSE68719 RNAseq CTR PFC Adult 19365 3012 44
GSE60862 GPL5175 CTR PFC Adult 22118 3153 127
GSE60863 GPL5188 CTR PFC Adult 22118 3153 127
GSE33000 GPL4372 CTR PFC Adult 15348 2813 157
GSE45642 GPL17027 CTR PFC Adult 9727 2507 161
GSE18069 GPL6244 CTR PFC Infant 16534 2747 10
GSE22570 GPL6244 CTR PFC Infant 16534 2747 10
GSE11512 GPL6879 CTR PFC Infant 14296 3045 18
GSE25219 GPL5175 CTR PFC Infant 18290 2746 26
GSE25219 GPL5188 CTR PFC Infant 18290 2769 26
GSE12654 GPL8300 MDD PFC Adult 6130 1717 11
GSE54570 GPL570 MDD PFC Adult 9230 2452 13
GSE54567 GPL570 MDD PFC Adult 14715 3072 15
GSE54568 GPL570 MDD PFC Adult 14715 3072 15
GSE53987 GPL570 MDD PFC Adult 15951 3105 17
GSE20168 GPL96 PD PFC Adult 9039 2433 14
GSE68719 RNAseq PD PFC Adult 18846 2989 29
GSE22521 GPL6244 RH PFC Adult 20338 3154 12
GSE51264 RNAseq RH PFC Adult 12220 2536 34
GSE12654 GPL8300 SCZ PFC Adult 6103 1728 13
GSE53987 GPL570 SCZ PFC Adult 15951 3105 17
GSE17612 GPL570 SCZ PFC Adult 13303 2981 28
GSE36980 GPL6244 AD TC Adult 16542 2755 10
GSE28521 GPL6883 ASD TC Adult 9005 2117 13
GSE28521 GPL6883 CTR TC Adult 9005 2117 13
GSE36980 GPL6244 CTR TC Adult 16522 2760 18
GSE21935 GPL570 CTR TC Adult 12508 2891 19
GSE25219 GPL5175 CTR TC Adult 18317 2794 20
GSE25219 GPL5188 CTR TC Adult 18268 2735 21
GSE60862 GPL5175 CTR TC Adult 22114 3153 119
GSE60863 GPL5188 CTR TC Adult 22114 3153 119
GSE25219 GPL5175 CTR TC Infant 18317 2794 31
GSE25219 GPL5188 CTR TC Infant 18268 2735 31
GSE21935 GPL570 SCZ TC Adult 13025 2943 23
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D
GO enrichment for Neurodegenerative
disorders
Table showing theGOenrichment for theneurodegenerative disorders, ADandPD.Humans
are used as controls. Adults are represented as CTR5 and infants as CTR0.
TABLE D.1: GO enrichment for Neurodegenerative disorders.
Φ̃ Term Annotated Expected Significant Classic Weight
γPD regulation of BMP signaling pathway 25 0.5500 0.0002 0.9918 0.0002
γPD cardiac septummorphogenesis 33 0.7300 0.0006 0.7130 0.0006
γPD negative regulation of oxidative stress-... 9 0.2000 0.0008 0.8769 0.0008
γPD fat cell differentiation 75 1.6600 0.0011 0.2373 0.0011
γPD adenohypophysis development 3 0.0700 0.0014 0.9988 0.0014
γPD ureteric bud development 39 0.8600 0.0014 0.5675 0.0014
γPD regulation of insulin-like growth factor... 4 0.0900 0.0028 0.9984 0.0028
γPD neuron fate determination 4 0.0900 0.0028 0.9983 0.0028
γPD positive regulation of astrocyte differe... 4 0.0900 0.0028 0.9984 0.0028
γPD common bile duct development 4 0.0900 0.0028 0.9993 0.0028
γPD energy homeostasis 4 0.0900 0.0028 0.9981 0.0028
γPD Wnt signaling pathway involved in midbra... 4 0.0900 0.0028 0.9994 0.0028
γPD regulation of phosphatase activity 16 0.3500 0.0003 0.9934 0.0036
γPD endochondral bone growth 5 0.1100 0.0046 0.9986 0.0046
γPD hepatocyte differentiation 5 0.1100 0.0046 0.9991 0.0046
γPD negative regulation of alcohol biosynthe... 5 0.1100 0.0046 0.2958 0.0046
γPD outflow tract morphogenesis 35 0.7700 0.0067 0.8138 0.0067
γPD negative regulation of transcription by ... 6 0.1300 0.0068 0.9565 0.0068
γPD Notch signaling pathway 57 1.2600 0.0076 0.0928 0.0076
γPD negative regulation of epidermal cell di... 7 0.1500 0.0094 0.4619 0.0094
γPD beta-catenin destruction complex disasse... 7 0.1500 0.0094 0.7607 0.0094
γCTR5.PD muscle cell cellular homeostasis 4 0.0300 0.0004 0.7410 0.0004
γCTR5.PD heart trabecula formation 6 0.0500 0.0010 0.9437 0.0010
γCTR5.PD dorsal aorta morphogenesis 7 0.0600 0.0014 0.9430 0.0014
γCTR5.PD eyelid development in camera-type eye 7 0.0600 0.0014 0.9995 0.0014
γCTR5.PD regulation of cell shape 12 0.1000 0.0044 0.8527 0.0044
γCTR5.PD cardiac muscle cell development 13 0.1100 0.0052 0.2880 0.0052
γCTR5.PD associative learning 15 0.1300 0.0069 0.5018 0.0069
γCTR5.PD regulation of heart rate by hormone 1 0.0100 0.0086 0.9999 0.0086
γCTR5.PD positive regulation of heart rate 1 0.0100 0.0086 1.0000 0.0086
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Φ̃ Term Annotated Expected Significant Classic Weight
γCTR5.PD uropod organization 1 0.0100 0.0086 0.9999 0.0086
γCTR5.PD nerve growth factor signaling pathway 1 0.0100 0.0086 0.9999 0.0086
γCTR5.PD natural killer cell degranulation 1 0.0100 0.0086 0.9999 0.0086
γCTR5.PD negative regulation of skeletal muscle t... 1 0.0100 0.0086 1.0000 0.0086
γCTR5.PD negative regulation of actin nucleation 1 0.0100 0.0086 0.9999 0.0086
γCTR5.PD potassium ion homeostasis 1 0.0100 0.0086 0.9999 0.0086
γCTR5.PD early endosome to recycling endosome tra... 1 0.0100 0.0086 0.9999 0.0086
γCTR5.PD membrane repolarization during ventricul... 1 0.0100 0.0086 0.9999 0.0086
γCTR5.PD negative regulation of potassium ion exp... 1 0.0100 0.0086 0.9999 0.0086
γCTR5.PD negative regulation of cardiac vascular ... 1 0.0100 0.0086 1.0000 0.0086
γCTR5.PD negative regulation of myoblast prolifer... 1 0.0100 0.0086 1.0000 0.0086
γCTR5.PD anterior/posterior axis specification 17 0.1500 0.0089 0.9900 0.0089
γCTR5.PD regulation of transcription initiation f... 18 0.1500 0.0099 0.9596 0.0099
γCTR5.CTR0.AD protein modification by small protein co... 219 38.2800 0.0000 0.7940 0.0001
γCTR5.CTR0.AD positive regulation of cytoplasmic mRNA ... 4 0.7000 0.0009 0.9340 0.0009
γCTR5.CTR0.AD neutrophil degranulation 27 4.7200 0.0010 0.7500 0.0010
γCTR5.CTR0.AD nuclear-transcribed mRNA catabolic proce... 19 3.3200 0.0025 0.9020 0.0017
γCTR5.CTR0.AD positive regulation of translational ini... 6 1.0500 0.0008 0.9910 0.0039
γCTR5.CTR0.AD regulation of deoxyribonuclease activity 5 0.8700 0.0040 0.9950 0.0040
γCTR5.CTR0.AD regulation of intracellular estrogen rec... 14 2.4500 0.0053 0.8450 0.0053
γCTR5.CTR0.AD positive regulation of activin receptor ... 3 0.5200 0.0053 0.9900 0.0053
γCTR5.CTR0.AD histone H4-K20 trimethylation 3 0.5200 0.0053 0.9450 0.0053
γCTR5.CTR0.AD establishment of integrated proviral lat... 3 0.5200 0.0053 0.9980 0.0053
γCTR5.CTR0.AD negative regulation of telomere maintena... 8 1.4000 0.0056 0.9530 0.0056
γCTR5.CTR0.AD DNA-templated transcription, elongation 86 15.0300 0.0022 0.6270 0.0060
γCTR5.CTR0.AD snRNA transcription by RNA polymerase II 42 7.3400 0.0091 0.6940 0.0091
γCTR5.CTR0.AD iron ion homeostasis 12 2.1000 0.0099 0.8300 0.0099
γCTR5.CTR0.AD positive regulation of NIK/NF-kappaB siγ.. 12 2.1000 0.0099 0.9520 0.0099
γCTR5.CTR0 histone lysine demethylation 19 2.2800 0.0047 0.9370 0.0047
γCTR5.CTR0 mitotic G2/M transition checkpoint 7 0.8400 0.0053 0.8010 0.0053
γCTR5.AD.PD ventricular cardiac muscle cell developm... 5 0.0700 0.0021 0.9990 0.0021
γCTR5.AD.PD heart trabecula formation 6 0.0900 0.0031 0.4985 0.0031
γCTR5.AD endocardiummorphogenesis 6 1.0700 0.0009 0.9993 0.0009
γCTR5.AD cellular response to ether 4 0.7100 0.0010 0.9679 0.0010
γCTR5.AD positive regulation of cardiac muscle ce... 10 1.7800 0.0034 0.9802 0.0034
γCTR5.AD cellular response to follicle-stimulatin... 3 0.5300 0.0056 0.9693 0.0056
γCTR5.AD regulation of NMDA receptor activity 3 0.5300 0.0056 0.9613 0.0056
γCTR5.AD post-translational protein modification 52 9.2600 0.0064 0.6060 0.0064
γCTR5.AD 7-methylguanosine mRNA capping 21 3.7400 0.0064 0.4703 0.0064
γCTR5 intracellular estrogen receptor signalin... 27 3.8000 0.0001 1.0000 0.0001
γCTR5 endocrine system development 54 7.6000 0.0002 0.9490 0.0006
γCTR5 visual perception 21 2.9600 0.0012 0.2960 0.0012
γCTR5 ear morphogenesis 34 4.7900 0.0004 0.2960 0.0016
γCTR5 dosage compensation by inactivation of X... 3 0.4200 0.0028 0.9570 0.0028
γCTR5 cell fate specification 33 4.6500 0.0039 0.8480 0.0066
γCTR5 epithelial cell maturation 7 0.9900 0.0095 0.7250 0.0095
γCTR5 regulation of macrophage derived foam ce... 7 0.9900 0.0095 0.8220 0.0095
γCTR5 replication fork processing 7 0.9900 0.0095 0.9720 0.0095
γCTR5 positive regulation of insulin secretion... 4 0.5600 0.0099 0.8980 0.0099
γCTR5 positive regulation of isotype switchinγ.. 4 0.5600 0.0099 0.9160 0.0099
γCTR5 establishment of skin barrier 4 0.5600 0.0099 0.9630 0.0099
γCTR5 positive regulation of histone H4 acetyl... 4 0.5600 0.0099 0.8780 0.0099
γCTR0.AD positive regulation of protein localizat... 15 0.3500 0.0045 0.5509 0.0045
γCTR0.AD response to ischemia 5 0.1200 0.0051 0.6607 0.0051
γCTR0.AD response to UV-B 5 0.1200 0.0051 0.9997 0.0051
γCTR0.AD regulation of release of sequestered cal... 5 0.1200 0.0051 0.6504 0.0051
γCTR0.AD cellular response to interleukin-1 17 0.4000 0.0065 0.8689 0.0065
γCTR0.AD response to amino acid 18 0.4200 0.0077 0.0765 0.0077
γCTR0.AD positive regulation of intracellular pro... 37 0.8600 0.0099 0.2942 0.0099
γCTR0 peripheral nervous system development 20 3.3700 0.0006 0.7687 0.0004
γCTR0 response to corticosterone 6 1.0100 0.0007 0.9755 0.0007
γCTR0 glial cell development 17 2.8700 0.0007 0.9815 0.0007
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γCTR0 glycogen biosynthetic process 4 0.6700 0.0008 0.9799 0.0008
γCTR0 regulation of gluconeogenesis by regulat... 4 0.6700 0.0008 0.9487 0.0008
γCTR0 positive regulation of T cell differenti... 3 0.5100 0.0048 0.9921 0.0048
γCTR0 spermatogenesis 89 15.0100 0.0048 0.1413 0.0053
γCTR0 oocyte maturation 7 1.1800 0.0021 0.8877 0.0089
γCTR0 histone H3-K27 trimethylation 6 1.0100 0.0090 0.9623 0.0090
γAD regulation of GTPase activity 53 7.0500 0.0003 0.7828 0.0003
γAD cellular response to mechanical stimulus 13 1.7300 0.0006 0.8581 0.0006
γAD pallium development 41 5.4500 0.0005 0.7377 0.0008
γAD regulation of I-kappaB kinase/NF-kappaB ... 48 6.3900 0.0009 0.7797 0.0009
γAD defense response to virus 36 4.7900 0.0004 0.9892 0.0012
γAD negative regulation of myoblast differen... 11 1.4600 0.0014 0.8479 0.0014
γAD regulation of extrinsic apoptotic signal... 36 4.7900 0.0016 0.3743 0.0016
γAD regulation of sodium ion transport 5 0.6700 0.0014 0.9946 0.0023
γAD activation of transmembrane receptor pro... 3 0.4000 0.0023 0.9933 0.0023
γAD branchiomotor neuron axon guidance 3 0.4000 0.0023 0.9683 0.0023
γAD negative regulation of multicellular orγ.. 3 0.4000 0.0023 0.9987 0.0023
γAD regulation of small GTPase mediated sign... 23 3.0600 0.0003 0.7994 0.0026
γAD negative regulation of cellular response... 20 2.6600 0.0026 0.7157 0.0026
γAD negative regulation of T cell differenti... 14 1.8600 0.0062 0.8928 0.0032
γAD regulation of germinal center formation 6 0.8000 0.0037 0.9202 0.0037
γAD negative regulation of transcription by ... 483 64.2600 0.0038 0.2385 0.0038
γAD SMAD protein signal transduction 30 3.9900 0.0039 0.9834 0.0039
γAD regulation of ossification 60 7.9800 0.0039 0.4022 0.0039
γAD response to wounding 84 11.1700 0.0001 0.9342 0.0040
γAD pharyngeal system development 13 1.7300 0.0040 0.5586 0.0040
γAD positive regulation of cell morphogenesi... 26 3.4600 0.0046 0.9799 0.0046
γAD regulation of pri-miRNA transcription by... 22 2.9300 0.0053 0.9924 0.0053
γAD semaphorin-plexin signaling pathway 11 1.4600 0.0014 0.9980 0.0057
γAD hemostasis 31 4.1200 0.0050 0.9927 0.0060
γAD regulation of transforming growth factor... 32 4.2600 0.0065 0.9868 0.0065
γAD negative regulation of DNA-binding trans... 59 7.8500 0.0083 0.2537 0.0083
γAD negative regulation of inflammatory resp... 19 2.5300 0.0083 0.7222 0.0083
γAD negative regulation of cytokine producti... 4 0.5300 0.0084 0.9089 0.0084
γAD common-partner SMAD protein phosphorylat... 4 0.5300 0.0084 0.9670 0.0084
γAD G0 to G1 transition 4 0.5300 0.0084 0.9997 0.0084
γAD regulation of axon extension involved in... 4 0.5300 0.0084 0.9579 0.0084
γAD negative chemotaxis 4 0.5300 0.0084 0.9789 0.0084
γAD response to cholesterol 4 0.5300 0.0084 0.9983 0.0084
γAD headmorphogenesis 11 1.4600 0.0094 0.9987 0.0094
α nucleotide-excision repair, DNA duplex u... 13 0.1500 0.0004 0.9857 0.0004
α nucleotide-excision repair, preincision ... 13 0.1500 0.0004 0.9515 0.0004
α nucleotide-excision repair, DNA incision... 13 0.1500 0.0004 0.9515 0.0004
α nucleotide-excision repair, DNA incision... 15 0.1800 0.0006 0.6690 0.0006
α nucleotide-excision repair, preincision ... 16 0.1900 0.0008 0.8050 0.0008
α global genome nucleotide-excision repair 16 0.1900 0.0008 0.9698 0.0008
α transcription-coupled nucleotide-excisio... 37 0.4400 0.0008 0.1411 0.0008
α protein monoubiquitination 19 0.2300 0.0013 0.6811 0.0013
α UV-damage excision repair 7 0.0800 0.0027 0.8011 0.0027
α post-translational protein modification 52 0.6200 0.0029 0.0445 0.0029
α trophectodermal cell differentiation 8 0.0900 0.0036 0.8097 0.0036
α DNA damage response, detection of DNA da... 10 0.1200 0.0058 0.5788 0.0058
α response to arsenic-containing substance 10 0.1200 0.0058 0.6074 0.0058
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E
GO enrichment for mental disorders
Table showing the GO enrichment for the psychiatric disorders Autism Spectrum Disorder
(ASD), Bipolar Disorder (BD), Major Depression Disorder (MDD) and Schizophrenia (SCZ).
Healthy humans adults are used as controls and are represented as CTR.
TABLE E.1: GO enrichment for mental disorders.
Φ̃ Term Annotated Expected Significant Classic Weight
γSCZ thalamus development 2 0.0200 0.0001 1.0000 0.0001
γSCZ cornification 2 0.0200 0.0001 1.0000 0.0001
γSCZ bundle of His cell-Purkinje myocyte adhe... 2 0.0200 0.0001 1.0000 0.0001
γSCZ regulation of ventricular cardiac muscle... 2 0.0200 0.0001 1.0000 0.0001
γSCZ intermediate filament organization 3 0.0300 0.0003 0.9101 0.0003
γSCZ canonical Wnt signaling pathway 66 0.6900 0.0005 0.4603 0.0005
γSCZ desmosome organization 4 0.0400 0.0006 0.6617 0.0006
γSCZ positive regulation of oligodendrocyte d... 4 0.0400 0.0006 0.8507 0.0006
γSCZ cellular response to indole-3-methanol 4 0.0400 0.0006 0.6492 0.0006
γSCZ regulation of heart rate by cardiac cond... 4 0.0400 0.0006 0.7206 0.0006
γSCZ extracellular matrix disassembly 5 0.0500 0.0010 0.9999 0.0010
γSCZ cellular response to lithium ion 6 0.0600 0.0015 0.9096 0.0015
γSCZ melanocyte differentiation 7 0.0700 0.0021 0.9282 0.0021
γSCZ negative regulation of T cell proliferat... 9 0.0900 0.0036 0.8306 0.0036
γSCZ positive regulation of protein import in... 9 0.0900 0.0036 0.1752 0.0036
γSCZ positive regulation of neuroblast prolif... 10 0.1000 0.0045 0.4949 0.0045
γSCZ neural crest cell migration 12 0.1300 0.0064 0.8645 0.0064
γSCZ spinal cord motor neuron differentiation 12 0.1300 0.0064 0.3359 0.0064
γSCZ positive regulation of transcription, DN... 696 7.2600 0.0038 0.0009 0.0071
γSCZ positive regulation of DNA-binding trans... 77 0.8000 0.0074 0.2091 0.0074
γSCZ positive regulation of mesenchymal cell ... 13 0.1400 0.0076 0.0749 0.0076
γSCZ regulation of osteoclast differentiation 13 0.1400 0.0076 0.9944 0.0076
γSCZ positive regulation of fibroblast prolif... 13 0.1400 0.0076 0.3790 0.0076
γSCZ ovarian follicle development 14 0.1500 0.0088 0.9768 0.0088
γMDD DNA damage response, signal transduction... 29 0.0800 0.0022 0.2115 0.0022
γMDD retinoic acid biosynthetic process 1 0.0000 0.0026 1.0000 0.0026
γMDD mRNA localization resulting in posttrans... 1 0.0000 0.0026 1.0000 0.0026
γMDD positive regulation of collateral sprout... 1 0.0000 0.0026 1.0000 0.0026
γMDD platelet alpha granule organization 1 0.0000 0.0026 1.0000 0.0026
γMDD positive regulation of DNA damage respon... 1 0.0000 0.0026 1.0000 0.0026
γMDD negative regulation of transcription inv... 2 0.0100 0.0052 0.9970 0.0052
γMDD regulation of fat cell differentiation 45 0.1200 0.0053 0.2174 0.0053
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γMDD lens fiber cell apoptotic process 3 0.0100 0.0078 0.5336 0.0078
γCTR.SCZ positive regulation of SMAD protein sign... 8 0.0100 0.0069 0.2160 0.0069
γCTR.MDD regulation of epithelial cell proliferat... 79 0.1400 0.0001 0.0127 0.0001
γCTR.MDD pharyngeal system development 13 0.0200 0.0002 0.0495 0.0002
γCTR.MDD metanephros development 32 0.0600 0.0000 0.8997 0.0003
γCTR.MDD regulation of cell division 17 0.0300 0.0003 0.1893 0.0003
γCTR.MDD negative regulation of ossification 25 0.0400 0.0007 0.6504 0.0007
γCTR.MDD neural tube closure 29 0.0500 0.0009 0.2812 0.0009
γCTR.MDD cell fate specification 31 0.0500 0.0010 0.6003 0.0010
γCTR.MDD response to estradiol 34 0.0600 0.0012 0.9235 0.0012
γCTR.MDD embryonic organ development 124 0.2200 0.0000 0.0356 0.0013
γCTR.MDD embryonic limbmorphogenesis 35 0.0600 0.0013 0.1816 0.0013
γCTR.MDD digestive tract development 38 0.0700 0.0016 0.1961 0.0016
γCTR.MDD response to mechanical stimulus 40 0.0700 0.0017 0.1947 0.0017
γCTR.MDD negative regulation of neuroblast prolif... 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD defense response to fungus, incompatible... 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD response to chlorate 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD negative regulation of extracellular mat... 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD positive regulation of fibroblast migrat... 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD negative regulation of macrophage cytoki... 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD neural plate axis specification 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD hyaluronan catabolic process 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD inductive cell-cell signaling 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD positive regulation of superoxide anion ... 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD positive regulation of vascular permeabi... 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD positive regulation of phosphatidylinosi... 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD ossification involved in bone remodeling 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD active induction of host immune response... 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD positive regulation of isotype switchinγ.. 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD negative regulation of release of seques... 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD olfactory bulb mitral cell layer develop... 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD ureteric bud invasion 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD negative regulation of hyaluronan biosyn... 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD positive regulation of NAD+ ADP-ribosylt... 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD transforming growth factor beta receptor... 1 0.0000 0.0017 1.0000 0.0017
γCTR.MDD response to ionizing radiation 44 0.0800 0.0021 0.5380 0.0021
γCTR.MDD epithelial cell differentiation 144 0.2500 0.0000 0.0043 0.0026
γCTR.MDD connective tissue replacement involved i... 2 0.0000 0.0035 0.6196 0.0035
γCTR.MDD tolerance induction to self antigen 2 0.0000 0.0035 0.4341 0.0035
γCTR.MDD olfactory nerve development 2 0.0000 0.0035 1.0000 0.0035
γCTR.MDD positive regulation of exit frommitosis 2 0.0000 0.0035 1.0000 0.0035
γCTR.MDD regulation of interleukin-23 production 2 0.0000 0.0035 1.0000 0.0035
γCTR.MDD negative regulation of interleukin-17 pr... 2 0.0000 0.0035 0.4341 0.0035
γCTR.MDD positive regulation of interleukin-17 pr... 2 0.0000 0.0035 1.0000 0.0035
γCTR.MDD receptor catabolic process 2 0.0000 0.0035 1.0000 0.0035
γCTR.MDD positive regulation of protein dephospho... 2 0.0000 0.0035 1.0000 0.0035
γCTR.MDD regulation of blood vessel remodeling 2 0.0000 0.0035 1.0000 0.0035
γCTR.MDD positive regulation of secondary heart f... 2 0.0000 0.0035 0.9364 0.0035
γCTR.MDD negative regulation of protein localizat... 2 0.0000 0.0035 1.0000 0.0035
γCTR.MDD positive regulation of receptor clusteri... 2 0.0000 0.0035 0.5467 0.0035
γCTR.MDD protein localization 275 0.4800 0.0062 0.0000 0.0047
γCTR.MDD establishment of mitotic spindle orienta... 3 0.0100 0.0052 0.5318 0.0052
γCTR.MDD common-partner SMAD protein phosphorylat... 3 0.0100 0.0052 1.0000 0.0052
γCTR.MDD germ cell migration 3 0.0100 0.0052 0.2957 0.0052
γCTR.MDD evasion or tolerance of host defenses by... 3 0.0100 0.0052 0.6164 0.0052
γCTR.MDD positive regulation of collagen biosynth... 3 0.0100 0.0052 0.2985 0.0052
γCTR.MDD negative regulation of multicellular orγ.. 3 0.0100 0.0052 0.9366 0.0052
γCTR.MDD positive regulation of odontogenesis 3 0.0100 0.0052 0.7620 0.0052
γCTR.MDD positive regulation of regulatory T cell... 3 0.0100 0.0052 0.3865 0.0052
γCTR.MDD lymph node development 3 0.0100 0.0052 0.6209 0.0052
γCTR.MDD negative regulation of phagocytosis 3 0.0100 0.0052 1.0000 0.0052
γCTR.MDD frontal suture morphogenesis 3 0.0100 0.0052 0.4808 0.0052
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γCTR.MDD branch elongation involved in mammary gl... 3 0.0100 0.0052 0.5677 0.0052
γCTR.MDD regulation of branching involved in mamm... 3 0.0100 0.0052 0.9770 0.0052
γCTR.MDD otic vesicle morphogenesis 3 0.0100 0.0052 0.5613 0.0052
γCTR.MDD positive regulation of mononuclear cell ... 3 0.0100 0.0052 0.9260 0.0052
γCTR.MDD negative regulation of production of miR... 3 0.0100 0.0052 1.0000 0.0052
γCTR.MDD positive regulation of production of miR... 3 0.0100 0.0052 0.7011 0.0052
γCTR.MDD regulation of sodium ion transport 4 0.0100 0.0069 0.8322 0.0069
γCTR.MDD histone dephosphorylation 4 0.0100 0.0069 0.6266 0.0069
γCTR.MDD mammary gland branching involved in thel... 4 0.0100 0.0069 0.8540 0.0069
γCTR.MDD positive regulation of extracellular mat... 4 0.0100 0.0069 0.8482 0.0069
γCTR.MDD membrane protein intracellular domain pr... 5 0.0100 0.0087 0.9859 0.0087
γCTR.MDD semicircular canal morphogenesis 5 0.0100 0.0087 1.0000 0.0087
γCTR.MDD smoothened signaling pathway involved in... 5 0.0100 0.0087 0.0359 0.0087
γCTR.BD.MDD heart valve morphogenesis 16 0.0200 0.0001 0.4015 0.0001
γCTR.BD.MDD negative regulation of cell proliferatio... 179 0.2300 0.0005 0.0698 0.0005
γCTR.BD.MDD marginal zone B cell differentiation 1 0.0000 0.0013 1.0000 0.0013
γCTR.BD.MDD chondrocyte hypertrophy 1 0.0000 0.0013 1.0000 0.0013
γCTR.BD.MDD male germ-line sex determination 1 0.0000 0.0013 1.0000 0.0013
γCTR.BD.MDD intrahepatic bile duct development 1 0.0000 0.0013 1.0000 0.0013
γCTR.BD.MDD epithelial cell proliferation involved i... 1 0.0000 0.0013 1.0000 0.0013
γCTR.BD.MDD regulation of cell proliferation involve... 1 0.0000 0.0013 1.0000 0.0013
γCTR.BD.MDD Harderian gland development 1 0.0000 0.0013 1.0000 0.0013
γCTR.BD.MDD ureter urothelium development 1 0.0000 0.0013 1.0000 0.0013
γCTR.BD.MDD negative regulation of G1/S transition o... 1 0.0000 0.0013 1.0000 0.0013
γCTR.BD.MDD Notch signaling pathway 51 0.0700 0.0014 0.1055 0.0014
γCTR.BD.MDD chondrocyte differentiation involved in ... 2 0.0000 0.0026 0.6218 0.0026
γCTR.BD.MDD otic vesicle formation 2 0.0000 0.0026 0.8552 0.0026
γCTR.BD.MDD astrocyte fate commitment 2 0.0000 0.0026 0.3766 0.0026
γCTR.BD.MDD retinal rod cell differentiation 2 0.0000 0.0026 0.3766 0.0026
γCTR.BD.MDD bronchus cartilage development 2 0.0000 0.0026 0.7990 0.0026
γCTR.BD.MDD regulation of branching involved in lunγ.. 2 0.0000 0.0026 1.0000 0.0026
γCTR.BD.MDD lung smooth muscle development 2 0.0000 0.0026 0.7990 0.0026
γCTR.BD.MDD cellular response to heparin 2 0.0000 0.0026 0.8813 0.0026
γCTR.BD.MDD renal vesicle induction 2 0.0000 0.0026 0.3766 0.0026
γCTR.BD.MDD ureter morphogenesis 2 0.0000 0.0026 0.3766 0.0026
γCTR.BD.MDD cell cycle process 245 0.3200 0.0012 0.0007 0.0027
γCTR.BD.MDD stem cell population maintenance 74 0.1000 0.0030 0.1284 0.0030
γCTR.BD.MDD cartilage condensation 3 0.0000 0.0039 0.5896 0.0039
γCTR.BD.MDD negative regulation of bone mineralizati... 3 0.0000 0.0039 0.8247 0.0039
γCTR.BD.MDD positive regulation of Ras protein signa... 3 0.0000 0.0039 0.9588 0.0039
γCTR.BD.MDD trachea cartilage development 3 0.0000 0.0039 0.6561 0.0039
γCTR.BD.MDD intestinal epithelial structure maintena... 3 0.0000 0.0039 1.0000 0.0039
γCTR.BD.MDD ureter smooth muscle cell differentiatio... 3 0.0000 0.0039 0.9972 0.0039
γCTR.BD.MDD metanephric nephron tubule formation 3 0.0000 0.0039 0.5255 0.0039
γCTR.BD.MDD positive regulation of mesenchymal stem ... 3 0.0000 0.0039 0.7046 0.0039
γCTR.BD.MDD regulation of cell cycle 245 0.3200 0.0012 0.0046 0.0047
γCTR.BD.MDD lacrimal gland development 4 0.0100 0.0052 0.0526 0.0052
γCTR.BD.MDD limb bud formation 4 0.0100 0.0052 0.8144 0.0052
γCTR.BD.MDD positive regulation of extracellular mat... 4 0.0100 0.0052 0.4878 0.0052
γCTR.BD.MDD positive regulation of intrinsic apoptot... 4 0.0100 0.0052 0.7186 0.0052
γCTR.BD.MDD positive regulation of cell proliferatio... 4 0.0100 0.0052 0.9702 0.0052
γCTR.BD.MDD regulation of epithelial cell proliferat... 4 0.0100 0.0052 0.6940 0.0052
γCTR.BD.MDD negative regulation of chondrocyte diffe... 5 0.0100 0.0065 0.2310 0.0065
γCTR.BD.MDD cellular protein-containing complex loca... 5 0.0100 0.0065 0.7051 0.0065
γCTR.BD.MDD negative regulation of photoreceptor cel... 5 0.0100 0.0065 0.5067 0.0065
γCTR.BD.MDD Sertoli cell development 5 0.0100 0.0065 0.0088 0.0065
γCTR.BD.MDD atrial septummorphogenesis 5 0.0100 0.0065 0.7898 0.0065
γCTR.BD.MDD positive regulation of male gonad develo... 5 0.0100 0.0065 1.0000 0.0065
γCTR.BD.MDD notochord development 6 0.0100 0.0078 0.1834 0.0078
γCTR.BD.MDD negative regulation of mesenchymal cell ... 6 0.0100 0.0078 0.6975 0.0078
γCTR.BD secretory columnal luminar epithelial ce... 3 0.0200 0.0002 0.9880 0.0002
γCTR.BD negative regulation of inflammatory resp... 16 0.1300 0.0002 0.6464 0.0002
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γCTR.BD regulation of I-kappaB kinase/NF-kappaB ... 45 0.3700 0.0004 0.6903 0.0004
γCTR.BD immune response 190 1.5700 0.0001 0.0944 0.0006
γCTR.BD cardiac left ventricle morphogenesis 5 0.0400 0.0006 0.9999 0.0006
γCTR.BD positive regulation of JAK-STAT cascade 5 0.0400 0.0006 0.9999 0.0006
γCTR.BD mitral valve morphogenesis 6 0.0500 0.0009 0.7180 0.0009
γCTR.BD pulmonary valve morphogenesis 6 0.0500 0.0009 0.9911 0.0009
γCTR.BD response to muramyl dipeptide 6 0.0500 0.0009 0.8380 0.0009
γCTR.BD negative regulation of ossification 25 0.2100 0.0010 0.7495 0.0010
γCTR.BD cilium assembly 26 0.2100 0.0011 0.1179 0.0011
γCTR.BD regulation of epithelial to mesenchymal ... 27 0.2200 0.0012 0.5340 0.0012
γCTR.BD vasculogenesis 28 0.2300 0.0014 0.9438 0.0014
γCTR.BD response to molecule of bacterial origin 58 0.4800 0.0011 0.0964 0.0018
γCTR.BD artery development 34 0.2800 0.0001 0.0545 0.0019
γCTR.BD foregut morphogenesis 9 0.0700 0.0022 0.9936 0.0022
γCTR.BD regulation of tumor necrosis factor-medi... 9 0.0700 0.0022 0.4999 0.0022
γCTR.BD embryonic axis specification 11 0.0900 0.0034 0.9997 0.0034
γCTR.BD positive regulation of cell-substrate ad... 11 0.0900 0.0034 0.9276 0.0034
γCTR.BD stem cell division 12 0.1000 0.0041 0.6553 0.0041
γCTR.BD negative regulation of BMP signaling pat... 13 0.1100 0.0048 0.7002 0.0048
γCTR.BD negative regulation of Wnt signaling pat... 52 0.4300 0.0082 0.2149 0.0082
γCTR.BD coronary vein morphogenesis 1 0.0100 0.0082 1.0000 0.0082
γCTR.BD Notch signaling pathway involved in regu... 1 0.0100 0.0082 1.0000 0.0082
γCTR.BD negative regulation of SMAD protein comp... 1 0.0100 0.0082 1.0000 0.0082
γCTR.BD detection of wounding 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD negative regulation of transcription by ... 1 0.0100 0.0082 1.0000 0.0082
γCTR.BD negative regulation of toll-like recepto... 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD negative regulation of toll-like recepto... 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD negative regulation of toll-like recepto... 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD negative regulation of toll-like recepto... 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD positive regulation of translational ini... 1 0.0100 0.0082 1.0000 0.0082
γCTR.BD embryonic ectodermal digestive tract mor... 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD induction of positive chemotaxis 1 0.0100 0.0082 1.0000 0.0082
γCTR.BD actin crosslink formation 1 0.0100 0.0082 1.0000 0.0082
γCTR.BD branching involved in open tracheal syst... 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD right lung morphogenesis 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD venous endothelial cell differentiation 1 0.0100 0.0082 1.0000 0.0082
γCTR.BD negative regulation of nucleotide-bindin... 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD negative regulation of nucleotide-bindin... 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD response to interleukin-9 1 0.0100 0.0082 1.0000 0.0082
γCTR.BD response to interleukin-11 1 0.0100 0.0082 1.0000 0.0082
γCTR.BD death-inducing signaling complex assembl... 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD protein deubiquitination involved in ubi... 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD glomerular capillary formation 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD tolerance induction to lipopolysaccharid... 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD mesenchymemigration 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD negative regulation of osteoclast prolif... 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD apoptotic process involved in embryonic ... 1 0.0100 0.0082 1.0000 0.0082
γCTR.BD positive regulation of aorta morphogenes... 1 0.0100 0.0082 1.0000 0.0082
γCTR.BD regulation of membrane repolarization du... 1 0.0100 0.0082 1.0000 0.0082
γCTR.BD positive regulation of ceramide biosynth... 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD negative regulation of CD40 signaling pa... 1 0.0100 0.0082 0.9999 0.0082
γCTR.BD negative regulation of endothelial cell ... 1 0.0100 0.0082 1.0000 0.0082
γCTR.BD positive regulation of integrin-mediated... 1 0.0100 0.0082 1.0000 0.0082
γCTR.BD positive regulation of neuron migration 1 0.0100 0.0082 1.0000 0.0082
γCTR.BD ventricular cardiac muscle tissue morpho... 18 0.1500 0.0091 0.3658 0.0091
γCTR.BD positive regulation of neural precursor ... 18 0.1500 0.0091 0.3461 0.0091
γCTR.ASD.BD negative regulation of transcription fro... 2 0.0000 0.0009 0.6285 0.0009
γCTR.ASD.BD negative regulation of histone H4 acetyl... 3 0.0000 0.0013 0.1847 0.0013
γCTR.ASD.BD white fat cell differentiation 7 0.0000 0.0030 0.7312 0.0030
γCTR.ASD.BD positive regulation of histone deacetyla... 9 0.0000 0.0039 0.2260 0.0039
γCTR.ASD negative regulation of histone methylati... 16 3.8400 0.0002 0.9200 0.0002
γCTR.ASD positive regulation of histone methylati... 20 4.8000 0.0006 0.7300 0.0006
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γCTR.ASD nuclear-transcribed mRNA catabolic proce... 19 4.5600 0.0063 0.9200 0.0020
γCTR.ASD positive regulation of chromatin silenci... 8 1.9200 0.0033 0.9500 0.0033
γCTR.ASD cellular macromolecule metabolic process 2122 508.8400 0.0008 1.0000 0.0050
γCTR.ASD cytoplasmic mRNA processing body assembl... 9 2.1600 0.0079 1.0000 0.0079
γCTR type B pancreatic cell differentiation 10 5.6700 0.0034 0.6300 0.0034
γCTR cell fate commitment involved in formati... 17 9.6400 0.0009 0.8400 0.0040
γCTR T cell receptor signaling pathway 23 13.0500 0.0083 0.9800 0.0083
γBD negative regulation of epidermis develop... 5 0.1200 0.0001 0.9985 0.0001
γBD angiogenesis 86 2.0200 0.0000 0.4399 0.0002
γBD negative regulation of gliogenesis 14 0.3300 0.0002 0.8436 0.0002
γBD regulation of bone mineralization 16 0.3800 0.0004 0.6916 0.0004
γBD regulation of astrocyte differentiation 7 0.1600 0.0004 0.9187 0.0004
γBD cellular response to organic cyclic comp... 175 4.1100 0.0000 0.0986 0.0005
γBD response to folic acid 2 0.0500 0.0005 0.9999 0.0005
γBD positive regulation of cell proliferatio... 176 4.1300 0.0000 0.3901 0.0006
γBD GABAergic neuron differentiation 8 0.1900 0.0006 0.7876 0.0006
γBD embryonic forelimbmorphogenesis 9 0.2100 0.0009 1.0000 0.0009
γBD negative regulation of transcription, DN... 628 14.7300 0.0008 0.1213 0.0011
γBD positive regulation of transmembrane rec... 35 0.8200 0.0011 0.3452 0.0011
γBD negative regulation of cell proliferatio... 179 4.2000 0.0002 0.4332 0.0013
γBD positive regulation of apoptotic process 128 3.0000 0.0001 0.3174 0.0013
γBD neuroendocrine cell differentiation 4 0.0900 0.0000 0.9993 0.0015
γBD adenohypophysis development 3 0.0700 0.0016 0.9993 0.0016
γBD negative regulation of aldosterone biosy... 3 0.0700 0.0016 0.9581 0.0016
γBD regulation of T-helper 2 cell differenti... 3 0.0700 0.0016 0.9988 0.0016
γBD cardiac neural crest cell development in... 3 0.0700 0.0016 0.9992 0.0016
γBD negative regulation of cortisol biosynth... 3 0.0700 0.0016 0.9581 0.0016
γBD negative regulation of neuron differenti... 48 1.1300 0.0000 0.7668 0.0016
γBD odontogenesis 31 0.7300 0.0001 0.9345 0.0018
γBD cardiac epithelial to mesenchymal transi... 16 0.3800 0.0004 0.8274 0.0022
γBD cerebral cortex neuron differentiation 12 0.2800 0.0023 0.8560 0.0023
γBD regulation of dendrite development 25 0.5900 0.0024 0.3066 0.0024
γBD negative regulation of programmed cell d... 188 4.4100 0.0001 0.1859 0.0027
γBD interferon-gamma-mediated signaling path... 26 0.6100 0.0028 0.3293 0.0028
γBD blood vessel endothelial cell migration 20 0.4700 0.0010 0.5463 0.0028
γBD olfactory bulb development 13 0.3000 0.0030 0.6804 0.0030
γBD negative regulation of DNA damage respon... 4 0.0900 0.0031 0.8967 0.0031
γBD regulation of insulin-like growth factor... 4 0.0900 0.0031 0.9997 0.0031
γBD cranial suture morphogenesis 4 0.0900 0.0031 0.5092 0.0031
γBD negative regulation of DNA binding 27 0.6300 0.0032 0.9678 0.0032
γBD positive regulation of cellular componen... 65 1.5200 0.0036 0.0065 0.0036
γBD SMAD protein signal transduction 29 0.6800 0.0042 0.6781 0.0042
γBD epithelial cell morphogenesis 5 0.1200 0.0052 0.9852 0.0052
γBD branching involved in salivary gland mor... 5 0.1200 0.0052 0.6756 0.0052
γBD visual perception 16 0.3800 0.0055 0.0996 0.0055
γBD positive regulation of lymphocyte prolif... 16 0.3800 0.0055 0.9799 0.0055
γBD muscle tissue development 126 2.9600 0.0005 0.2032 0.0063
γBD response to epidermal growth factor 17 0.4000 0.0066 0.8715 0.0066
γBD negative regulation of DNA-binding trans... 53 1.2400 0.0072 0.4290 0.0072
γBD subpallium development 8 0.1900 0.0006 0.7572 0.0074
γBD positive regulation of meiotic nuclear d... 6 0.1400 0.0076 0.9614 0.0076
γBD cell migration involved in heart develop... 6 0.1400 0.0076 0.9979 0.0076
γBD positive regulation of NF-kappaB transcr... 35 0.8200 0.0083 0.4983 0.0083
γBD roof of mouth development 35 0.8200 0.0083 0.8741 0.0083
γASD IRE1-mediated unfolded protein response 8 1.1100 0.0020 0.9860 0.0020
γASD oocyte differentiation 12 1.6700 0.0030 0.9900 0.0030
γASD cell-matrix adhesion 18 2.5000 0.0076 0.9960 0.0076
γASD positive regulation of response to endop... 7 0.9700 0.0091 0.6300 0.0091
γASD myelination in peripheral nervous system 4 0.5600 0.0096 0.7550 0.0096
γASD apoptotic cell clearance 4 0.5600 0.0096 0.9530 0.0096
γASD negative regulation of ubiquitin-depende... 4 0.5600 0.0096 0.9900 0.0096
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F
GO enrichment for genes involved in the
primate evolution
Table showing the GO enrichment for the evolution of Transcription Factors (TFs). Humans
were compared to Chimpanzee (CMP) and Rhesus macaque (RH).
TABLE F.1: GO enrichment for genes involved in the primate evolution.
Φ̃ Term Annotated Significant Classic Weight
γCMP translational elongation 11 3 0.00085 0.00085
γCMP regulation of long-term synaptic potenti... 3 2 0.00097 0.00097
γCMP positive regulation of DNA-binding trans... 89 6 0.00497 0.00497
γCTR transcription initiation from RNA polyme... 144 132 0.00085 0.0035
γCTR mRNA processing 163 147 0.00281 0.0072
γCTR transcription-coupled nucleotide-excisio... 36 35 0.00754 0.0075
γCTR.RH endothelial cell activation 6 3 0.0028 0.0028
γCTR.RH DNA double-strand break processing invol... 2 2 0.0030 0.0030
γCTR.RH central nervous system neuron axonogenes... 7 3 0.0048 0.0048
γCTR.RH G2 DNA damage checkpoint 7 3 0.0048 0.0048
γCTR.RH double-strand break repair via homologou... 23 5 0.0069 0.0069
γCTR.RH negative regulation of phagocytosis 3 2 0.0086 0.0086
γCTR.RH positive regulation of mesenchymal stem ... 3 2 0.0086 0.0086
γCTR.RH transforming growth factor beta receptor... 55 8 0.0090 0.0090
γRH tube closure 37 11 0.00054 0.00047
γRH negative regulation of aldosterone biosy... 3 3 0.00093 0.00093
γRH negative regulation of cortisol biosynth... 3 3 0.00093 0.00093
γRH regulation of GTPase activity 56 13 0.00225 0.00225
γRH positive regulation of epithelial cell p... 51 12 0.00293 0.00293
γRH negative regulation of extrinsic apoptot... 27 8 0.00322 0.00322
γRH desmosome organization 4 3 0.00345 0.00345
γRH regulation of cell shape 12 5 0.00385 0.00385
γRH response to hypoxia 84 16 0.00624 0.00624
γRH regulation of fibroblast proliferation 31 9 0.00210 0.00642
γRH regulation of heart rate 9 4 0.00761 0.00761
γRH positive regulation of MAP kinase activi... 37 11 0.00054 0.00768
γRH adult walking behavior 5 3 0.00799 0.00799
γRH negative regulation of insulin secretion 5 3 0.00799 0.00799
γRH angiogenesis 106 20 0.00260 0.00820
γRH BMP signaling pathway involved in heart ... 2 2 0.00955 0.00955
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Φ̃ Term Annotated Significant Classic Weight
γRH substrate-dependent cell migration 2 2 0.00955 0.00955
γRH olfactory nerve development 2 2 0.00955 0.00955
γRH regulation of hippo signaling 2 2 0.00955 0.00955
γRH regulation of odontogenesis of dentin-co... 2 2 0.00955 0.00955
γRH maintenance of epithelial cell apical/ba... 2 2 0.00955 0.00955
γRH musculoskeletal movement 2 2 0.00955 0.00955
γRH sensory perception of taste 2 2 0.00955 0.00955
γRH regulation of branching involved in sali... 2 2 0.00955 0.00955
γRH cornification 2 2 0.00955 0.00955
γRH mesenchymal cell proliferation involved ... 2 2 0.00955 0.00955
γRH bundle of His cell-Purkinje myocyte adhe... 2 2 0.00955 0.00955
γRH regulation of ventricular cardiac muscle... 2 2 0.00955 0.00955
γRH cellular response to drug 81 15 0.01040 0.00959
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Bipartite network is anetworkwhere thenodes canbedivided into twodisjoint sets of nodes
such that links connect nodes from the two sets to each other, but never
inside the same set
Bootstrap The basic idea of bootstrapping is that inference about a population from
sample data can be modelled by resampling the sample data and per-
forming inference about a sample from resampleddata. Because thepop-
ulation is unknown, the true error in a sample statistic against its popula-
tion value is unknown. In bootstrap-resamples, the population is in fact
the sample, and this is known; hence the quality of inference of the true
sample from resampled data is measurable
CRISPR/CAS9 It is a genome editing technology, short for clustered regularly interspaced
short palindromic repeats and CRISPR-associated protein 9. This method
is faster, cheaper, more accurate, and more efficient than other exist-
ing genome editing methods, such as transfactions and vectors. it was
adapted from a naturally occurring genome editing system in bacteria,
where it capture snippets of DNA from invading viruses and use them to
create DNA segments known as CRISPR arrays. This allow the bacteria
to "remember" the viruses. And, if the viruses attack again, the bacte-
ria produce RNA segments from the CRISPR arrays to target the viruses’
DNA.Thebacteria thenuseCas9or a similar enzyme tocut theDNAapart,
which disables the virus. In the lab, the CRISPR-Cas9 system works simi-
larly. A small piece of RNA is created. It contains a short guide sequence
that binds to a specific target sequence ofDNA in a genome. TheRNAalso
binds to the Cas9 enzyme. and it is used to recognise the DNA sequence,
and theCas9 enzymecuts theDNAat the targeted location. Once theDNA
is cut, the cell’s uses its ownDNA repairmachinery to add or delete pieces
of genetic material, or to make changes to the DNA by replacing an exist-
ing segment with a customised DNA sequence
26 Glossary
Degree is the number of nodes each node interacts with
Direction The direction of a link specifies the source (starting point) and a target
(endpoint) where the interaction occurs
Edge Connection between two graph vertices
Gene The fundamental physical and functional unit of inheritance. They are
parts of Deoxyribonucleic Acid (DNA) sequence. Genes can be a recipe
for constructing proteins, but not all genes code for proteins. They vary
a lot in size, in humans, genes can be few hundred DNA base pair (bp) to
more than 2 million bases. The Human Genome Project estimated that
humans have around 20, 000 and 25, 000 genes
Genome The complete set of genes or genetic material present in an organism
Global measures Aremeasures that describe the whole network, for example degree distri-
bution; average clustering coefficient; path length; modularity index.
Hub nodes with the with a much large degree compared with the average de-
gree value
Link Connection between two network nodes
Local measures Are characteristics of individual nodes of a network, such as their degree
and centrality
Microarray A chip containing spots where DNA is attached. The amount of cDNA
that hybridises to theDNAof the array can bemeasured by a fluorescence
emission
Node The fundamental unity in a network
Pipeline A set of data processing tools plugged in series, where the output of one
tool is the input of the next one
Replication The process that the DNA copies itself into a DNAmolecule
Strength The strength of a node is the sum of the weights attached to links belong-
ing to a node
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Transcription The process that the DNA copies its information into an RNAmolecule
Transcriptome The complete set of transcripts present in an cell. It is the major determi-
nant of a cellular phenotype
Translation The process that mRNA information is translated into a chain of
aminoacids, that later is processed into a protein
Vertex The fundamental unity in a graph







Bioinformatician and Statistician with a solid background in Biotechnology. Extensive ex-
perience with Big Data, transcriptomics and developing methods for construction and com-
parison of biological networks. Passionate about complex systems biology. Independent
Consultant for statistics in Medical Science. Developed and implemented public available
R packages. Organized, communicative, creative and fast learner with outstanding writ-
ing skills. Works well in teams and alone. Fluent in English and Portuguese, proficient in
Spanish an German.
Experience
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Candidate at the Bioinformatics and Swarm Intelligence and Op-
timization groups, studying the evolution of cognition in primates
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Prof. Dr. Martin Middendorf, PhD and Prof. Dr. Peter Stadler,
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of links). Supervisor: Prof. Dr. Eivind Almaas, PhD.
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Sao Paulo, Brazil
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sible for modeling Auto Finance portfolio origination and mainte-
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11/2011 – 05/2012 Internship HSBC Multiply Bank, Curitiba, Brazil
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08/2011 - 11/2011 Internship Advanced Group in Animal Breeding, Curitiba, Brazil
Development of statistical methods for breeding selection of
horses from the Military Police, with better features related with
equestrian activities such as running.
02/2011 - 06/2011 Internship Laboratory of extra-cellular matrix protein biochemistry and poison
biotechnology - UFPR, Curitba, Brazil
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rification of DNA and proteins, sequencing, vector preparation,
strains transformation for expression assays using recombining
proteins of the Loxoceles intermedia venom.
07/2010 - 12/2010 Internship Department of Statistics - UFPR, Curitiba, Brazil
Developments of statistical skills in quality control, population
structures and linkage disequilibrium using databases for ge-
nomic studies using SNP chips for Genome Wide Association
Analysis (GWAS).
Education
10/2015 - Now PhD in Computer Science - Bioinformatics Leipzig University
Development of measures for comparing multiple co-expression
networks build using transcriptomics data. Pre-processing, pro-
cessing and quality control of transcriptome arrays and RNAseq.
Supervisors: Prof. Dr. Katja Nowick - Freie Universitaet Berlin
; Prof. Dr. Martin Middendorf - Leipzig University and Prof. Dr.
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ology Course Free University of Berlin
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ology Course Leipzig University
2017 Basic Statistics at 6th Programming for Evolutionary Biology
Course Leipzig University
2016 Teaching Assistant at 5th Programming for Evolutionary Bi-
ology Course Leipzig University
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Submitted. 2019.
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2019.
5. Geffre, A. ;Gernat, T. ;Toth, A. ; Robinson, G.; Bonning, B. ; Hamilton, A.; Jones, B. ;
Gysi; D. M.; Dolezal. A. Pathogen manipulation in the Anthropocene: Viruses of
managed honey bees alter host social behaviour. In preparation, 2019.
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1. Gysi, D. M.; Fragoso, T. M.; Almaas E.; Nowick, K. Co-expression Differential Net-
work Analysis, XXIX International Biometric Conference, 2018.
2. Gysi, D. M.; Fragoso, T. M.; Almaas E.; Nowick, K. Comparing multiple co-expression
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overlap networks, XIV Herbstseminar der Bioinformatik, 2016.
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functions in primates, XIII Herbstseminar der Bioinformatik, 2015.
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1. Gysi, D. M.; Fragoso, T. M. ; Almaas, E. ; Nowick, K. How to build and compare
co-expression networks, BenGenDiv, Berlin, 2018.
2. Gysi, D. M.; Voigt, A. ; Fragoso, T. M. ; Almaas, E. ; Nowick, K. An R package for
calculating the Weighted Topological Overlap Network with a visualization tool,
CompleNet’18, Boston, 2018.
3. Gysi, D. M.; Voigt, A. ; Fragoso, T. M. ; Almaas, E. ; Nowick, K. wTO, an R pack-
age for computing the weighted Topological Overlap and Consensus Networks,
NORBIS annual conference, Tromso, 2017.
4. Kutsche, L. K.; Gysi, D. M.; Lenk, K.; Petri, R.; Jakobsson, J.; Nowick, K.; Busskamp,
V. A systems level view on miR-124 function during neuronal differentiation from
human iPS cells, Intelligent Systems for Molecular Biology, Prague, 2017.
5. Kutsche, L. K.; Gysi, D. M.; Lenk, K.; Petri, R.; Jakobsson, J.; Nowick, K.; Busskamp,
V. A systems level view on miR-124 function during neuronal differentiation from
human iPS cells, Gene regulatory mechanisms in neural fate decisions, San Juan
de Alicante, 2017.
6. Bertoli, W; Gysi, D. M.. Bayesian Estimation of the Zero-Inflated quasi Poisson-
Lindley Model, 4th Workshop on Probabilistic and Statistical Methods, 2016, Sao
Carlos, Brazil.
7. Gysi, D. M.; Pilar, P. G.; Giolo, S. R. Modelo de Sobrevivência com Fração de
Cura Aplicado aos Dados de Pacientes com Câncer de Colo do Útero, IV WASA
- Workshop em Analise de Sobrevivência e Aplicações, 2015, Belo Horizonte.
8. Bertoli, W.; Gysi, D. M. Métodos Estatísticos na Análise de Dados Genômicos,
Workshop on Probabilistic and Statistical Methods, São Carlos, 2013.
9. Gysi, D. M.; Pilar, P. G.; Giolo, S. R. Análise da sobrevida de pacientes com câncer
do colo do útero, XIII Escola de Modelos de Regressão, Maresias, 2013.
10. Gysi, D. M.; Giolo, S. R. Metodologias Estatísticas Aplicadas à Genética Quan-
titativa e Genômica. Encontro de Iniciação Científica da UFPR, 2012, Curitiba.
Caderno de Resumos Evinci, 2012.
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11. Bertoli, W.; Gysi, D. M. Análise de Componentes Principais Para Obtenção de
Grupos de SNPs Informativos. VI Bienal da Sociedade Brasileira de Matemática,
2012, Campinas. Anais da VI Bienal da Sociedade Brasileira de Matemática, 2012.
12. Gysi, D. M.; Giolo, S. R. Estatística Computacional em Genética Quantitativa e
Genômica. Encontro de Iniciação Científica da UFPR, 2011, Curitiba. Caderno de
Resumos Evinci, 2011.
13. Gysi, D. M.; Rakin, S.; Saez, R. Elaboração de um banco de Dados de DNA de
pacientes com fissura lábio palatina não sindrômica. XVIII Seminário de Iniciação
Científica - PUC–PR, 2010, Curitiba. XVIII Seminário de Iniciação Científica. Editora
Champanag, 2010.
14. Novelino, A.; Rakin, S.; Gysi, D. M.; Saez, R.; Grabowski, M.; Souza, J. Elaboração
de banco de DNA de pacientes com fissuras labiopalatais. XVII Seminário de
Iniciação Científica - PUC–PR, V PIBIC Jr., XII Mostra de Pesquisa, II SPPGEM,
Curitiba, 2009.
15. Gysi, D. M.; Rakin, S.; Saez, R.; Grabowski, M.; Souza, J.; Novelino, A. Elaboração
de banco de dados epidemiológico, clínico, e genético de pacientes com fis-
suras labiopalatais. XVII Seminário de Iniciação Científica, V PIBIC Jr., XII Mostra
de Pesquisa, II SPPGEM, Curitiba, 2009.
Undergraduate research
08/2010 - 07/2012 Statistical Methodologies Applied to Quantitative Genetics
and Genomics Federal University of Parana
Development of statistical models for associating genes with dis-
eases via robust statistical methodologies. Finding associated
Single Nucleotide Polymorphims associated with diseases, cor-
recting by population structures. Supervisor: Suely Ruiz Giolo,
PhD.
08/2008 - 07/2010 Preparation of a DNA bank from patients with Cleft-LipPontifi-
cal Catholic University of Parana
Acquisition of knowledge in the laboratory, in the field of molecular
biology. Extraction, sample preparation of DNA, PCR, prepara-
tion of reagents and chemical solvents. The computational part
of this project focused on the creation, development and main-
tenance of a database (development in Access). Supervisor:
Salmo Raskin, PhD.
Honors & Awards
04/2015 - 09/2015 German Course DAAD
Fellowship awarded for a 6 months course of German language.
10/2015 - now PhD Science without borders - CNPq
Fellowship awarded for a 36 months PhD in Germany.
2010- 2012 Undergraduate Research fellowship UFPR - CNPq
Fellowship for Undergraduate Research awarded by the Brazilian
Government in partnership with Federal University of Parana
08/2012 First-Place award: Undergraduate Research 20º. Evento de
Iniciação Científica da Universidade Federal do Paraná
Best undergraduate student award at Federal University of
Parana. Thesis: Statistical Methodologies Applied to Quantita-
tive Genetics and Genomics. Supervisor: Suely Giolo, PhD
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08/2011 First-Place award: Undergraduate Research 19º. Evento de
Iniciação Científica da Universidade Federal do Paraná
Best undergraduate student award at Federal University of
Parana. Thesis: Computational Statistics Applied to Quantitative
Genetics and Genomics. Supervisor: Suely Giolo, PhD
2008- 2010 Undergraduate Research fellowship PUCPR - CNPq
Fellowship for Undergraduate Research awarded by the Brazilian
Government in partnership with Pontifical Catholic University of
Parana
Selected Courses and Extensions
2018 - 2018 Scientific Writing Leipzig, Germany.
2018 - 2018 Leadership and working in multiprofessional teams Leipzig,
Germany.
2018 - 2018 4th Summer school in Complex Networks. Como, Italy.
2018 - 2018 Network Meta-Analysis with R. Barcelona, Spain.
2018 - 2018 Summer school of Bioinformatics. USP, Sao Paulo, Brazil.
2017 - 2017 sDIV-working group ``The genomic evolution of key adap-
tive traits - utilizing the potential of non-model organisms
sGENEVA!. Leipzig, Germany.
2017 - 2017 Metabolic pathway analysis. NORBIS, Trondheim, Norway.
2017 - 2017 Large genetic studies in biobanks: GWAS and beyond. NOR-
BIS, Oslo, Norway.
2017 - 2017 Algebraic Statistics Day. Max Plank Institute fuer Matematik, Leipzig,
Germany
2017 - 2017 Workshop Big Data in Business.Universität Leipzig, Leipzig, Germany
2016 - 2016 A beginner's Guide to RNA-Seq Data Analysis Course. ESeq
Bioinformatics, Leipzig, Germany
2013 - 2013 Regression Models with limited and censured response. Uni-
versity of São Paulo, Sao Paulo, Brazil.
2013 – 2013 Statistical Inference using bootstrap and application.University
of São Paulo, Sao Paulo, Brazil.
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2012 - 2012 Modelling Academy HSBC Bank Brazil, Curitiba, Brazil.
2012 - 2012 Statistical modelling for credit risk analysis. Federal University of
São Carlos, São Carlos, Brazil.
2012 - 2012 Non Linear mixed models using R. Fundação de Estudos Agrários
Luiz de Queiroz, Piracicaba, Brazil.
2012 - 2012 Computational Methods in Statistical Inference Federal
University of Parana, Curitiba, Brazil.
2012 - 2012 Mixed Models using R Fundação de Estudos Agrários Luiz de Queiroz,
Piracicaba, Brazil.
2011 - 2011 Introduction to Proteomics Analysis. Federal University of Parana,
Curitiba, Brazil.
2011 - 2011 II Winter school of Biochemistry and molecular biology. Fed-
eral University of Parana, Curitiba, Brazil.
2011 - 2011 Population Genetics. Federal University of Parana, Curitiba, Brazil.
2011 - 2011 Association Studies of Genes with human diseases. Federal
University of Parana, Curitiba, Brazil.
2011 - 2011 IV Winter school of genetics. Federal University of Parana, Curitiba,
Brazil.
2010 - 2010 Pirosequencing: A molecular approach. Federal University of
Parana, Curitiba, Brazil.
2010 - 2010 Genome Wide Association Studies. Federal University of Santa
Catarina, UFSC, Brazil.
2008 - 2008 Research with human embrionary stem cell. Pontifical Catholic
University of Parana, Curitiba, Brazil.
2008 - 2008 Electronic Microscopy. Pontifical Catholic University of Parana, Curitiba,
Brazil.
2008 - 2008 Virus, vaccines and antivirals. Federal University of Parana, Curitiba,
Brazil.
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2018 - now Representative of Caucus women in Statistics German
representative of Women in Statistics.
2017 - now R-Ladies chapter Leader Leipzig leader of the Global R-Ladies.
